Search criteria | ||||
Effectively Leveraging RWD for External Controls: A Systematic Literature Review of Regulatory and HTA Decisions | ||||
Oriol Sola- Morales (1), Lesley H. Curtis (2), Julien Heidt (3),*, Laura Walsh (4), Deborah Casso (5),?, Susan Oliveria (6),?, Patrick Saunders- Hastings (7), Yufei Song (8),?, Tiffany Mercado (3), Robbert Zusterzeel (3),?, Vera Mastey (9), James Harnett (9) and Ruben G. W. Quek (9) | ||||
(1) Fundació Health Innovation Technology Transfer and International, University of Catalonia, Barcelona, Spain; (2) Duke Clinical Research Institute, Durham, North Carolina, USA; (3) IQVIA, Regulatory Science and Strategy, Falls Church, Virginia, USA; (4) IQVIA, Epidemiology and Drug Safety Practice, Boston, Massachusetts, USA; (5) IQVIA, Epidemiology and Drug Safety Practice, Seattle, Washington, USA; (6) IQVIA, Epidemiology and Drug Safety Practice, New York, New York, USA; (7) Epi Excellence LLC, Garnet Valley, Pennsylvania, USA; (8) IQVIA, Epidemiology and Drug Safety Practice, Beijing, China; (9) Regeneron Pharmaceuticals Inc., Health Economics & Outcomes Research, Tarrytown, New York, USA | ||||
Clinical pharmacology and therapeutics vol. 114,2 (2023): 325-355. doi:10.1002/cpt.2914 |
||||
, Article | ||||
, Europe, USA | ||||
Abstract: https://ascpt.onlinelibrary.wiley.com/doi/epdf/10.1002/cpt.2914 | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment, Methodology, Regulatory | 2023 | English | , Review | |
Regulatory and HTA Considerations for Development of Real- World Data Derived External Controls | ||||
Lesley H. Curtis (1), Oriol Sola-Morales (2), Julien Heidt (3),*, Patrick Saunders- Hastings (4), Laura Walsh (5), Deborah Casso (6),?, Susan Oliveria (7),?, Tiffany Mercado (3), Robbert Zusterzeel (3),?, Rachel E. Sobel (8), Jessica J. Jalbert (9), Vera Mastey (9), James Harnett (9) and Ruben G. W. Quek (9) | ||||
1Duke Department of Population Health Sciences and Duke Clinical Research Institute, Durham, North Carolina, USA; 2Fundació HiTT and Universitat Internacional de Catalunya (UIC), Barcelona, Spain; 3IQVIA, Regulatory Science and Strategy, Falls Church, Virginia, USA; 4Epi Excellence LLC, Garnet Valley, Pennsylvania, USA; 5IQVIA, Epidemiology and Drug Safety Practice, Boston, Massachusetts, USA; 6IQVIA, Epidemiology and Drug Safety Practice, Seattle, Washington, USA; 7IQVIA, Epidemiology and Drug Safety Practice, New York, New York, USA; 8Regeneron Pharmaceuticals Inc., Pharmacoepidemiology, Tarrytown, New York, USA; 9Regeneron Pharmaceuticals Inc., Health Economics & Outcomes Research, Tarrytown, New York, USA. | ||||
Clin Pharmacol Ther, 114: 303-315. https://doi.org/10.1002/cpt.2913 |
||||
, Article | ||||
, USA | ||||
Abstract: https://ascpt.onlinelibrary.wiley.com/doi/epdf/10.1002/cpt.2913 | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment, Methodology, Regulatory | 2023 | English | , Review | |
Assessing definitions and incentives adopted for innovation for pharmaceutical products in five high-income countries: a systematic literature review | ||||
Naohiko Wakutsu 1, Emi Hirose 2, Naohiro Yonemoto 3, Sven Demiya 4 (rwesheorj 4) | ||||
1) Graduate School of Economics, Nagoya City University, Nagoya, Japan 2) Health & Value, Pfizer Japan Inc., Tokyo, Japan. emi.hirose@pfizer.com 3) Health & Value, Pfizer Japan Inc., Tokyo, Japan 4) IQVIA Solutions Japan K.K., Tokyo, Japan | ||||
Pharmaceutical Medicine |
||||
, Article | ||||
, France, Germany, Japan, UK, USA | ||||
Abstract: https://link.springer.com/article/10.1007/s40290-022-00457-5 | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous | 2023 | English | , Literature Review | |
Comparison of depression trends in the Japanese and US populations before and during the COVID-19 pandemic: a retrospective observational study using real-world data | ||||
Sven Demiya 1, Shujiro Takeno 1, Louis P. Watanabe 1, Wen Shi Lee 1, Yuri Sakai 1, Todd D. Taylor 1, Seok-Won Kim 1 (rwesheorj 1) | ||||
1) IQVIA Solutions Japan KK, Tokyo Japan | ||||
Value & Outcomes Spotlight |
||||
, Article | ||||
, Japan, USA | ||||
Abstract: https://www.ispor.org/publications/journals/value-outcomes-spotlight/vos-archives/issue/view/mental-health-the-silent-pandemic/comparison-of-depression-trends-in-the-japanese-and-us-populations-before-and-during-the-covid-19-pandemic-a-retrospective-observational-study-using-real-world-data | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2023 | English | , Database Study, Observational study, Retrospective database analysis | |
The emerging role of real-world data in advanced breast cancer therapy: Recommendations for collaborative decision-making | ||||
Paul Cottu 1, Scott David Ramsey 2, Oriol Solà-Morales 3, Patricia A Spears 4, Lockwood Taylor 5 | ||||
1Department of Medical Oncology, Institut Curie, 26 Rue D'Ulm, 75005, Paris, France. Electronic address: paul.cottu@curie.fr. 2Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, M2-B232, Seattle, WA, 98155, USA. Electronic address: sramsey@fredhutch.org. 3Health Innovation Technology Transfer Foundation, Aragó 60, E-08015, Barcelona, Spain. Electronic address: osola@fhitt.org. 48605 Carolingian Court, Raleigh, NC, 27615, USA. Electronic address: paspears88@gmail.com. 5Epidemiology, Real World Solutions at IQVIA, 4820 Emperor Boulevard, Durham, NC, 27703, USA. Electronic address: lockwood.taylor@iqvia.com. | ||||
Breast. 2021 Dec 22;61:118-122. doi: 10.1016/j.breast.2021.12.015. |
||||
, Article | ||||
, France, Italy, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/34959093/ | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment, Drug safety, Oncology, Regulatory | 2022 | English | , Review | |
Georgraphic Variation in the Use of Gabapentinoids and Opioids for Pain in a Commercially Insured Adult Population in the United States | ||||
Danni Zhao, Jonggyu Baek, Anne L Hume, Emily A McPhillips, and Kate L Lapane | ||||
1Department of Population and Quantitative Health Sciences, UMass Chan Medical School, Worcester, MA, USA. 2Department of Family Medicine, Alpert Medical School, Brown University, Memorial Hospital of Rhode Island, Providence, RI, USA. 3Department of Pharmacy Practice, College of Pharmacy, University of Rhode Island, Kingston, RI, USA. | ||||
J Pain Res . 2022 Feb 11;15:443-454. doi: 10.2147/JPR.S345521. eCollection 2022. |
||||
, Article | ||||
, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/35177933/ | ||||
Condition | Year | Language | Analysis type | |
, Drug Utlization Study, Pain | 2022 | English | , Epidemiological study, Observational study, Public Health | |
Validation of safety outcomes in routinely collected data: lessons learned from a multinational post-approval safety study | ||||
Arena PJ, Huang K, Löfling L, Bahmanyar S, Mo J, Schachterle SE, Nunes AP, Smits E, Juuti R, Hoti F, Korhonen P, Adelborg K, Sundbøll J, Rasmussen TR, Løkke A, Ehrenstein V. | ||||
"Pfizer Inc., New York, New York, United States of America. Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California, United States of America. EPID Research (an IQVIA company), Espoo, Finland." | ||||
Pharmacoepidemiol Drug Saf. 2022 Dec 10. doi: 10.1002/pds.5582 |
||||
, Article | ||||
, Denmark, Finland, Netherlands , Sweden, USA | ||||
Abstract: https://onlinelibrary.wiley.com/doi/10.1002/pds.5582 | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Drug safety, Oncology | 2022 | English | , Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Retrospective database analysis | |
Prevalence of depression in Japan and the US populations before and during the COVID-19 pandemic: a retrospective observational study using real-world data | ||||
Demiya S 1, Takeno S 1, Kim SW 2, Lee WS 3, Sakai Y 1 (rwesheorj 1-3) | ||||
1) IQVIA Solutions Japan, Tokyo, Japan 2) IQVIA Solutions Japan, Tokyo, 13, Japan 3) IQVIA Solutions Japan, Tokyo, 12, Japan | ||||
ISPOR Europe |
||||
, Conference, Poster, Presentation | ||||
, Japan, USA | ||||
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2022-3564/119994 | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2022 | English | , Database Study, Retrospective database analysis | |
Leveraging unstructured data to identify hereditary angioedema patients in electronic medical records | ||||
Emily S Brouwer 1 , Emily W Bratton 2 , Aimee M Near 2 , Lynn Sanders 1 , Christina D Mack 2 | ||||
1 Takeda Pharmaceutical Company Limited, 300 Shire Way, Lexington, MA, USA. 2 IQVIA, Durham, NC, USA. | ||||
Allergy Asthma Clin Immunol . 2021 Apr 20;17(1):41. doi: 10.1186/s13223-021-00541-6. |
||||
, Article | ||||
, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/33879228/ | ||||
Condition | Year | Language | Analysis type | |
, Rare disease | 2021 | English | , Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective database analysis | |
Epidemiology of Concussion in the National Football League, 2015-2019 | ||||
Christina D Mack 1, Gary Solomon 2 3, Tracey Covassin 4, Nicholas Theodore 5, Javier Cárdenas 6, Allen Sills 2 3 | ||||
1 IQVIA, Durham, NC, USA. 2 Department of Neurological Surgery and Vanderbilt Sports Concussion Center, Vanderbilt University School of Medicine, Nashville, Tennessee 3 National Football League Player Health and Safety Department, New York, New York 4 Department of Kinesiology, Michigan State University, East Lansing, Michigan 5 Department of Neurological Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland 6 Department of Neurology, Barrow Neurological Institute, Phoenix, Arizona | ||||
Sports Health . 2021 Apr 19;19417381211011446. doi: 10.1177/19417381211011446. |
||||
, Article | ||||
, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/33872087/#:~:text=Results%3A%20A%20total%201302%20concussions,80%25%20occurred%20in%20NFL%20games. | ||||
Condition | Year | Language | Analysis type | |
, Injuries | 2021 | English | , Epidemiological study, Observational study, Retrospective database analysis | |
SARS-CoV-2 Transmission Risk Among National Basketball Association Players, Staff, and Vendors Exposed to Individuals With Positive Test Results After COVID-19 Recovery During the 2020 Regular and Postseason | ||||
Christina D. Mack; John DiFiori; Caroline G. Tai; Kristin Y. Shiue; Yonatan H. Grad; Deverick J. Anderson; David D. Ho; Leroy Sims; Christopher LeMay; Jimmie Mancell; Lisa L Maragakis | ||||
1 IQVIA, Durham, NC, USA (Mack, Tai, Shiue) 2 Hospital for Special Surgery (DiFiori) 3 National Basketball Association, New York, New York (DiFiori, Sims, LeMay) 4 Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts (Grad) 5 Duke Center for Antimicrobial Stewardship and Infection Prevention, Durham, North Carolina (Anderson) 6 Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, New York (Ho) 7 Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee(Mancell) 8 Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland (Maragakis) | ||||
JAMA Intern Med. Published online April 22, 2021. doi:10.1001/jamainternmed.2021.2114 |
||||
, Article | ||||
, USA | ||||
Abstract: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2779287 | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2021 | English | , Epidemiological study, Observational study, Retrospective database analysis | |
How well can we assess the validity of non-randomised studies of medications? A systematic review of assessment tools | ||||
Elvira D'Andrea, Lydia Vinals, Elisabetta Patorno, Jessica M. Franklin, Dimitri Bennett , Joan A. Largent, Daniela C. Moga, Hongbo Yuan, Xuerong Wen, Andrew R. Zullo, Thomas P. A. Debray, Grammati Sarri | ||||
D'Andrea: Harvard; Largent: IQVIA | ||||
http://orcid.org/0000-0002-5263-3964PubMed articles |
||||
, Article | ||||
, Europe, USA | ||||
Abstract: https://bmjopen.bmj.com/content/11/3/e043961 | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2021 | English | , Literature Review | |
Framework for the synthesis of non-randomised studies and randomised controlled trials: a guidance on conducting a systematic review and meta-analysis for healthcare decision making | ||||
Grammati Sarri 1, Elisabetta Patorno 2, Hongbo Yuan 3, Jianfei Jeff Guo 4, Dimitri Bennett 5, Xuerong Wen 6, Andrew R Zullo 7, Joan Largent 8, Mary Panaccio 9, Mugdha Gokhale 10, Daniela Claudia Moga 11, M Sanni Ali 12 13 14, Thomas P A Debray 15 16 | ||||
1Real World Evidence Sciences, Visible Analytics Ltd, Oxford, UK grammati.sarri@visibleanalytics.co.uk. 2Division of Pharmacoepidemiology and Pharmacoeconomics, Dept. of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. 3Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa, Ontario, Canada. 4Department of Pharmacy Practice & Administrative Sciences, University of Cincinnati College of Pharmacy, Cincinnati, Ohio, USA. 5Takeda, Cambridge, Massachusetts, USA. 6Pharmacy Practice, College of Pharmacy, University of Rhode Island, Kingston, Rhode Island, USA. 7Health Services, Policy, and Practice, Brown University, Providence, Rhode Island, USA. 8Real-World Solutions, IQVIA, California, Colorado, USA. 9Epidemiology and Outcomes Research, Research Outcomes Innovations LLC, New York City, New York, USA. 10GlaxoSmithKline USA, Philadelphia, Pennsylvania, USA. 11University of Kentucky, Department of Pharmacy Practice and Science, Lexington, Kentucky, USA. 12NDORMS, Center for Statistics in Medicine, University of Oxford, Oxford, UK. 13Department of Non-communicable Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine (LSHTM), London, UK. 14Department of Public Heath, Environments and Society, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine (LSHTM), London, UK. 15Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands. 16Smart Data Analysis and Statistics, Utrecht, The Netherlands. | ||||
PMID: 33298465 DOI: 10.1136/bmjebm-2020-111493 |
||||
, Article | ||||
, Europe, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/33298465/ | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2021 | English | , Literature Review | |
Risk Factors and Medical Resource Utilization of Respiratory Syncytial Virus, Human Metapneumovirus and Influenza Related Hospitalizations in Adults – A Global Study During the 2017-2019 Epidemic Seasons (Hospitalized Acute Respiratory Tract Infection [HARTI] Study) | ||||
Ann R Falsey, Edward E Walsh, Stacey House, Yannick Vandenijck, Xiaohui Ren, Sofia Keim, Diye Kang, Pascale Peeters, James Witek, Gabriela Ispas | ||||
University Of Rochester School Of Medicine and Rochester Regional Health, Rochester, NY, United States; Washington University School of Medicine, St Louis, MO, United States; Janssen Infectious Diseases, Beerse, Belgium; IQVIA Real-World Solutions, Courbevoie, France; Janssen Research & Development, LLC, Titusville, NJ, United States | ||||
, Article | ||||
, Argentina, Australia, Brazil, Canada, France, Germany, Japan, Korea, Malaysia, Mexico, South Africa, USA | ||||
Abstract: https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofab491/6381446 | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2021 | English | , Burden of illness, Clinical setting: hospital, Epidemiological study, Observational study, Patient questionnaire, Prospective study | |
Impact of lurasidone and other antipsychotics on body weight: real-world, retrospective, comparative study of 15,323 adults with schizophrenia | ||||
Pochiero I, Calisti F, Comandini A, Del Vecchio A, Costamagna I, Rosignoli MT, Cattaneo A, Nunna S, Peduto I, Heiman F, Chang H, Chen C, Correll C | ||||
Pochiero I: Angelini Regulatory, Research & Development, Angelini Pharma S.p.A., Rome, Italy; Peduto I and Heiman F: IQVIA Solutions Italy Srl, RWS | ||||
Int J Gen Med. 2021 Jul 31;14:4081-4094. doi: 10.2147/IJGM.S320611. PMID: 34366678; PMCID: PMC8336993. |
||||
, Article | ||||
, Italy, USA | ||||
Abstract: https://www.dovepress.com/impact-of-lurasidone-and-other-antipsychotics-on-body-weight-real-worl-peer-reviewed-fulltext-article-IJGM | ||||
Condition | Year | Language | Analysis type | |
, Mental health, Metabolic Disorders | 2021 | English | , Clinical setting: Primary care, Epidemiological study, Retrospective database analysis | |
Prevalence of prescription opioid use during pregnancy in eight US health plans during 2001-2014 | ||||
Pocobelli G, Dublin S, Bobb JF, Albertson-Junkans L, Andrade S, Cheetham TC, Salgado G, Griffin MR, Raebel MA, Smith D, Li DK, Pawloski PA, Toh S, Taylor LG, Hua W, Horn P, Trinidad JP, Boudreau DM | ||||
"L Taylor: EPI OR, RWS, IQVIA; 1Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA. 2Meyers Primary Care Institute, Worcester, Massachusetts, USA. 3Kaiser Permanente Southern California, Department of Research & Evaluation, Pasadena, CA, Chapman University, School of Pharmacy, Irvine, CA, USA. 4Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee, USA. 5Institute for Health Research, Kaiser Permanente Colorado, Colorado, USA. 6Kaiser Permanente Center for Health Research, Portland, Oregon, USA. 7Kaiser Foundation Research Institute, Oakland, California, USA. 8Health Partners Institute, Bloomington, Minnesota, USA. 9Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA. 10Food and Drug Administration, Silver Spring, Maryland, USA." | ||||
Pharmacoepidemiol Drug Saf. 2021 Nov;30(11):1541-1550. doi: 10.1002/pds.5312. |
||||
, Article | ||||
, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/34169607/ | ||||
Condition | Year | Language | Analysis type | |
, Drug Utlization Study, Womens Health | 2021 | English | , Epidemiological study, Population Based Study | |
Validation of an ICD-10-based algorithm to identify stillbirth in the Sentinel System | ||||
Andrade SE, Shinde M, Moore Simas TA, Bird ST, Bohn J, Haynes K, Taylor LG, Lauring JR, Longley E, McMahill-Walraven CN, Trinacty CM, Saphirak C, Delude C, DeLuccia S, Zhang T, Cole DV, DiNunzio N, Gertz A, Fazio-Eynullayeva E, Stojanovic D | ||||
"1The Meyers Primary Care Institute, a joint endeavor of the University of Massachusetts Medical School, Reliant Medical Group, and Fallon Health, University of Massachusetts Medical School, Worcester, Massachusetts, USA. 2Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Massachusetts, USA. 3Department of Obstetrics and Gynecology, University of Massachusetts Medical School/UMass Memorial Health Care, Worcester, Massachusetts, USA. 4Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA. / L Taylor - IQVIA - RWS 5Department of Scientific Affairs, HealthCore, Inc., Wilmington, Delaware, USA. 6Community Health Care Family Medicine Residency, Tacoma, Washington, USA. 7CVS Health Clinical Trial Services, Part of the CVS Health Family of Companies, Blue Bell, Pennsylvania, USA. 8Kaiser Permanente Center for Integrated Health Care Research Hawaii and Office of Public Health Studies, University of Hawai'i Manoa, Honolulu, Hawaii, USA." | ||||
"Pharmacoepidemiol Drug Saf. 2021 Sep;30(9):1175-1183. doi: 10.1002/pds.5300. Epub 2021 Jun 11. PMID: 34089206" |
||||
, Article | ||||
, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/34089206/ | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Womens Health | 2021 | English | , Epidemiological study, Retrospective database analysis | |
Incorporating patient generated health data into pharmacoepidemiological research. Pharmacoepidemiology and Drug Safety. | ||||
Alison Bourke 1, William G Dixon 2, Andrew Roddam 3, Kueiyu Joshua Lin 4, Gillian C Hall 5, Jeffrey R Curtis 6, Sabine N van der Veer 7, Montse Soriano-Gabarró 8, Juliane K Mills 9, Jacqueline M Major 10, Thomas Verstraeten 11, Matthew J Francis 12, Dorothee B Bartels 13 | ||||
1Real World Solutions, IQVIA, London, UK. 2Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, UK. 3Data & Computational Sciences, GSK, London, UK. 4Brigham and Women's & Department of Medicine, Boston, Massachusetts, USA. 5Gillian Hall Epidemiology Ltd, London, UK. 6Division of Clinical Immunology & Rheumatology, The University of Birmingham, Birmingham, Alabama, USA. 7Centre for Health Informatics, Division of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK. 8Bayer AG, Berlin, Germany. 9PRA Health Sciences, Raleigh, North Carolina, USA. 10Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA. 11P95 Pharmacovigilance and Epidemiology, Leuven, Belgium. 12The Procter & Gamble Company, Cincinnati, Ohio, USA. 13UCB Pharma, Anderlecht, Belgium. | ||||
Pharmacoepidemiol Drug Saf . 2020 Dec;29(12):1540-1549. doi: 10.1002/pds.5169. Epub 2020 Nov 13. |
||||
, Article | ||||
, Belgium, Germany, UK, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/33146896/ | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Health status & patient reported outcomes, Patient Registries & Real-World Study Methods | 2021 | English | , Patient questionnaire, Review | |
Modernizing Oncology Approvals | ||||
Christina Mack | ||||
CAEG | ||||
PharmaVoice. 2021 Mar |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.pharmavoice.com/news/2021-03-modernizing-oncology-approvals/612107/ | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2021 | English | , clinical setting: Secondary care | |
Real-world evidence to support regulatory decision making: New or expanded medical product indications | ||||
Franklin JM, Liaw KL, Iyasu S, Critchlow CW, Dreyer NA. | ||||
1Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. 2Center for Observational and Real-world Evidence, Merck & Co., Inc, Kenilworth, New Jersey, USA. 3Research & Development Strategy and Operations, Amgen, Thousand Oaks, California, USA. 4Real World Solutions, IQVIA, Cambridge, Massachusetts, USA. | ||||
Pharmacoepidemiol Drug Saf . 2021 Jun;30(6):685-693. doi: 10.1002/pds.5222. Epub 2021 Mar 18. |
||||
, Article | ||||
, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/33675248/ | ||||
Condition | Year | Language | Analysis type | |
, Guidelines, Regulatory | 2021 | English | , Real World Data, Real World Evidence | |
Breaking barriers: studying fracture healing in the BONES program. | ||||
Christina D Mack 1, Alessandra Pavesio 2, Kim Kelly 2, Debra E Irwin 3, Greg Maislin 4, John Jones 2, Tawana Wester 2, Robert Zura 5 | ||||
1IQVIA Real-World Solutions, Durham, NC. 2Research & Development, Bioventus, Durham, NC. 3IBM Watson Health, Wynnewood, PA. 4Biomedical Statistical Consulting, Wynnewood, PA; and. 5Department of Orthopaedics, Louisiana State University Health Sciences Center, New Orleans, LA. | ||||
J Orthop Trauma . 2021 Mar 1;35(Suppl 1):S22-S27. doi: 10.1097/BOT.0000000000002035. |
||||
, Article | ||||
, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/33587543/ | ||||
Condition | Year | Language | Analysis type | |
, Orthopedics | 2021 | English | , Clinical setting: Primary care, Epidemiological study, Observational study | |
Comparison of ICD-9-CM to ICD-10-CM Crosswalks Derived by Physician and Clinical Coder vs. Automated Methods | ||||
Jason C Simeone, Xinyue Liu, Tarun Bhagnani, Matthew W Reynolds, Jenna Collins, Edward A Bortnichak | ||||
CAEG | ||||
Perspective Health Information Management 2021 Mar 15;18(Spring):1e. |
||||
, Article | ||||
, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/34035786/ | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2021 | English | ||
Bridging the Gap Between RCTs and RWE Through Endpoint Selection | ||||
Robert J LoCasale 1, Chris L Pashos 2, Ben Gutierrez 3, Nancy A Dreyer 4, Toby Collins 5, Alan Calleja 5, Michael J Seewald 6, Jonathan M Plumb 7, Johan Liwing 8, Maurille Feudjo Tepie 9, Sajan Khosla 10 | ||||
1Real World Evidence, Sanofi, Bridgewater, NJ, USA. 2AbbVie, Chicago, IL, USA. 3GSK, Philadelphia, PA, USA. 4IQVIA, Real-World Solutions, Cambridge, MA, USA. 5IQVIA, Real-World Solutions, London, UK. 6Novartis Pharma AG/Pharma Medical Affairs, Basel, Switzerland. 7Ferring Pharmaceuticals SA, St Prex, Switzerland. 8CellProtect Nordic Pharmaceuticals, Stockholm, Sweden. 9Center for Observational Research, Amgen, Cambridge, UK. 10Real-World Evidence Center of Excellence, AstraZeneca, Cambridge, UK. sajan.khosla@astrazeneca.com. | ||||
Ther Innov Regul Sci . 2021 Jan;55(1):90-96. doi: 10.1007/s43441-020-00193-5. Epub 2020 Jul 6. |
||||
, Article | ||||
, USA | ||||
Abstract: https://doi.org/10.1007/s43441-020-00193-5 | ||||
Condition | Year | Language | Analysis type | |
, Regulatory | 2021 | English | , Real World Data, Real World Evidence | |
When Can We Trust Real-World Data To Evaluate New Medical Treatments? | ||||
Gregory E Simon 1, Andrew B Bindman 2, Nancy A Dreyer 3, Richard Platt 4, Jonathan H Watanabe 5, Michael Horberg 6, Adrian Hernandez 7, Robert M Califf 8 | ||||
1Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA. 2Kaiser Foundation Health Plan and Hospitals, Redwood City, California, USA. 3IQVIA Real World Solutions, Durham, North Carolina, USA. 4Harvard Pilgrim Health Care Institute and Harvard Medical School, Hartford, Connecticut, USA. 5University of California Irvine School of Pharmacy and Pharmaceutical Sciences, Irvine, California, USA. 6Kaiser Permanente Mid-Atlantic Permanente Research Institute and Mid-Atlantic Permanente Medical Group, Rockville, Maryland, USA. 7Duke Clinical Research Institute, Durham, North Carolina, USA. 8Verily Life Sciences and Google Health, South San Francisco, California, USA. | ||||
Clinical Pharmacology & Therapeutics 2022; 111(1):24-29, 2022/1 |
||||
, Article | ||||
, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/33932030/ | ||||
Condition | Year | Language | Analysis type | |
, Regulatory | 2021 | English | , Real World Data | |
When Can Nonrandomized Studies Support Valid Inference Regarding Effectiveness or Safety of New Medical Treatments? | ||||
Jessica M Franklin 1 2, Richard Platt 3, Nancy A Dreyer 4, Alex John London 5, Gregory E Simon 6, Jonathan H Watanabe 7, Michael Horberg 8, Adrian Hernandez 9, Robert M Califf 10 | ||||
1Optum Epidemiology, Boston, Massachusetts, USA. 2Division of Pharmacoepidemiology & Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. 3Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, Massachusetts, USA. 4IQVIA Real World Solutions, Cambridge, Massachusetts, USA. 5Philosophy Department & Center for Ethics and Policy, Carnegie Mellon University, Pittsburgh, Pennsylvania, USA. 6Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA. 7School of Pharmacy and Pharmaceutical Sciences, University of California Irvine, Irvine, California, USA. 8Kaiser Permanente Mid-Atlantic Permanente Research Institute and Mid-Atlantic Permanente Medical Group, Bethesda, Maryland, USA. 9Duke Clinical Research Institute, Durham, North Carolina, USA. 10Verily Life Sciences and Google Health, Cambridge, Massachusetts, USA. | ||||
Clinical Pharmacology & Therapeutics. 2021 Apr 7. |
||||
, Article | ||||
, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/33826756/ | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2021 | English | , Real World Data | |
Uncontrolled Extensions of Clinical Trials and the Use of External Controls–scoping opportunities and methods. | ||||
Ching-Yu Wang 1, Jesse A Berlin 2, Barry Gertz 3, Kourtney Davis 4, Jie Li 5, Nancy A Dreyer 6, Wei Zhou 7, John D Seeger 8, Nancy Santanello 9, Almut G Winterstein 1 | ||||
1Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety, University of Florida, Gainesville, Florida, USA. 2Epidemiology, Johnson & Johnson, Titusville, New Jersey, USA. 3Blackstone Life Sciences, Cambridge, Massachusetts, USA. 4Global Epidemiology, Janssen R&D, Titusville, New Jersey, USA. 5US Food and Drug Administration, Silver Spring, Maryland, USA. 6Real-World Solutions, IQVIA, Cambridge, Massachusetts, USA. 7Merck & Co., Inc., Kenilworth, New Jersey, USA. 8Optum, Boston, Massachusetts, USA. 9Pharmacoepidemiology Consultant, New Hope, Pennsylvania, USA. | ||||
Clinical Pharmacology & Therapeutics. 2021 Jun 24. |
||||
, Article | ||||
, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/34165790/ | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2021 | English | , Real World Data | |
Modernizing Regulatory Evidence with Trials and Real-World Studies | ||||
Nancy A. Dreyer PhD, MPH, FISPE, Marni Hall PhD, MPH & Jennifer B. Christian PharmD, MPH, PhD, FISPE | ||||
IQVIA Real World Solutions, 201 Broadway, 5th Floor, Cambridge, MA, 02139, USA Nancy A. Dreyer PhD, MPH, FISPE IQVIA Real-World Solutions, Rockville, MD, USA Marni Hall PhD, MPH IQVIA Real World Solutions, Research Triangle Park, NC, USA Jennifer B. Christian PharmD, MPH, PhD, FISPE | ||||
Ther Innov Regul Sci (2020). https://doi.org/10.1007/s43441-020-00131-5 |
||||
, Article | ||||
, USA | ||||
Abstract: https://link.springer.com/article/10.1007%2Fs43441-020-00131-5 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2020 | English | , Retrospective database analysis | |
Use of Low Density Lipoprotein-Lowering Therapies Before and After PCSK9 Inhibitors (PCSK9i) Initiation | ||||
Rymer JA, Mues KE, Monda KL, Bratton EW, Wirtz HS, Okerson T, Overman RA, Brookhart MA, Muntner P, Wang TY | ||||
From the Duke Clinical Research InstituteDurham NC (J.A.R., T.Y.W.); Center for Observational ResearchAmgen IncThousand Oaks CA (K.E.M., K.L.M., H.S.W., T.O.); IQVIA, Real‐World Evidence SolutionsDurham NC (E.W.B.); NoviSci, IncDurham NC (R.A.O., M.A.B.); University of North Carolina at Chapel HillChapel Hill NC (M.A.B.); Department of EpidemiologyUniversity of Alabama at BirminghamAL (P.M.). | ||||
Originally published24 Apr 2020https://doi.org/10.1161/JAHA.119.014347Journal of the American Heart Association. ;0:e014347 |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ahajournals.org/doi/10.1161/JAHA.119.014347 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Medication compliance | 2020 | English | , Epidemiological study | |
High clinician- and patient-reported satisfaction with individualized onabotulinumtoxinA treatment for spasticity across several etiologies from the ASPIRE study | ||||
Gerard E.Franciscoa; Daniel S.Bandari; Ganesh Bavikattec; Wolfgang H.Jost; Emily McCusker; Joan Largent; Alekse Zuzek; Alberto Esquenazi | ||||
a The University of Texas Health Science Center McGovern Medical School and TIRR Memorial Hermann, Houston, TX, USA b Multiple Sclerosis Center of California & Research Group, Newport Beach, CA, USA c The Walton Centre, Liverpool, UK d University of Freiburg, Department of Neurology, Freiburg im Breisgau, Germany e Parkinson-Klinik Ortenau, Wolfach, Germany f Allergan, an AbbVie Company, Irvine, CA, USA g IQVIA Real-World Evidence Solutions, Cambridge, MA, USA h MossRehab Gait and Motion Analysis Laboratory, Elkins Park, PA, USA | ||||
PM R . 2020 Jan 17. doi: 10.1002/pmrj.12328. PMID: 31953896 DOI: 10.1002/pmrj.12328 |
||||
, Article | ||||
, Asia Pacific, Europe, USA | ||||
Abstract: https://www.sciencedirect.com/science/article/pii/S2590171020300187?via%3Dihub | ||||
Condition | Year | Language | Analysis type | |
, Drug Utlization Study, Medication compliance | 2020 | English | , Methodology, Observational study | |
Who owns patient data? The answer is not that simple | ||||
Alison Bourke, Georgina Bourke | ||||
Scientific Director, Centre of Advanced Evidence Generation, IQVIA, and Past President of the International Society for Pharmacoepidemiology. Designer and Strategist at Projects by IF, a technology studio that focuses on the ethical and practical uses of data and AI. | ||||
BJMOpinion August 6, 2020 |
||||
, Article | ||||
, UK, USA | ||||
Abstract: https://blogs.bmj.com/bmj/2020/08/06/who-owns-patient-data-the-answer-is-not-that-simple/ | ||||
Condition | Year | Language | Analysis type | |
, COVID-19, Health policy | 2020 | English | , Market impact | |
Replication of randomized clinical trial results using real-world data: paving the way for effectiveness decisions | ||||
Kristin M Sheffield , Nancy A Dreyer , James F Murray, Douglas E Faries & Megan N Klopchin | ||||
1Global Patient Outcomes & Real World Evidence, Eli Lilly & Company, Indianapolis, IN 46225, USA 2IQVIA Real-World & Analytic Solutions, Cambridge, MA 02139, USA 3Real World Analytics, Eli Lilly & Company, Indianapolis, IN 46225, USA | ||||
Published Online:11 Sep 2020https://doi.org/10.2217/cer-2020-0161 |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.futuremedicine.com/doi/10.2217/cer-2020-0161 | ||||
Condition | Year | Language | Analysis type | |
, Drug safety, Drug Utlization Study, Guidelines, Methodology, Public Health | 2020 | English | , Methodology, Observational study, Population Based Study | |
Combatting COVID-19 With Real-World Evidence | ||||
Jennifer B. Christian, PharmD, MPH, PhD , Matthew W. Reynolds, PhD | ||||
Jennifer B. Christian, PharmD, MPH, PhD, is vice president of Clinical Evidence & Epidemiology, Real World Solutions, IQVIA Matthew W. Reynolds, PhD, is vice president, Real World Evidence, IQVIA | ||||
AJMC.org (UVPM: 137,786) September 7, 2020 Jennifer B. Christian, PharmD, MPH, PhD , Matthew W. Reynolds, PhD |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ajmc.com/view/combatting-covid-19-with-real-world-evidence | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2020 | English | , Burden of illness, direct to patient research, Methodology | |
Comparison of Laboratory and On-Field Performance of American Football Helmets | ||||
Ann M Bailey 1, Timothy L McMurry 2, Joseph M Cormier 3, James R Funk 3, Jeff R Crandall 3, Christina D Mack 4, Barry S Myers 5, Kristy B Arbogast 6 | ||||
1 Biomechanics Consulting and Research, LLC, Charlottesville, VA, USA. abailey@bicorellc.com. 2 Department of Public Health Sciences, University of Virginia, Charlottesville, VA, USA. 3 Biomechanics Consulting and Research, LLC, Charlottesville, VA, USA. 4 IQVIA, Durham, NC, USA. 5 Department of Biomedical Engineering, Duke University, Durham, NC, USA. 6 Center for Injury Research and Prevention, Children's Hospital of Philadelphia, Pennsylvania, USA. | ||||
PMID: 33025320 DOI: 10.1007/s10439-020-02627-5 |
||||
, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/33025320/ | ||||
Condition | Year | Language | Analysis type | |
, Injuries | 2020 | English | , Clinical setting: Primary care, direct to patient research, Machine Learning/Artificial Intelligence, Observational study, Public Health | |
Sports Performance and Injury Research: Methodologic Limitations and Recommendations for Future Improvements | ||||
Travis G.MaakM.D.ab Christina D.MackPh.D., MSPHacBrian J.ColeMD, M.B.A.adMackenzie M.HerzogPh.D, M.P.HacJohnDifioriM.D., F.A.M.S.S.M.aPeterMeiselM.S.P.H.a | ||||
a National Basketball Association, Research Committee, U.S.A. b Department of Orthopaedics, University of Utah, Salt Lake City, Utah, U.S.A. c IQVIA Real-World Solutions, Research Triangle Park, Durham, North Carolina, U.S.A. d Midwest Orthopaedics at Rush, Rush University Medical Center, Chicago, Illinois, U.S.A. | ||||
https://doi.org/10.1016/j.arthro.2020.08.038 |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.sciencedirect.com/science/article/pii/S0749806320307398 | ||||
Condition | Year | Language | Analysis type | |
, Injuries | 2020 | English | , Clinical setting: Primary care, Cost of illness, direct-to-patient research, Machine Learning/Artificial Intelligence, Market impact, Methodology | |
Incidence of Lower Extremity Injury in the National Football League: 2015 to 2018 | ||||
Christina D. Mack, PhD, MSPH*, †, Richard W. Kent, PhD‡, Michael J. Coughlin, MD§, ‖, Kristin Y. Shiue, MPH†, Leigh J. Weiss, PT, DPT, ATC¶, James R. Jastifer, MD#, **, Edward M. Wojtys, MD††, Robert B. Anderson, MD‡‡on behalf of the NFL Musculoskeletal Committee | ||||
†IQVIA Real World Solutions, Research Triangle Park, North Carolina, USA ‡Center for Applied Biomechanics, University of Virginia, Biomechanics Consulting & Research (Biocore), Charlottesville, Virginia, USA §University of California, San Francisco, San Francisco, California, USA ‖Coughlin Foot and Ankle Clinic, Saint Alphonsus Hospital, Boise, Idaho, USA ¶New York Football Giants, Quest Diagnostics Training Center, East Rutherford, New Jersey, USA #Borgess Orthopedics, Kalamazoo, Michigan, USA **WMU Homer Stryker M.D. School of Medicine, Kalamazoo, Michigan, USA ††MedSport, Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, Michigan, USA ‡‡Bellin Health Titletown Sports Medicine and Orthopedics, Green Bay, Wisconsin, USA | ||||
https://doi.org/10.1177/0363546520922547 |
||||
, Article | ||||
, USA | ||||
Abstract: https://journals.sagepub.com/doi/10.1177/0363546520922547?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0pubmed& | ||||
Condition | Year | Language | Analysis type | |
, Injuries | 2020 | English | , Epidemiological study | |
Clinical Research in the National Football League: The Player Scientific and Medical Research Protocol | ||||
Christina Mack 1, Matthew Matava 2, Kristina Zeidler 1, Allen Sills, Gary Solomon | ||||
1IQVIA Research Triangle Park, NC. 2Department of Orthopedic Surgery, Washington University School of Medicine St. Louis, MO. | ||||
PMID: 32358299 DOI: 10.1249/JSR.0000000000000711 |
||||
, Article | ||||
, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/32358299/ | ||||
Condition | Year | Language | Analysis type | |
, Injuries | 2020 | English | , Epidemiological study | |
RWE is the Future of Clinical Research: Time to Get Onboard | ||||
Nancy A. Dreyer, | ||||
Chief Scientific Officer and Senior VP, IQVIA Real World Solutions | ||||
PharmaVOICE - March 2020 |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.pharmavoice.com/article/2020-03-rwe-research/#:~:text=We've%20been%20talking%20about,tools%20are%20coming%20into%20use. | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Health status & patient reported outcomes | 2020 | English | , Economic evaluation, Literature Review, Market impact | |
Comparison of electronic self-reported prescription medication use during pregnancy with the national prescription register in Denmark | ||||
Maja Laursen 1, Christine E Hallgreen 2 3, Nancy Dreyer 4, Alison Bourke 5, Shahrul Mt-Isa 2 6, Stella Blackburn 5 | ||||
1The Danish Health Data Authority, Copenhagen, Denmark. 2School of Public Health, Imperial College London, London, UK. 3Copenhagen Center for Regulatory Science, Department of Pharmacy, SUND, University of Copenhagen, Copenhagen, Denmark. 4IQVIA Real-World and Analytic Solutions, Boston, Massachusetts. 5IQVIA Real-World and Analytic Solutions, London, UK. 6Biostatistics and Research Decision Sciences, MSD Research Laboratories, London, UK. | ||||
Pharmacoepidemiol Drug Saf . 2020 Mar;29(3):328-336. doi: 10.1002/pds.4937. Epub 2019 Dec 6. |
||||
, Article | ||||
, Denmark, UK, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/31811680/ | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods, Pregnancy | 2020 | English | , Epidemiological study, Methodology, Patient questionnaire, Real World Data | |
Real-world evidence to support regulatory decision-making for medicines: Considerations for external control arms | ||||
Mehmet Burcu 1, Nancy A Dreyer 2, Jessica M Franklin 3, Michael D Blum 4, Cathy W Critchlow 5, Eleanor M Perfetto 6, Wei Zhou 1 | ||||
1Center for Observational and Real-World Evidence, Merck & Co., Inc., West Point, Pennsylvania, United States. 2Real-World Solutions, IQVIA, Cambridge, Massachusetts. 3Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. 4Center for Drug Evaluation and Research, Office of Surveillance and Epidemiology, U.S. Food and Drug Administration, White Oak, Maryland. 5Center for Observational Research, Amgen Inc., Thousand Oaks, California. 6National Health Council, Washington, District of Columbia, and University of Maryland Baltimore (UMB), Baltimore, Maryland. | ||||
Pharmacoepidemiol Drug Saf . 2020 Oct;29(10):1228-1235. doi: 10.1002/pds.4975. Epub 2020 Mar 11. |
||||
, Article | ||||
, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/32162381/ | ||||
Condition | Year | Language | Analysis type | |
, Drug safety | 2020 | English | , Epidemiological study, Real World Data, Real World Evidence | |
Considerations when evaluating real-world data quality in the context of fitness for purpose | ||||
Matthew W Reynolds 1, Alison Bourke 2, Nancy A Dreyer 3 | ||||
1Real World Solutions, IQVIA, Maryland, USA. 2Real World Solutions, IQVIA United Kingdom, UK. 3Real World Solutions, IQVIA, Massachusetts, USA. | ||||
Pharmacoepidemiol Drug Saf . 2020 Oct;29(10):1316-1318. doi: 10.1002/pds.5010. Epub 2020 May 6. |
||||
, Article | ||||
, UK, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/32374042/ | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes | 2020 | English | , Real World Data, Real World Evidence | |
Leveraging Real-World Data for COVID-19 Research: Challenges and Opportunities | ||||
Matthew W. Reynolds, Jennifer B Christian, Christina D Mack, Marni Hall and Nancy A Dreyer | ||||
Matthew W. Reynolds, PhD, FISPE Vice President, Real World Evidence, IQVIA Christina Mack, PhD, MSPH Vice President, Epidemiology and Clinical Evidence, IQVIA Adjunct Faculty, UNC-Chapel Hill Marni Hall, PhD, MPH Vice President of Clinical Evidence, IQVIA Nancy Dreyer, PhD, FISPE Chief Scientific Officer and Senior Vice President, IQVIA Jennifer B. Christian, PharmD, MPH, PhD, FISPE | ||||
Precision Medicine 2020; 6 (2), June |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.thejournalofprecisionmedicine.com/leveraging-real-world-data-for-covid-19-research-challenges-and-opportunities/ | ||||
Condition | Year | Language | Analysis type | |
, COVID-19 | 2020 | English | , Data linkage, Observational study, Population Based Study, Real World Data, Real World Evidence | |
Bridging the Gap Between RCTs and RWE Through Endpoint Selection | ||||
Robert J LoCasale 1, Chris L Pashos 2, Ben Gutierrez 3, Nancy A Dreyer 4, Toby Collins 5, Alan Calleja 5, Michael J Seewald 6, Jonathan M Plumb 7, Johan Liwing 8, Maurille Feudjo Tepie 9, Sajan Khosla 10 | ||||
1Real World Evidence, Sanofi, Bridgewater, NJ, USA. 2AbbVie, Chicago, IL, USA. 3GSK, Philadelphia, PA, USA. 4IQVIA, Real-World Solutions, Cambridge, MA, USA. 5IQVIA, Real-World Solutions, London, UK. 6Novartis Pharma AG/Pharma Medical Affairs, Basel, Switzerland. 7Ferring Pharmaceuticals SA, St Prex, Switzerland. 8CellProtect Nordic Pharmaceuticals, Stockholm, Sweden. 9Center for Observational Research, Amgen, Cambridge, UK. 10Real-World Evidence Center of Excellence, AstraZeneca, Cambridge, UK. sajan.khosla@astrazeneca.com. | ||||
Published online 2020 Jul 6. doi: 10.1007/s43441-020-00193-5 |
||||
, Article | ||||
, Sweden, Switzerland, UK, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785541/ | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes | 2020 | English | , Real World Data, Real World Evidence | |
The Certainty Framework for Assessing Real‐World Data in Studies of Medical Product Safety and Effectiveness | ||||
Noelle M. Cocoros Peter Arlett Nancy A. Dreyer Chieko Ishiguro Solomon Iyasu Miriam Sturkenboom Wei Zhou Sengwee Toh | ||||
1Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA. 2Data Analytics and Methods Task Force, European Medicines Agency, Amsterdam, The Netherlands. 3London School of Hygiene and Tropic Medicine, London, UK. 4Center for Advanced Evidence Generation, IQVIA Real World Solutions, Cambridge, Massachusetts, USA. 5Division of Epidemiology, Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan. 6Center for Observational and Real-world Evidence, Merck & Co., Inc., Kenilworth, New Jersey, USA. 7Julius Center, Global Health, University Medical Center Utrecht, Utrecht, The Netherlands. | ||||
https://doi.org/10.1002/cpt.2045 |
||||
, Article | ||||
, Japan, Netherlands, USA | ||||
Abstract: https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.2045 | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes | 2020 | English | , direct to patient research, Real World Data, Real World Evidence | |
Methods for external control groups for single arm trials or long-term uncontrolled extensions to randomized clinical trials | ||||
John D Seeger 1, Kourtney J Davis 2, Michelle R Iannacone 3, Wei Zhou 4, Nancy Dreyer 5, Almut G Winterstein 6, Nancy Santanello 7, Barry Gertz 8, Jesse A Berlin 2 | ||||
1Life Sciences Epidemiology, Optum, Boston, Massachusetts, USA. 2Global Epidemiology, Johnson & Johnson, Titusville, New Jersey, USA. 3Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA. 4Pharmacoepidemiology, Merck & Co., Inc., Kenilworth, New Jersey, USA. 5Real-World Solutions, IQVIA, Cambridge, Massachusetts, USA. 6University of Florida, Gainesville, Florida, USA. 7Nancy Santanello Research Consultant, Philadelphia, Pennsylvania, USA. 8Blackstone, Cambridge, Massachusetts, USA. | ||||
PMID: 32964514 PMCID: PMC7756307 DOI: 10.1002/pds.5141 Published online 2020 Oct 4. doi: 10.1002/pds.5141 |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756307/ | ||||
Condition | Year | Language | Analysis type | |
, Guidelines | 2020 | English | , Epidemiological study, Real World Data, Real World Evidence | |
High clinician- and patient-reported satisfaction with individualized onabotulinumtoxinA treatment for spasticity across several etiologies from the ASPIRE study | ||||
Gerard E Francisco 1, Daniel S Bandari 2, Ganesh Bavikatte 3, Wolfgang H Jost 4 5, Emily McCusker 6, Joan Largent 7, Aleksej Zuzek 6, Alberto Esquenazi 8 | ||||
1The University of Texas Health Science Center McGovern Medical School and TIRR Memorial Hermann, Houston, TX, USA. 2Multiple Sclerosis Center of California & Research Group, Newport Beach, CA, USA. 3The Walton Centre, Liverpool, UK. 4University of Freiburg, Department of Neurology, Freiburg im Breisgau, Germany. 5Parkinson-Klinik Ortenau, Wolfach, Germany. 6Allergan, an AbbVie Company, Irvine, CA, USA. 7IQVIA Real-World Evidence Solutions, Cambridge, MA, USA. 8MossRehab Gait and Motion Analysis Laboratory, Elkins Park, PA, USA. | ||||
PMID: 32875289 PMCID: PMC7452133 DOI: 10.1016/j.toxcx.2020.100040 |
||||
, Article | ||||
, Europe, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/32875289/ | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2020 | English | , Epidemiological study, Observational study | |
Individualized OnabotulinumtoxinA Treatment for Upper Limb Spasticity Resulted in High Clinician- and Patient-Reported Satisfaction: Long-Term Observational Results from the ASPIRE Study | ||||
Gerard E Francisco 1, Wolfgang H Jost 2, Ganesh Bavikatte 3, Daniel S Bandari 4, Simon F T Tang 5, Michael C Munin 6, Joan Largent 7, Aubrey M Adams 8, Aleksej Zuzek 8, Alberto Esquenazi 9 | ||||
1The University of Texas Health Science Center McGovern Medical School and TIRR Memorial Hermann, Houston, TX. 2Department of Neurology, University of Freiburg, Freiburg im Breisgau, Germany. 3The Walton Centre, Liverpool, UK. 4Multiple Sclerosis Center of California & Research Group, Newport Beach, CA. 5Department of Physical Medicine and Rehabilitation, Lotung Poh-Ai Hospital, Yilan, Taiwan. 6Department of Physical Medicine and Rehabilitation, University of Pittsburgh School of Medicine, Pittsburgh, PA. 7IQVIA Real-World Evidence Solutions, Cambridge, MA. 8Allergan plc, Irvine, CA. 9MossRehab Gait and Motion Analysis Laboratory, Elkins Park, PA. | ||||
PMID: 31953896 PMCID: PMC7687094 DOI: 10.1002/pmrj.12328 |
||||
, Article | ||||
, Asia Pacific, Europe, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/31953896/ | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2020 | English | , Epidemiological study, Observational study | |
Multicenter Prospective Evaluation of Parenteral Nutrition Preparation Time and Resource Utilization: 3-Chamber Bags Compared With Hospital Pharmacy-Compounded Bags | ||||
Sarah V Cogle 1 2, Robert G Martindale 3, Mafalda Ramos 4, Gregory J Roberti 5, Pamela R Roberts 6, Kaci Taylor 7, Gordon S Sacks 1 8 | ||||
1Department of Pharmacy Practice, Auburn University, Auburn, Alabama, USA. 2Department of Pharmacy, East Alabama Medical Center, Opelika, Alabama, USA. 3Department of Surgery, Oregon Health and Science University, Portland, Oregon, USA. 4IQVIA, Zaventem, Belgium. 5Department of Pharmacy, Oregon Health and Science University, Portland, Oregon, USA. 6Department of Anesthesiology, University of Oklahoma College of Medicine, Oklahoma City, Oklahoma, USA. 7Department of Pharmacy, OU Medical Center, Oklahoma City, Oklahoma, USA. 8Medical Affairs, Fresenius Kabi, LLC, Lake Zurich, Illinois, USA. | ||||
Journal of Parenteral and Enteral Nutrition Volume 0 Number 0 November 2020 1–7 DOI: 10.1002/jpen.2045 PMID: 33188572 DOI: 10.1002/jpen.2045 |
||||
, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/33188572/ | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Neurological disorders | 2020 | English | , Clinical setting: hospital, Cost effectiveness, Prospective study | |
Budget IMPACT Analysis of a Reduced Maintenance Dose of Certolizumab Pegol in Patients with Axial Spondyloarthritis in the United Kingdom | ||||
Kiri S, Arteaga Duarte C, Lamotte M, Gerlier L | ||||
IQVIA HEOR Zaventem | ||||
ISPOR Europe 2020 Virtual conference Milano Nov 16-19 Abstract ID# 107821 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2020 | English | , clinical setting: Secondary care, Cost effectiveness | |
Cost-Effectiveness Analysis of Certolizumab Pegol Versus Secukinumab and Ixekizumab in Non-Radiographic Axial Spondyloarthritis in the U.S | ||||
Kiri S, Arteaga Duarte Ca, Lee E, Low R, Tsakeu E, Lamotte M, Gerlier L. | ||||
IQVIA HEOR Zaventem | ||||
AMCP Nexus 2020 Virtual October 19. |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2020 | English | , clinical setting: Secondary care, Cost effectiveness | |
A quantitative bias analysis of the confounding effects due to smoking on the association between fluoroquinolones and risk of aortic aneurysm. | ||||
Zhang M, Falconer M, Taylor LG | ||||
"1Division of Epidemiology, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA. 2Real World Solutions, IQVIA™, Durham, North California, USA." | ||||
Pharmacoepidemiol Drug Saf. 2020 Aug;29(8):958-961. doi: 10.1002/pds.5019. Epub 2020 May 13.PMID: 32406104 |
||||
, Article | ||||
, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/32406104/ | ||||
Condition | Year | Language | Analysis type | |
, Drug safety, Methodology | 2020 | English | , Observational study | |
Validity of diagnosis and procedure codes for identifying neural tube defects in infants | ||||
Cheetham TC, Dublin S, Pocobelli G, Bobb JF, Andrade S, Hechter RC, Portugal C, Munis M, Albertson-Junkans L, Salgado G, Wong L, Maarup TJ, Carroll K, Griffin MR, Raebel MA, Smith D, Li DK, Pawloski PA, Toh S, Taylor L, Hua W, Dinatale M, Ceresa C, Trinidad JP, Boudreau DM | ||||
"1Chapman University - School of Pharmacy, Irvine, California, USA. 2Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA. 3Meyers Primary Care Institute & University of Massachusetts Medical School, Worcester, Massachusetts, USA. 4Kaiser Permanente Department of Research & Evaluation, Pasadena, California, USA. 5The Permanente Medical Group, Clinical Genetics, Oakland, California, USA. 6Southern California Permanente Medical Group, Genetics Department, Downey, California, USA. 7Department of Pediatrics, Vanderbilt University Medical School, Nashville, Tennessee, USA. 8Department of Health Policy, Vanderbilt University Medical School, Nashville, Tennessee, USA. 9Institute for Health Research, Kaiser Permanente Colorado, Denver, Colorado, USA. 10Kaiser Permanente Northwest, Center for Health Research, Portland, Oregon, USA. 11Division of Research, Kaiser Permanente Northern California, Oakland, California, USA. 12HealthPartners Institute, Bloomington, Minnesota, USA. 13Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Research Institute, Boston, Massachusetts, USA. 14CDER, Food and Drug Administration, Office of Surveillance and Epidemiology, Silver Spring, Maryland, USA. L Taylor: EPI OR, RWS, IQVIA 15Division of Pediatric and Maternal Health, CDER, Food and Drug Administration, Silver Spring, Maryland, USA." | ||||
Pharmacoepidemiol Drug Saf. 2020 Nov;29(11):1489-1493. doi: 10.1002/pds.5128. Epub 2020 Sep 15.PMID: 32929845 |
||||
, Article | ||||
, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/32929845/ | ||||
Condition | Year | Language | Analysis type | |
, Pediatrics, Womens Health | 2020 | English | , Epidemiological study, Retrospective database analysis | |
Registries for Evaluating Patient Outcomes: A User’s Guide (Prepared by the Outcome DEcIDE Center [Outcome Sciences, Inc., a Quintiles company] under Contract No. 290 2005 00351 TO7.) AHRQ Publication No. 13(14)-EHC111. Rockville, MD: Agency for Healthcare Research and Quality. April 2014. 1st edition, April 2007; 2nd Edition, September, 2010; Third edition, 2014. also available in Korean (Korean National Evidence-based Healthcare Collaborating Agency, published December 2010), and in Chinese (University of Peking, published December 2012). 4th edition, in press, 2019. | ||||
Gliklich R, Dreyer N, Leavy M, eds. | ||||
, Book | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
2019 | English | |||
Lessons on Data Collection and Curation from the NFL Injury Surveillance Program. Sports Health, in press. | ||||
Dreyer NA. Mack CD, Anderson RB, Wojtys EM, Hershman EB, Sills A | ||||
Sports Health 2019; 11(5): 440-445. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Injuries | 2019 | English | ||
The Establishment and Refinement of the National Basketball Association Player Injury and Illness Database. Journal of Athletic Training, in press. | ||||
Mack C, Meisel P, Herzog M, Oakkar E, Walden T, Callahan L, Shapre J, Dreyer N, DiFiori J. | ||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Injuries | 2019 | English | ||
ONE-YEAR ECONOMIC BURDEN AMONG PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA (CAP) INITIALLY MANAGED IN THE OUTPATIENT SETTING- A RETROSPECTIVE US COHORT STUDY, 2012-2017 | ||||
Divino V, Schranz J, Shah H, Jiang M, DeKoven M, Zilberberg M | ||||
IQVIA, Nabriva | ||||
Conference. ISPOR 2019, New Orleans, USA, 18-22 May 2019 |
||||
, Oral presentation | ||||
, USA | ||||
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation-paper/intl2019-2608/9913/one-year-economic-burden-among-patients-with-community-acquired-pneumonia-cap-initially-managed-in-the-outpatient-setting-a-retrospective-us-cohort-study-2012-2017 | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2019 | English | , Burden of illness, Retrospective database analysis | |
ECONOMIC OUTCOMES OF PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA (CAP) HOSPITALIZATIONS IN THE US- A RETROSPECTIVE COHORT STUDY, 2012-2017 | ||||
Divino V, Schranz J, Shah H, Jiang M, DeKoven M, Zilberberg M | ||||
IQVIA, Nabriva | ||||
Conference. ISPOR 2019, New Orleans, USA, 18-22 May 2019 |
||||
, Poster | ||||
, USA | ||||
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/intl2019-1479/89813 | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2019 | English | , Burden of illness, Retrospective database analysis | |
Cost per Episode of Care With Collagenase Clostridium histolyticum Versus Fasciectomy for Dupuytren Contracture: A Real-World Claims Database Analysis | ||||
Camper S, Divino V, Hurley D, DeKoven M | ||||
Endo; IQVIA | ||||
Journal of Hand Surgery Global Online. 2019; 1(2):57-64. |
||||
, Article | ||||
, USA | ||||
Abstract: https://doi.org/10.1016/j.jhsg.2018.12.005 | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2019 | English | , Cost analysis, Retrospective database analysis | |
Return to Function in Adults with Dupuytren Contracture Treated with Collagenase Clostridium Histolyticum Versus Fasciectomy | ||||
Divino V, DeKoven M, Hurley D | ||||
IQVIA; Endo | ||||
Conference. 74TH ANNUAL MEETING OF THE ASSH. Las Vegas, Nevada, USA, 5-7 September 2019 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2019 | English | , Retrospective database analysis | |
REAL WORLD OUTCOMES OF ADJUVANTED TRIVALENT INFLUENZA VACCINE COMPARED TO FLUZONE-HD AND EGG-BASED QUADRIVALENT AND TRIVALENT VACCINES AMONG THE US ELDERLY DURING 2016-2018 FLU SEASONS USING CLAIMS DATA | ||||
Victoria Divino, Joaquin Mould-Quevedo, Miao Jiang, Mitchell DeKoven, Girishanthy Krishnarajah | ||||
IQVIA; Seqirus | ||||
Conference. Options X for the Control of Influenza. Singapore, 28 August - 1 September 2019 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Respiratory disease | 2019 | English | , Retrospective database analysis | |
HOSPITALIZATION ENCOUNTERS FOLLOWING VACCINATION WITH ADJUVANTED TRIVALENT INFLUENZA VACCINE COMPARED TO FLUZONE-HD AND EGG-BASED QUADRIVALENT AND TRIVALENT VACCINES AMONG THE US ELDERLY USING CLAIMS DATA | ||||
Victoria Divino, Joaquin Mould-Quevedo, Mitchell DeKoven, Miao Jiang, Girishanthy Krishnarajah | ||||
IQVIA; Seqirus | ||||
Conference. Options X for the Control of Influenza. Singapore, 28 August - 1 September 2019 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Respiratory disease | 2019 | English | , Retrospective database analysis | |
Validating an algorithm for multiple myeloma based on administrative data using a SEER tumor registry and medical record review. | ||||
Brandenburg NA1, Phillips S2, Wells KE3, Woodcroft KJ3, Amend KL4, Enger C4, Oliveria SA2 | ||||
1 - Global Drug Safety and Risk Management, Celgene Corporation, Summit, New Jersey, USA. 2 - IQVIA, New York, New York, USA. 3 - Department of Public Health Sciences, Henry Ford Health System, Detroit, Michigan, USA. 4 - Department of Epidemiology, Optum, Ann Arbor, Michigan, USA | ||||
Front Oncol. 2016;6:224. Published 2016 Oct 27. doi:10.3389/fonc.2016.00224 |
||||
, Article | ||||
, USA | ||||
Abstract: https://onlinelibrary.wiley.com/doi/epdf/10.1002/pds.4711 | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Oncology | 2019 | English | , Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis | |
Multiple imputation for systematically missing confounders within a distributed data drug safety network: a simulation study and real-world example | ||||
Secrest MH, Platt RW, Reynier P, Dormuth CR, Benedetti A, and Filion KB | ||||
IQVIA, Cambridge, MA | ||||
Pharmacoepidemiology & Drug Safety (In press) |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2019 | English | , Epidemiological study, Retrospective database analysis | |
Methods, Results, and Lessons Learned from Two Postmarketing Drug Safety Surveillance Studies Linking State Cancer Registry Data to Large Pharmacy Databases | ||||
Harris D1; Casso D2; Midkiff K1; Anderson A2; Gilsenan A1; Oliveria SA2; Andrews E1; KellierSteele N3 | ||||
1RTI Health Solutions, Research Triangle Park, NC, United States 2IQVIA, Plymouth Meeting, PA, United States 3Eli Lilly and Company, Indianapolis, IN, United States | ||||
NAACCR / IACR Combined Annual Conference, Vancouver, Canada, 9-13 June 2019 |
||||
, Abstract | ||||
, USA | ||||
Abstract: https://www.naaccr.org/wp-content/uploads/2019/06/NAACCR_IACR_Abstract_Program_Final_.pdf | ||||
Condition | Year | Language | Analysis type | |
, Drug safety | 2019 | English | , Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis | |
Osteosarcoma Surveillance Program Estimating the Incidence of Osteosarcoma Among Teriparatide (Forteo) Users by Linking State Cancer Registry Data to Pharmacy Database Data (United States) | ||||
Kellier-Steele N1, Anderson A2, Casso D2, Oliveria SA2, Gilsenan A3, Midkiff K3, Harris D3, Andrews E3 | ||||
1Eli Lilly and Company, Indianapolis, USA, 2IQVIA, Durham, USA, 3RTI-HS, Raleigh, USA | ||||
WCO, Paris France, 4-7 April 2019 |
||||
, Abstract | ||||
, USA | ||||
Abstract: https://www.wco-iof-esceo.org/sites/wco19/pdf/WCO19-AbstractBook.pdf | ||||
Condition | Year | Language | Analysis type | |
, Drug safety | 2019 | English | , Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis | |
Long term treatment patterns and visual outcomes of anti-vascular endothelial growth factor agents among people with neovascular age-related macular degeneration in the US | ||||
Skelly A1, Khanani AM2, Griner R3, Bezlyak V1, Clark J4, Sagkriotis A1 | ||||
1. Novartis Pharma AG, Basel, Switzerland; 2. Sierra Eye Associates, Reno, Nevada, USA; 3. IQVIA, Cambridge, MA, US; 4. Novartis Pharmaceuticals, East Hanover, NJ, US | ||||
ARVO, Vancouver, Canada, April 28 - May 2 2019 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2019 | English | , clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective database analysis | |
Clinical effectiveness of switching between ranibizumab and aflibercept in treatment of neovascular AMD: US real-world outcomes | ||||
Dugel PU1, Griner R2, Ferreira A3, Milnes F3, Lotery AJ4 | ||||
1. Retinal Consultants of Arizona LTD, Retinal Research Institute LLC, Phoenix, AZ, USA; 2. IQVIA Real World Solutions, USA; 3. Novartis Pharma AG, Basel, Switzerland; 4. Eye Unit, University Hospital Southampton NHS Foundation Trust, Southampton, UK | ||||
J Vitreoretin Dis. 2019 3(3):127-134 |
||||
, Article | ||||
, USA | ||||
Abstract: https://doi.org/10.1177%2F2474126419836614 | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2019 | English | , clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective database analysis | |
Patient characteristics and initiation of mineralocorticoid receptor antagonists in patients with chronic kidney disease in routine clinical practice in the US: a retrospective cohort study | ||||
Blankenburg M1, Fett AK2, Eisenring S3, Haas G2, Gay A4 | ||||
1. Bayer AG, Market Access, Berlin, Germany; 2. IQVIA Commercial GmbH & Co OHG, Frankfurt/Main, Germany; 3. IQVIA, Basel, Switzerland; 4. Bayer AG, Medical Affairs, Berlin, Germany | ||||
BMC Nephrology 2019;20:171 |
||||
, Article | ||||
, USA | ||||
Abstract: https://doi.org/10.1186/s12882-019-1348-4 | ||||
Condition | Year | Language | Analysis type | |
, Nephrology | 2019 | English | , Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective database analysis | |
An Exploratory Analysis of Real-World Endpoints for Assessing Outcomes Among Immunotherapy-Treated Patients with Advanced Non-Small Cell Lung Cancer. | ||||
Stewart M, Norden AD, Dreyer N, Henk HJ, Abernethy AP, Chrischilles E, Kushi L, Mansfield AS, Khozin S, Sharon E, Arunajadai S, Carnahan R, Christian JB, Miksad RA, Sakoda LC, Torres AZ, Valice E, Allen J. | ||||
JCO Clinical Care Informatics 2019. 3:1-15. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2019 | English | ||
Ankle Sprains in the National Basketball Association, 2013-14 through 2016-17. | ||||
Herzog MM, Mack CD, Dreyer NA, Wikstrom EA, Padua DA, Kocher MS, DiFiori JP, Marshall SW | ||||
American Journal of Sports Medicine 2019 Sep;47(11):2651-2658. doi: 10.1177/0363546519864678. Epub 2019 Aug 7 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Injuries | 2019 | English | ||
Comparative Efficacy and Tolerability of Lurasidone versus Other Oral Atypical Antipsychotics for the Treatment of Pediatric Schizophrenia: A Network Meta-Analysis | ||||
Arango C, Ng-Mak D, Finn E, Byrne A, Rajagopalan K, Loebel A | ||||
Chair Child and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense, IBERSAM, Madrid, Spain Senior Director, Global Health Economics & Outcomes Research, Sunovion Pharmaceuticals Inc, Marlborough, MA, USA QuintilesIMS, London, United Kingdom Head of Global HEOR, Global Health Economics and Outcomes Research, Sunovion Pharmaceuticals, Marlborough, MA Executive Vice President, Chief Medical Officer, Research & Development, Sunovion Pharmaceuticals Inc., Fort Lee, NJ, USA | ||||
30th Annual U.S. Psych Congress; 2017 Sept 15-19; New Orleans (USA) European Psychiatric Association; 2018 Mar 3-6; Nice, France. NEI Congress Scientific Poster Session; 2017 Nov 10; Colorado Springs (USA). Lurasidone in Bipolar Depression: Update of SLR and NMA |
||||
, Poster | ||||
, USA | ||||
Abstract: https://www.psychcongress.com/posters/comparative-efficacy-and-tolerability-lurasidone-versus-other-oral-atypical-antipsychotics | ||||
Condition | Year | Language | Analysis type | |
, Mental health, Pediatrics | 2019 | English | , Meta analysis, Retrospective cohort analysis | |
Outcome measurement in pregnancy exposure registries: A preliminary review of publicly available resources | ||||
Suzanne N. Landi, Jessica R. Probst , Katherine Lee, , Elsa García Hernández , Kristen Hahn | ||||
IQVIA, Durham, NC NoviSci Inc., Durham, NC | ||||
, Europe, USA | ||||
Condition | Year | Language | Analysis type | |
, Pregnancy | 2019 | English | , Population Based Study, Review | |
When Context Is Hard to Come By: External Comparators and How to Use Them. | ||||
Mack C, Christian J, Brinkley E, Warren EJ, Hall M, Dreyer N | ||||
IQVIA Real-World & Analytic Solutions, Durham, NC, USA. IQVIA Real-World & Analytic Solutions, Rockville, MD, USA. IQVIA Real-World & Analytic Solutions, Cambridge, MA, USA | ||||
Ther Innov Regul Sci. 2019 Nov 5:2168479019878672. |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31690113 | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2019 | English | , Retrospective database analysis | |
Extracting UMLS Concepts from Medical Text Using General and Domain-Specific Deep Learning Models | ||||
Kathleen C. Fraser1, Isar Nejadgholi1, Berry De Bruijn1, Muqun Li2, Astha LaPlante2 , Khaldoun Zine El Abidine2 | ||||
1National Research Council Canada 2Privacy Analytics Inc., Ottawa, Canada | ||||
[v1] Thu, 3 Oct 2019 01:51:17 UTC |
||||
, Article | ||||
, USA | ||||
Abstract: https://arxiv.org/abs/1910.01274 | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous | 2019 | English | , Methodology, Observational study, Public Health | |
A network meta analysis comparing C1 and kallikrein inhibitors approved for prophylaxis of hereditary angioedema in the United States | ||||
P. Saharia1, P. Soni2, M. Chatterjee3 | ||||
IQVIA, Gurugram, HR, India; IQVIA, Delhi, India; IQVIA, Gurugram, India | ||||
DOI: https://doi.org/10.1016/j.jval.2019.04.1641 |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(19)31833-9/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Rare Diseases | 2019 | English | , Literature Review, Meta analysis | |
Epidemiology of Ankle Sprains and Chronic Ankle Instability. | ||||
Herzog MM, Kerr ZY, Marshall SW, Wikstrom EA | ||||
Department of Epidemiology, University of North Carolina at Chapel Hill; Real-World Analytics Solutins, IQVIA; University of North Carolina Injury Prevention Research Center | ||||
J Athl Train. 2019 Jun;54(6):603-610. doi: 10.4085/1062-6050-447-17 |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31135209 | ||||
Condition | Year | Language | Analysis type | |
, Injuries, Orthopedics | 2019 | English | , Epidemiological study | |
Ankle Sprains in the National Basketball Association, 2013-2014 Through 2016-2017 | ||||
Herzog MM, Mack CD, Dreyer NA, Wikstrom EA, Padua DA, Kocher MS, DiFiori JP, Marshall SW. | ||||
Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill; University of North Carolina Injury Prevention Research Center; Injury Surveillance and Analytics, Real-World Analytics Solutins, IQVIA | ||||
Am J Sports Med. 2019 Sep;47(11):2651-2658 |
||||
, Article | ||||
, USA | ||||
Abstract: ncbi.nlm.nih.gov/pubmed/31389712 | ||||
Condition | Year | Language | Analysis type | |
, Injuries, Orthopedics | 2019 | English | , Epidemiological study | |
The Establishment and Refinement of the National Basketball Association Player Injury and Illness Database | ||||
Mack CD, Meisel P, Herzog MM, Callahan L, Oakkar EE, Walden T, Sharpe J, Dreyer NA, DiFiori J | ||||
IQVIA Real-World & Analytics Solutions, Research Triangle Park, Durham, NC. University of North Carolina at Chapel Hill. National Basketball Association, New York, NY. Hospital for Special Surgery, New York, NY. National Basketball Athletic Trainers Association, Charlotte, NC. | ||||
ncbi.nlm.nih.gov/pubmed/31074633 |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31074633 | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Injuries, Orthopedics | 2019 | English | , Epidemiological study, Observational study, Retrospective database analysis | |
Natural hisotry of oral human papillomavirus infection in healthy populations: Design of the Prevalence of Oral HPV infection, a Global assessment, THE PROGRESS STUDY | ||||
Pedros M1, Morais E2, Roset M1, Kothari S3, Alemany L5, Mirghani H6, Mehanna H7, Waterboer T8, Roberts C3, Vendetti N3, Walia A3, Drury R2, Luxembourg A3, Giuliano A9 | ||||
1 IQVIA, Barcelona, Spain 2 MSD, Lyon, France 3 Merck & Co, Inc., Kenilworth, NJ, US 5 Catalan Institute of Oncology, Cancer Epidemiology Research Program and IDIBELL i CIBERESP, Barcelona, Spain 6 Hôpital Européen Georges-Pompidou Université Paris-Descartes, Paris, France 7 Institute of Head & Neck Studies and Education (InHANSE), University of Birmingham, Birmingham, United kingdom 8 German Cancer Research Center (DKFZ), Heidelberg, Germany 9 Moffitt Cancer Center, Florida, US | ||||
EUROGIN, Monaco, France, 4-7 December 2019 |
||||
, Oral presentation | ||||
, China, France, Germany, Italy, Japan, Spain, UK, USA | ||||
Abstract: http://merck.creative.studios.s3-website-us-east-1.amazonaws.com/EUROGIN_2019/2019_EUROGIN_Pedros_NaturalHistory.pdf | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Infectious disease, Methodology | 2019 | English | , Epidemiological study, Observational study, Population Based Study | |
A Retrospective Study of Comorbidities and Complications Among Acute Myeloid Leukemia Patients and Non-cancer Controls in the US. | ||||
Near A, Iqbal S, Huang H, Dhopeshwarkar N, Lang K, Wallis N. | ||||
ASH 59th Annual Meeting and Exposition |
||||
, USA | ||||
Condition | Year | Language | Analysis type | |
2018 | English | |||
US Multicenter Study of Time, Operational and Economic Efficiences Associated with Using a New Preloaded IOL Delivery System | ||||
Damien Goldberg, Katharine Coyle, Michael Jones, Stephen Lane, Terry Kim. Michael Keith | ||||
Damien Goldberg, Wolstan and Goldberg Eye Associates, Katharine Coyle, IQVIA | ||||
Conference |
||||
, Abstract | ||||
, USA | ||||
Abstract: plyvnas02heorCLIENT2017_Alcon Lens ObservationalAbstractAAOAlcon-AAO-pstr-2017.pdf | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2018 | English | , Observational study | |
Concordance with prescribing information dosage recommendations for dipeptidyl-peptidase-4 inhibitors among type 2 diabetes mellitus patients with moderate to severe chronic kidney disease | ||||
Huan Huang, Sharash Shetty, Elise Bauer, Kathleen Lang | ||||
Huan Huang, IQVIA | ||||
Current Medical Research and Opinion |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.tandfonline.com/eprint/PqtzuUz9tjZ3mSt7AaIz/full | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2018 | English | , Population Based Study, Retrospective database analysis | |
Real-world clinical responses in patients with type 2 diabetes mellitus adding exenatide BID (EBID) or mealtime insulin to basal insulin: a retrospective study using electronic medical record data | ||||
Kathleen Lang, Hiep Nguyen, Huan Huang, Elise Bauer, Philip Levin | ||||
Huan Huang, IQVIA | ||||
Current Medical Research and Opinion |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.tandfonline.com/doi/full/10.1080/03007995.2018.1437027 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2018 | English | , Population Based Study, Retrospective database analysis | |
A cost–benefit analysis of smoking cessation prescription coverage from a US payer perspective | ||||
Baker CL, Ding Y, Ferrufino CP, Kowal S, Tan J, Subedi P. A | ||||
Baker, Subedi: Pfizer; Ferrufino, Kowal and Tan: IQVIA | ||||
ClinicoEconomics and outcomes research |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052927/pdf/ceor-10-359.pdf | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2018 | English | , Cost benefit | |
The Effect of Medicare's Annual Wellness Visit on Preventive Care for the Elderly | ||||
Miao Jiang; Danny Hughes; Wenyi Wang | ||||
Miao Jiang (IQVIA); Danny Hughes (Georgia Tech and Neiman HPI); Wenyi Wang (Medstar) | ||||
Preventive Medicine |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Health policy | 2018 | English | , Observational study, Population Based Study, Public Health, Retrospective cohort analysis | |
Use of Breast Cancer Screening and Its Association with Later Use of Preventive Services among Medicare Beneficiaries | ||||
Stella Kang; Miao Jiang; Richard Duszak, Jr.; Samantha Heller; Danny Hughes; Linda Moy | ||||
Stella Kang (Department of Radiology, NYU School of Medicine); Miao Jiang (IQVIA); | ||||
Radiology |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29869958 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Oncology | 2018 | English | , Observational study, Population Based Study, Public Health, Retrospective cohort analysis | |
A HEALTH STATE UTILITY MODEL ESTIMATING THE IMPACT OF IVOSIDENIB ON QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA | ||||
Wehler EA, Storm M, Kowal S, Campbell C, Boscoe A | ||||
IQVIA | ||||
European Hematology Association |
||||
, Poster | ||||
, USA | ||||
Abstract: https://learningcenter.ehaweb.org/eha/2018/stockholm/215730/michael.storm.a.health.state.utility.model.estimating.the.impact.of.ivosidenib.html?f=ce_id=1346*ot_id=19069*media=3*speaker=664497 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Utility analysis | |
HEALTHCARE RESOURCE UTILIZATION AND COSTS IN PATIENTS WITH PERSISTENT ASTHMA BY ATTAINMENT OF HEALTHCARE EFFECTIVENESS AND DATA INFORMATION SET (HEDIS) MEASURES | ||||
Mosnaim G, Ariely R, Depietro M, Near A, Huang H, Batista A, Lang K | ||||
Huan Huang and Aimee Near are at IQVIA | ||||
ISPOR |
||||
, Poster | ||||
, USA | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(18)31892-8/abstract | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2018 | English | , Population Based Study | |
A Retrospective Real-World Study of Dapagliflozin Versus Other Oral Antidiabetic Therapies Added to Metformin in Patients with Type 2 Diabetes (T2D). | ||||
Huang H, Bell K, Gani R, Tugwell C, Eudicone J, Krukas‐Hampel MR | ||||
Huan Huang is at IQVIA | ||||
Am J Manag Care |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ajmc.com/journals/supplement/2018/real-world-evidence-type2-diabetes-sglt2-inhibitors/retrospective-realworld-study-dapagliflozin-vs-oral-antidiabetic | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2018 | English | , Population Based Study | |
Real-World Study of Comorbidities and Complications in Relapsed/Refractory Acute Myeloid Leukemia Patients Identified Using a Claims-based Algorithm | ||||
Shahed Iqbal, Aimee Near, Neil Dhopeshwarkar, Huan Huang, Maribel Salas, Kathy Lang | ||||
Huan Huang and Aimee Near are IQVIA authors | ||||
ICPE (International Conference on Pharmacoepidemiology and Therapeutic Risk Management) |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Population Based Study, Retrospective database analysis | |
Real-world Treatment Patterns for Patients with Head and Neck Squamous Cell Carcinoma (HNSCC) Treated with Immuno-oncology Therapy | ||||
Huan Huang, Rahul Shenolikar, Brian Seal, Jenny Tse, Chakkarin Burudpakdee | ||||
Huan Huang, Jenny Tse and Chakkarin Burudpakdee are IQVIA authors | ||||
ISPOR |
||||
, Poster | ||||
, USA | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(18)30588-6/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Population Based Study, Retrospective database analysis | |
Review and Validation of Cardiovascular Risk Prediction Models in East Asian Populations. | ||||
Foos V, McEwan P, Lamotte M | ||||
IQVIA, Zaventem, Belgium | ||||
Value in Health, Volume 21, Supplement 1, May 2018, Page S220 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Health economics | 2018 | English | , Cost effectiveness | |
The relationship of predicted benefits in life expectancy and quality adjusted life expectancy for improved glucose control in type 2 diabetes simulation modeling. | ||||
Ramos M, Foos V, McEwan P, Lamotte M | ||||
IQVIA, Zaventem, Belgium | ||||
ISPOR 20th Annual European Congress, 2017, November 4-8, Glasgow, Scotland |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Health economics | 2018 | English | , Cost effectiveness | |
Slow Titration and Delayed Intensification of Basal Insulin Among Patients with Type 2 Diabetes | ||||
Mocarski M, Yeaw J, Divino V, DeKoven M, Guerrero G, Langer J, Thorsted BL | ||||
Novo Nordisk, IQVIA | ||||
J Manag Care Spec Pharm |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.jmcp.org/doi/10.18553/jmcp.2017.17218 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2018 | English | , Utility analysis | |
Two-year adherence and costs for biologic therapy for rheumatoid arthritis | ||||
Stolshek BS, Wade S, Mutebi A, De AP, Wade RL, Yeaw J | ||||
Amgen, IQVIA | ||||
Am J Manag Care |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ajmc.com/journals/issue/2018/2018-vol24-sp8/twoyear-adherence-and-costs-for-biologic-therapy-for-rheumatoid-arthritis?p=1 | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2018 | English | , Cost analysis, Retrospective cohort analysis | |
Healthcare resource utilization and costs associated with long-term corticosteroid exposure in patients with systemic lupus erythematosus | ||||
Kabadi S, Yeaw J, Bacani AK, Tafesse E, Bos K, Karkare S, DeKoven M, Vina ER | ||||
AstraZeneca, IQVIA | ||||
Lupus |
||||
, Article | ||||
, USA | ||||
Abstract: http://journals.sagepub.com/doi/abs/10.1177/0961203318790675?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed& | ||||
Condition | Year | Language | Analysis type | |
, Rare Diseases | 2018 | English | , Cost analysis, Retrospective cohort analysis | |
Anti-VEGF dosing intervals in patients with neovascular age-related macular degeneration: a retrospective cohort study in Australia | ||||
Skelly A1, Rodriguez Torres L1, Griner R2, Bezlyak V1, Kap E2, Sagkriotis A1 | ||||
1 Novartis Pharma AG, Basel, Switzerland 2 IQVIA, Cambridge, Massachusetts, USA 3 IQVIA, Frankfurt, Germany | ||||
International Society For Pharmacoeconomics and Outcomes Research (ISPOR) 23rd Annual International Meeting, 2018, Baltimore, US |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2018 | English | , Epidemiological study, Observational study, Retrospective cohort analysis | |
Health Care Resource Utilization Among a US Cohort Treated for Hereditary Angioedema, 2010–2015 | ||||
Tachdjian R, Johnson KE, Casso D, Oliveria SA, Devercelli G, Jain G. | ||||
Tachdjian R: UCLA School of Medicine; Johnson KE: IQVIA (formerly); Casso D: IQVIA; Oliveria SA: IQVIA; Devercelli G: Shire; Jain G: Shire | ||||
2018 American Academy of Allergy, Asthma and Immunology (AAAAI)/World Allergy Organization (WAO) Joint Congress |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods, Rare Diseases | 2018 | English | , Cost analysis, Database Study, Epidemiological study, Retrospective database analysis | |
Treatment Patterns, Adherence, and Persistence among Psoriasis Patients Treated with Biologics in a Real-World Setting, Overall and by Disease Severity | ||||
Murage MJ, Anderson A, Oliveria SA, Casso D, Ojeh CK, Muram TM, Merola JF, Zbrozek A, Araujo AB | ||||
Murage MJ: Eli Lilly and Company; Anderson A: IQVIA; Oliveria SA: IQVIA; Casso D: IQVIA; Ojeh CK: Eli Lilly and Company; Muram TM: Eli Lilly and Company; Merola JF: cBrigham and Women’s | ||||
Journal of Dermatological Treatment |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.tandfonline.com/doi/abs/10.1080/09546634.2018.1479725?journalCode=ijdt20 | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Drug Utlization Study, Patient Registries & Real-World Study Methods | 2018 | English | , Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis | |
Healthcare Resource Utilization and Costs among Psoriasis Patients Treated with Biologics, Overall and by Disease Severity | ||||
Murage MJ, Anderson A, Oliveria SA, Casso D, Ojeh CK, Muram TM, Merola JF, Araujo AB | ||||
Murage MJ: Eli Lilly and Company; Anderson A: IQVIA; Oliveria SA: IQVIA; Casso D: IQVIA; Ojeh CK: Eli Lilly and Company; Muram TM: Eli Lilly and Company; Merola JF: Harvard Medical School; Araujo AB: Eli Lilly and Company | ||||
Journal of Medical Economics |
||||
, Article | ||||
, USA | ||||
Abstract: https://doi.org/10.1080/13696998.2018.1472097 | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Patient Registries & Real-World Study Methods, Pricing and reimbursement | 2018 | English | , Cost analysis, Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis | |
Database Analysis of Venous Thromboembolism Treatment Patterns in Inpatients vs Outpatient Settings | ||||
Woodcroft KJ, Phillips S, Maranzano G, Caberwal H | ||||
Woodcroft KJ: Henry Ford Health System; Phillips S: IQVIA; Maranzano G: Boehringer Ingelheim Pharmaceuticals; Caberwal H: Boehringer Ingelheim Pharmaceuticals | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Patient Registries & Real-World Study Methods | 2018 | English | , Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis | |
Developing a Multiphase Claims-Based Algorithm for Non-Live Pregnancy Outcomes Research | ||||
Secrest MH, Phillips S, Shen SW, Woodcroft WJ, Oliveria SA, Simon TA | ||||
Secrest MH: IQVIA; Phillips S: IQVIA; Shen SW: Bristol-Myers Squibb; Woodcroft WJ: Henry Ford Health System; Oliveria SA: IQVIA; Simon TA: Bristol-Myers Squibb | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Health status & patient reported outcomes, Patient Registries & Real-World Study Methods, Pregnancy | 2018 | English | , Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis | |
Measuring Colorectal Cancer Screening Rates in a US Administrative Claims Database | ||||
Carrington CM, Johnson KE, Fedwa S, Wiatrek S, Lombardo J, Pirolli M, Oliveria SA | ||||
Carrington CM: IQVIA; Johnson KE: IMPAQ International; Fedwa S: American Cancer Society, Atlanta GA; Wiatrek S: American Cancer Society, Austin TX; Lombardo J: American Cancer Society Philadelphia PA; Pirolli M: American Cancer Society Philadelphia PA; Oliveria SA: IQVIA | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Oncology | 2018 | English | , Database Study, Epidemiological study, Retrospective database analysis | |
Demographic Characteristics and Treatment Patterns among Patients Treated for Hereditary Angioedema in a U.S. Cohort, 2006-2015 | ||||
Tachdjian R, Johnson KE, Casso D, Oliveria SA, Devercelli G, Jain G | ||||
Tachdjian R: UCLA School of Medicine (Department of Medicine and Pediatrics), Johnson KE: IQVIA (formerly); Casso D: IQVIA; Oliveria SA: IQVIA; Devercelli G: Shire; Jain G: Shire. | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rare Diseases | 2018 | English | , Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis | |
Developing a Multiphase Claims-Based Algorithm for Live Pregnancy Outcomes Research | ||||
Secrest MH, Phillips S, Shen SW, Woodcroft WJ, Oliveria SA, Simon TA | ||||
Secrest MH: IQVIA; Phillips S: IQVIA; Shen SW: Bristol-Myers Squibb; Woodcroft WJ: Henry Ford Health System; Oliveria SA: IQVIA; Simon TA: Bristol-Myers Squibb | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Health status & patient reported outcomes, Patient Registries & Real-World Study Methods, Pregnancy | 2018 | English | , Database Study, Epidemiological study, Retrospective database analysis | |
Adherence and Persistence to Biologics Among Psoriasis Patients, Overall and by Disease Severity | ||||
Murage MJ, Anderson A, Oliveria SA, Al Sawah S, Casso D, Malatestinic WN, Tanaka Y, Muram TM, Ojeh CK, Zbrozek A, Araujo AB | ||||
Murage MJ: Eli Lilly and Company; Anderson A: IQVIA; Oliveria SA: IQVIA; Al Sawah S: Eli Lilly and Company; Casso D: IQVIA; Malatestinic WN: Eli Lilly and Company; Tanaka Y: Eli Lilly and Company; Muram TM: Eli Lilly and Company; Ojeh CK: Eli Lilly and Company; Zbrozek A: Eli Lilly and Company, Araujo AB: Eli Lilly and Company | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Dermatology, Drug Utlization Study, Urology | 2018 | English | , Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis | |
Healthcare Resource Utilization and Costs Among Psoriasis Patients Treated with Biologics, Overall and by Disease Severity | ||||
Al Sawah S, Anderson A, Casso D, Murage MJ, Oliveria SA, Malatestinic WN, Tanaka Y, Muram TM, Ojeh CK, Zbrozek A, Araujo AB | ||||
Al Sawah S: Eli Lilly and Company; Anderson A: IQVIA; Casso D: IQVIA; Murage MJ: Eli Lilly and Company; Oliveria SA: IQVIA; Malatestinic WN: Eli Lilly and Company; Tanaka Y: Eli Lilly and Company; Muram TM, Ojeh CK: Eli Lilly and Company; Zbrozek A, Araujo AB: Eli Lilly and Company | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Drug Utlization Study, Patient Registries & Real-World Study Methods | 2018 | English | , Database Study, Epidemiological study, Retrospective database analysis | |
The impact of non-medical switch on type 2 diabetes patients treated with canagliflozin in the commercially insured US population. | ||||
Blonde L, Burudpakdee C, Divino V, Bookhart B, Cai J, Pfeifer M, Coleman CI. | ||||
Ochsner Medical Center, Hartford Hospital Evidence-Based Practice Center, Janssen Scientific Affairs, Janssen Medical Affairs, IQVIA | ||||
Curr Med Res Opin. |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29671627 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2018 | English | , Retrospective database analysis | |
Resource utilization and charges of patients with and without diagnosed venous thromboembolism during primary hospitalization and after elective inpatient surgery: a retrospective study. | ||||
Sepassi A, Chingcuanco F, Gordon R, Meier A, Divino V, DeKoven M, Ben-Joseph R. | ||||
Skaggs School of Pharmacy and Pharmaceutical Sciences , University of California; Department of Anesthesiology , UC San Diego Health System; Millennium Health; IQVIA | ||||
J Med Econ. 2018 Jun;21(6):595-602. doi: 10.1080/13696998.2018.1445635. Epub 2018 Mar 1. PMID: 29480088. |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29480088 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Surgery | 2018 | English | , Retrospective database analysis | |
Comparative effectiveness of uterine fibroids procedures using linked medical record and claims data | ||||
Aaron B Mendelsohn, Emma Brinkley, Kristina M Franke, Kathy Lang, Evan R Myers & Priscilla Velentgas | ||||
IQVIA; Department of Obstetrics & Gynecology, Duke University Medical Center, Durham, NC 27710, USA | ||||
, Article | ||||
, USA | ||||
Abstract: https://www.futuremedicine.com/doi/full/10.2217/cer-2018-0049 | ||||
Condition | Year | Language | Analysis type | |
, Womens Health | 2018 | English | ||
Trends in Incidence of ACL Reconstruction and Concomitant Procedures Among Commercially-Insured Individuals in the United States, 2002-2014. | ||||
Herzog MH, Marshall SW, Lund JL, Pate V, Mack CD, Spang JT. | ||||
Sports Health. 2018. Accepted. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Injuries | 2018 | English | ||
Higher Rates of Lower Extremity Injury on Synthetic Turf compared to Natural Turf Among National Football League Athletes: Epidemiologic Confirmation of a Biomechanical Mechanism. | ||||
Mack CM, Hershman E, Anderson R, Coughlin M, McNitt A, Sendor RJ, Kent R. | ||||
American J of Sports Medicine. 2018. AJSM. In press. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Injuries | 2018 | English | ||
A close look at Synthetic Turf: History, Design, Maintenance and Athlete Safety. | ||||
Jastifer J, Anderson R, Coughlin M, McNitt A, Mack CM, Kent R. | ||||
Sports Health. 2018. In press. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Injuries | 2018 | English | ||
The economic burden of CIDP in the United States: A case-control study. | ||||
Divino V, Mallick R, DeKoven M, Krishnarajah G | ||||
IQVIA; CLS Behring | ||||
Journal. PLoS One. 2018 Oct 23;13(10):e0206205. |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30352101 | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2018 | English | , Cost of illness, Retrospective database analysis | |
Identifying the confuonders that explain the difference in readouts between non-interventional and randomized controlled trials: the case of treatments in neovascular age-related macular degeneration | ||||
Sakriotis A1, Griner R2, Durus A1, Doyle OM2, Rodriguez-Torres L1, Wintermantel T2, Clemens A13 | ||||
1. Novartis Pharma AG, Basel, Switzerland; 2. IQVIA Real World Insights, Switzerland/UK/US; 3. Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Germany | ||||
ISPOR Europe, Barcelona, Spain, 10-14 November 2018 |
||||
, Poster | ||||
, Australia, UK, USA | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2018 | English | , clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective database analysis | |
Trends in Incidence of ACL Reconstruction and Concomitant Procedures Among Commercially Insured Individuals in the United States, 2002-2014. | ||||
Herzog MM, Marshall SW, Lund JL, Pate V, Mack CD, Spang JT | ||||
Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill; University of North Carolina Injury Prevention Research Center; Injury Surveillance and Analytics, IQVIA | ||||
Sports Health. 2018 Nov/Dec;10(6):523-531 |
||||
, Article | ||||
, USA | ||||
Abstract: ncbi.nlm.nih.gov/pubmed/30355175 | ||||
Condition | Year | Language | Analysis type | |
, Injuries, Orthopedics | 2018 | English | , Epidemiological study, Observational study, Retrospective database analysis | |
Fundamentals of Sports Analytics | ||||
Wasserman EB, Herzog MM, Collins CL, Morris SN, Marshall SW | ||||
Datalys Center for Sports Injury Research and Prevention, Inc.; Department of Epidemiology, University of North Carolina at Chapel Hill; Real-World Evidence, IQVIA; University of North Carolina Injury Prevention Research Center | ||||
Clin Sports Med. 2018 Jul;37(3):387-400 |
||||
, Article | ||||
, USA | ||||
Abstract: ncbi.nlm.nih.gov/pubmed/29903381 | ||||
Condition | Year | Language | Analysis type | |
, Injuries, Orthopedics | 2018 | English | , Epidemiological study, Literature Review, Review | |
A Second Look at NBA Game Schedules: Response to Teramoto et al. | ||||
Mack CD, Herzog MM, DiFiori JP, Meisel PL, Dreyer NA | ||||
QuintilesIMS Real-World Insights, Research Triangle Park, USA. Electronic address: christina.mack@quintilesims.com. QuintilesIMS Real-World Insights, Research Triangle Park, USA. National Basketball Association, USA; Division of Sports Medicine and Non-Operative Orthopaedics, University of California Los Angeles, USA. National Basketball Association, USA. QuintilesIMS Real-World Insights, Cambridge, USA. | ||||
J Sci Med Sport. 2018 Mar;21(3):228-229 |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28823474 | ||||
Condition | Year | Language | Analysis type | |
, Injuries, Methodology | 2018 | English | , Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis | |
Using Real World Data to Inform Smarter Clinical Trials and Prospective Observational Studies. | ||||
Mehta S, Mountford W, McDonald M, Stolper R, Zakar J, Lobeck F, Christian J, Lang K. | ||||
ISPOR 22nd Annual International Meeting |
||||
, USA | ||||
Condition | Year | Language | Analysis type | |
2017 | English | |||
PREDICTIVE ANALYSIS FOR IDENTIFYING PATIENT CHARACTERISTICS ASSOCIATED WITH PRIMARY MEDICATION NONADHERENCE FOR LIPID LOWERING THERAPIES | ||||
Jerrold Hill (IQVIA), Pallavi B. Rane (Amgen Inc.), Dionne M. Hines (IQVIA), Jeetvan Patel (Amgen Inc.), David J. Harrison (Amgen Inc.), Rolin L. Wade (IQVIA) | ||||
IQVIA, Amgen | ||||
ISPOR |
||||
, Podium presentation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
2017 | English | |||
Using Real-World Data to Support Protocol Optimization: A Multi-Country Approach in Ulcerative Colitis. | ||||
Brinkley E, Midha Y, Lobeck F, Dreyer N, Lang K, Christian J. | ||||
ISPOR 22nd Annual International Meeting |
||||
, USA | ||||
Condition | Year | Language | Analysis type | |
2017 | English | |||
Primary Care Physicians’ Utilization of Type 2 Diabetes Screening Guidelines and Referrals to Behavioral Interventions: A Survey-Linked Retrospective Study. | ||||
Mehta S, Mocarski M, Wisniewski T, Gillespie K, Narayan KM, Lang K. | ||||
BMJ Open Diabetes Research and Care |
||||
, USA | ||||
Condition | Year | Language | Analysis type | |
2017 | English | |||
Real World Investigation of Dosing Patterns for the Three FDA-Approved Medications in the Treatment of Fibromyalgia. | ||||
White C, Kwong W, Armstrong H, Behling M, Niemira J, Lang K. | ||||
American Health and Drug Benefits |
||||
, USA | ||||
Condition | Year | Language | Analysis type | |
2017 | English | |||
Economic burden of toxicities associated with treating metastatic melanoma in eight countries | ||||
Wehler EA, Zhao Z, Bilir S Pinar, Munakata J, Barber B | ||||
Eur J Health Econ. 2017; 18: 49-58 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/26721505 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Cost analysis | |
THE IMPACT OF RESPIRATORY DEPRESSION FOLLOWING PLANNED INPATIENT SURGERIES ON HOSPITAL RESOURCE UTILIZATION AND CHARGES ACROSS THE UNITED STATES | ||||
Ben-Joseph R1, Gordon RJ2, Chingcuanco F1, Zhao S1, Ni W1, Divino V3, DeKoven M3, Meier A2 | ||||
1Millennium Health, San Diego, CA, USA, 2University of California at San Diego, La Jolla, CA, USA, 3QuintilesIMS, Fairfax, VA, USA | ||||
ISPOR 22nd Annual International Meeting, Boston, 2017 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease, Surgery | 2017 | English | , Retrospective database analysis | |
THE TREATMENT OF PATIENTS WITH INJECTABLE OPIOIDS FOR UNCONTROLLED POSTOPERATIVE PAIN IN THE INPATIENT SETTING: INCIDENCE AND IMPACT ON HOSPITAL CHARGES | ||||
Chingcuanco F1, Divino V2, DeKoven M2, Gordon RJ3, Meier A3, Ben-Joseph R1 | ||||
1Millennium Health, San Diego, CA, USA, 2QuintilesIMS, Fairfax, VA, USA, 3University of California at San Diego, La Jolla, CA, USA | ||||
ISPOR 22nd Annual International Meeting, Boston, 2017 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Anesthesiology, perioperative medicine, Pain | 2017 | English | , Retrospective database analysis | |
THE ECONOMIC IMPACT OF DELAYING BRAIN METASTASES IN ALK-POSITIVE NON-SMALL CELL LUNG CANCER IN THE COMMERCIALLY INSURED US POPULATION | ||||
Wong W1, Burudpakdee C2, Seetasith A2, Corvino F3, Yeh D1, Gubens M4 | ||||
1Genentech, Inc., South San Francisco, CA, USA, 2QuintilesIMS, Fairfax, VA, USA, 3Genesis Research, Hoboken, NJ, USA, 4University of California, San Francisco, San Francisco, CA, USA | ||||
ISPOR 22nd Annual International Meeting, Boston, 2017 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Budget impact, Retrospective database analysis | |
Brexpiprazole use in long-term care patients with major depressive disorder: Results from a retrospective analysis of long-term care data | ||||
Greene M1, Seetasith A2, Hartry A3, Burudpakdee C2, 4 | ||||
1Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA 2QuintilesIMS, Fairfax, VA, USA 3Lundbeck, LLC, Deerfield, IL, USA 4University of North Carolina at Charlotte, Charlotte, NC, USA | ||||
ISPOR 22nd Annual International Meeting, Boston, 2017 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2017 | English | , Retrospective database analysis | |
Adherence and treatment patterns of early adopters of brexpiprazole therapy with schizophrenia – Results from a retrospective analysis of longitudinal prescription data | ||||
Greene M1, Seetasith A2, Hartry A3, Burudpakdee C2, 4 | ||||
1Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA 2QuintilesIMS, Fairfax, VA, USA 3Lundbeck, LLC, Deerfield, IL, USA 4Universitiy of North Carolina at Charlotte, Charlotte, NC, USA | ||||
ISPOR 22nd Annual International Meeting, Boston, 2017 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2017 | English | , Retrospective database analysis | |
Adherence and treatment patterns in brexpiprazole therapy in long-term care patients with schizophrenia: Results from a retrospective analysis of long-term care data | ||||
Greene M1, Seetasith A2, Hartry A3, Burudpakdee C2, 4 | ||||
1Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA 2QuintilesIMS, Fairfax, VA, USA 3Lundbeck, LLC, Deerfield, IL, USA 4University of North Carolina at Charlotte, Charlotte, NC, USA | ||||
ISPOR 22nd Annual International Meeting, Boston, 2017 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2017 | English | , Retrospective database analysis | |
Brexpiprazole use in patients with major depressive disorder: Results from a retrospective analysis of longitudinal prescription data | ||||
Greene M1, Seetasith A2, Hartry A3, Burudpakdee C2, 4 | ||||
1Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA 2QuintilesIMS, Fairfax, VA, USA 3Lundbeck, LLC, Deerfield, IL, USA 4Universitiy of North Carolina at Charlotte, Charlotte, NC, USA | ||||
ISPOR 22nd Annual International Meeting, Boston, 2017 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2017 | English | , Retrospective database analysis | |
Impact of A Pharmacist Medication Adherence Consultation Program on Health Care Costs and Risk of Hospitalization | ||||
Wade R.L.1, Hill J.W.1, Akinbosoye O.2, Jiang Z.2, Mu Y.2, Sun K.1, Karkare S3, Taitel M.S.2 | ||||
1IMS Health, Plymouth Meeting, PA, USA, 2Walgreen Co., Deerfield, IL, USA, 3IMS Health,Deerfield, IL, USA | ||||
VALUE IN HEALTH. 2015. 18(3):A3 |
||||
, Podium presentation | ||||
, USA | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(15)00074-1/pdf | ||||
Condition | Year | Language | Analysis type | |
, Medication compliance | 2017 | English | , Retrospective database analysis, Survey research | |
Real-World Treatment Patterns, Time to Next Treatment, and Economic Outcomes in Relapsed or Refractory Multiple Myeloma Patients Treated with Pomalidomide or Carfilzomib. | ||||
Chen CC1, Parikh K2, Abouzaid S2, Purnomo L2, McGuiness C1B, Hussein M2, Wade RL1 | ||||
1QuintilesIMS, Plymouth Meeting, Pennsylvania. 2Celgene, Summit, New Jersey | ||||
J Manag Care Spec Pharm. 2017 Feb;23(2):236-246 |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.jmcp.org/doi/pdf/10.18553/jmcp.2017.23.2.236 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Budget impact, Retrospective database analysis | |
A Budget Impact Model of Third-Line or Later Trifluridine/Tipiracil Treatment of Metastatic Colorectal Cancer. | ||||
Ferrufino C, Wiseman F, Wert TD, Barghout V | ||||
QuintilesIMS Health, Falls Church, VA; Taiho Oncology, Priceton, NJ; Taiho Oncology, Inc, Princeton, NJ; VEB Healthcare, Morristown, NJ | ||||
ASCO |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Budget impact | |
Estimation of Missed Statin Prescription Use in an Administrative Claims Dataset | ||||
Wade R., Jeetvan P., Hill J., De A., Harrison D. | ||||
QuintilesIMS Health, Amgen | ||||
Journal of Managed Care & Specialty Pharmacy Vol.23, No. 9, 936-944 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Database Validity and methodology | 2017 | English | , Compliance, Methodology, Retrospective database analysis | |
Patient-Level Simulation-Based Sensitivity Analysis To Evaluate The Impact Of Under-Recording Of Underlying Comorbidities In A Retrospective Claims Database Analysis. | ||||
Zorina O1, Ferreira A1, Korn J2, Bezlyak V1, Sagkriotis A1, Skelly A1, Zangvil E1, Snow H1, Zuurman L1, Holekamp N3 | ||||
1 Novartis Pharma AG, Basel, Switzerland 2 QuintilesIMS, Burlington, Massachusetts, United States 3 Pepose Vision Institute, Chesterfield, Missouri, United States | ||||
International Society For Pharmacoeconomics and Outcomes Research (ISPOR) 22nd Annual International Meeting, 2017, Boston, MA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2017 | English | , clinical setting: Secondary care, Epidemiological study, Observational study | |
Real world visual acuity outcomes between ranibizumab and aflibercept in treatment of neovascular AMD in a large US data set. | ||||
Lotery A1,2 Griner R3, Ferreira A4, Milnes F4, Dugel P5 | ||||
1 Eye Unit, University Hospital Southampton NHS Foundation Trust, Southampton, UK 2 Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK 3 QuintilesIMS, Cambridge, MA, USA 4 Novartis Pharma AG, Basel, Switzerland 5 Retinal Consultants of Arizona LTD, Phoenix, AZ, USA | ||||
Eye (2017). epub July 21, 2017 |
||||
, Article | ||||
, USA | ||||
Abstract: http://dx.doi.org/10.1038/eye.2017.143 | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2017 | English | , clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective cohort analysis | |
Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA. | ||||
Nghiem-Buffet S1, Baillif S2, Reginer S3, Skely A4, Yu N5, Sodi A6 | ||||
1 Centre Ophtalmologique d’Imagerie et de Laser, Paris, France, Department of Ophthalmology, Hôpital Avicenne, Assistance Publique, Hôpitaux de Paris and Paris 13 University, Bobigny, France 2 Department of Ophthalmology, Pasteur II University Hospital, Nice, France 3 Novartis Pharma AG, Basel, Switzerland 4 Novartis Ireland Limited, Dublin, Ireland 5 Real-World Evidence Solutions, IMS Health, London, UK 6 Department of Ophthalmology, Careggi University Hospital, Florence, Italy | ||||
Eye (2017) 31, 551-559 |
||||
, Article | ||||
, USA | ||||
Abstract: http://dx.doi.org/10.1038/eye.2016.269 | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2017 | English | , clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective cohort analysis | |
A matched cohort study comparing ranibizumab monotherapy vs ranibizumab to aflibercept switch in nAMD. | ||||
Chakravarthy U1, Bezlyak V2, Griner R3, Skelly A2, Sagkriotis A2, Boyer D4, Milnes F2 | ||||
1 Centre for Experimental Medicine, Queen's University Belfast, Belfast, UK 2 Novartis Pharma AG, Basel, Switzerland 3 QuintilesIMS, Cambridge, Massachusetts, USA 4 Retina Vitreous Associates Medical Group, Los Angeles, USA | ||||
17th annual Congress of the European Society of Retina Specialists (EURETINA) 2017, Barcelona, Spain |
||||
, Oral presentation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2017 | English | , clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective cohort analysis | |
Creating a Rare Disease Cohort Using Ambulatory Electronic Medical Record (AEMR) Data: Duchenne Muscular Dystrophy (DMD) | ||||
Anderson A1, Casso D1, Susan A. Oliveria SA 1, Douglas Kou T 2 | ||||
1 QuintilesIMS ,2 BMS | ||||
33rd International Conference on Pharmacoepidemiology & Thereputic Risk Management; August, 28, 2017; Montreal, Canada |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Musculoskeletal disease, Patient Registries & Real-World Study Methods, Rare Diseases | 2017 | English | , Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis | |
Measuring Breast Cancer Screening Rates in a US Administrative Claims Database | ||||
Karin E. Johnson, Stacey Fedewa, Dawn Wiatrek, Jennifer Lomardo, Melissa Pirolli, Susan A. Oliveria | ||||
QuintilesIMS | ||||
33rd International Conference on Pharmacoepidemioligy, Montreal, Canada; August 2017 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology, Patient Registries & Real-World Study Methods | 2017 | English | , Retrospective cohort analysis, Retrospective database analysis | |
Creating a Rare Disease Cohort Using Ambulatory Electronic Medical Record Data: Progressive Supranuclear Palsy | ||||
Anderson A, Casso D, Oliveria SA, Kou TD | ||||
AA, DC, and SAO are employees of QuintilesIMS. TDK is an employee of BMS | ||||
33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management, August 26-30, 2017; Montreal, Canada |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders, Patient Registries & Real-World Study Methods, Rare Diseases | 2017 | English | , Epidemiological study, Retrospective cohort analysis | |
Demographic Characteristics and Treatment Patterns Among Patients Treated for Hereditary Angioedema in a US Cohort, 2006-2015 | ||||
Raffi Tachdjian, Karin E. Johnson, Deborah Casso1, Susan A. Oliveria1, Giovanna Devercelli2, Gagan Jain2 | ||||
1, QuintilesIMS ; 2, Shire Development LLC | ||||
North American Rhinology & Allergy Conference, February 9–11, 2017, Puerto Rico |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods, Rare Diseases | 2017 | English | , Epidemiological study, Retrospective cohort analysis | |
Can Valid Cases of Schizophrenia Be Identified in Administrative Claims Data? | ||||
Syd Phillips, Matthew Sidovar, Deb Casso, Jeremiah J. Trudeau, Kimberley J. Woodcroft, Susan A. Oliveria | ||||
P, DC, and SAO QuintilesIMS. MT, JT Boehringer Pharmaceuticals (BI | ||||
Conference: 33rd International Conference of Pharmacoepidemiology and Therapeutic Risk Management |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Mental health, Patient Registries & Real-World Study Methods | 2017 | English | , Retrospective cohort analysis | |
Development of a Multi-Phase Claims-Based Algorithm for Pregnancy Research | ||||
Syd Phillips, Karin Johnson, Sophie W. Shen, Kimberley J. Woodcroft, Susan A. Oliveria, Teresa A. Simon | ||||
IQVIA, Epidemiology and Drug Safety, Seattle, WA; (2) Bristol-Myers Squibb, Global Pharmacovigilance and Epidemiology, Hopewell, NJ; (3) Henry Ford Health System, Department of Public Health Sciences, Detroit, MI; IQVIA, Epidemiology and Drug Safety, New York, NY | ||||
33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management. August 26-30, 2017; Montreal, Canada |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2017 | English | , Retrospective database analysis | |
Adherence and persistence in patients with type 2 diabetes mellitus newly initiating canagliflozin, dapagliflozin, dpp-4s, or glp-1s in the United States. | ||||
Cai J., Divino V., Burudpakdee C. | ||||
Janssen. IMS authors: Divino V, Burudpakdee C | ||||
Curr Med Res Opin. |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28418262 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2017 | English | , Retrospective database analysis | |
Characteristics and treatment patterns among US patients with hairy cell leukemia: a retrospective claims analysis. | ||||
Divino V., Karve S., Gaughan A., DeKoven M., Gao G., Knopf KB., Lanasa MC. | ||||
AstraZeneca, MedImmune. IMS authors: Divino V, DeKoven M | ||||
J Comp Eff Res. |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28485619 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Retrospective database analysis | |
Assessing the impact of the extended-release/long-acting opioid an-algesics risk evaluation and mitigation strategies on opioid prescrip-tion volume. | ||||
Divino V., Cepeda S., Coplan P., Maziere JY., Yuan Y., Wade RL. | ||||
Janssen, Purdue. IMS authors: Divino V, Yuan Y, Wade RL. | ||||
J Opioid Manag. |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28829517 | ||||
Condition | Year | Language | Analysis type | |
, Pain | 2017 | English | , Retrospective database analysis | |
Real-World Basal Insulin Intensification Patterns in the United States | ||||
Mocarski M., Yeaw J., Divino V., DeKoven M., Guerrero G., Langer J., Thorsted B. | ||||
Novo Nordisk. IMS authors: Yeaw J, Divino V, DeKoven M | ||||
AMCP Managed Care & Specialty Pharmacy Annual Meeting 2017 |
||||
, Poster | ||||
, USA | ||||
Abstract: http://www.jmcp.org/mwg-internal/de5fs23hu73ds/progress?id=4SaagFc0EJa9TDRbm9m3nOTNIHytJhnoIrRBnUTh5TE,&dl | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2017 | English | , Retrospective database analysis | |
THE BURDEN AND JOURNEY OF PATIENTS WITH CIDP: A CASE-CONTROL ANALYSIS | ||||
Krishnarajah S., Divino V., Mallick R., DeKoven M. | ||||
CSL Behring. IMS authors: Divino V, DeKoven M | ||||
2017 Peripheral Nerve Society (PNS) Annual Meeting |
||||
, Poster | ||||
, USA | ||||
Abstract: https://www.pnsociety.com/files/Abstract%20Presenters.pdf | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2017 | English | , Retrospective database analysis | |
Characteristics of patients with epilepsy newly initiated on brivaracetam: a retrospective claims database analysis | ||||
Jesse Fishman,1 Chakkarin Burudpakedee,2,3 Keiko Wada,2 Melinda Martin1 | ||||
1UCB Pharma, Smyrna, GA, USA 2QuintilesIMS, Fairfax, VA, USA 3University of North Carolina at Charlotte, Charlotte, NC, USA | ||||
AES 2017 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2017 | English | , Observational study, Retrospective cohort analysis, Retrospective database analysis, Utility analysis | |
Real-world basal insulin intensification patterns in the United States | ||||
Thorsted B, Divino V, DeKoven M, Guerrero G,Langer J, Yeaw J, | ||||
Novo Nordisk. IMS authors: Yeaw J, Divino V, DeKoven M | ||||
53rd EASD Annual Meeting |
||||
, Poster | ||||
, USA | ||||
Abstract: https://www.easd.org/virtualmeeting/home.html#!resources/real-world-basal-insulin-intensification-patterns-in-the-united-states-cc3f25a7-276f-451c-9618-05a417f5fce9 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2017 | English | , Retrospective database analysis | |
Patterns of use of systemic therapies among patients with metastatic melanoma: a retrospective claims database analysis in the United States | ||||
Qiufei Ma1, Yaozhu Juliette Chen, Dionne M Hines2, Julie Munakata2, Nicolas Batty1, Beth Louise Barber1, Zhongyun Zhao1 | ||||
1Amgen, 2QuintilesIMS | ||||
J Dermatolog Treat. 2017 Sep;28(6):549-553 Journal of Dermatological Treatment |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.tandfonline.com/doi/full/10.1080/09546634.2016.1277176 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Retrospective database analysis | |
Persistence and Adherence with Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Clinical Practice | ||||
Dionne M Hines1, Pallavi B. Rane2, Jeetval Patel2, David J. Harrison2, Rolin Wade2 | ||||
1QuintilesIMS, 2Amgen | ||||
Scientific Session of the American College of Cardiology |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2017 | English | , Retrospective database analysis | |
Healthcare Resource Utilization and Costs of Skeletal-Related Events in Patients with Multiple Myeloma | ||||
Debajyoti Bhowmik1, Dionne M. Hines2, Michele Intorcia1, Catherine B. McGuiness2, Rolin L. Wade2 | ||||
1Amgen, 2QuintilesIMS | ||||
ISPOR |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Retrospective database analysis | |
Treatment Patterns among Early Initiators of Evolocumab and Alirocumab | ||||
Dionne M. Hines1, Pallavi B Rane2, Jeetvan Patel2, David J Harrison2, Rolin L Wade1 | ||||
1QuintilesIMS, 2Amgen | ||||
AMCP Managed Care & Specialty Pharmacy |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2017 | English | , Retrospective database analysis | |
Dosing Concordance with Prescribing Information (PI) of Dipeptidyl-Peptidase-IV Inhibitors (DPP4-is) When Renal Function | ||||
Huang H, Shetty S, Weijia W, Bauer E, Pascual JR, White C | ||||
QuintilesIMS | ||||
Annual Congress of Endocrine Disorders and Therapies 2017 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2017 | English | , Epidemiological study, Population Based Study, Retrospective database analysis | |
Adding Reslizumab to U.S. Managed Care Formulary for Treatment of Severe Eosinophilic Asthma Resulted in Net Total Cost Savings. | ||||
Huang H, Gani R, Ariely R, Sun SX | ||||
QuintilesIMS | ||||
ISPOR 2017 |
||||
, Poster | ||||
, USA | ||||
Abstract: https://www.ispor.org/research_pdfs/55/pdffiles/PRS10.pdf | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2017 | English | , Budget impact | |
A Retrospective Real-World Study of Dapagliflozin vs. Other Oral Antidiabetic Therapies Added to Metformin in Patients with Type 2 Diabetes (T2D) | ||||
Huan Huang, Kelly Bell, Ray Gani, Cathy Tugwell, James Eudicone, Michelle R. Krukas-Hampel | ||||
QuintilesIMS | ||||
American Diabetes Association 2017 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2017 | English | , Epidemiological study, Retrospective database analysis | |
A Retrospective Real-World Study of Dapagliflozin versus Other Oral Antidiabetic (OAD) Therapies Added to Metformin in Patients with Type 2 Diabetes (T2D) and hypertension | ||||
Huan Huang, Kelly Bell, Ray Gani, Cathy Tugwell, James Eudicone, Michelle R. Krukas-Hampel | ||||
QuintilesIMS | ||||
ISPOR 2017 |
||||
, Poster | ||||
, USA | ||||
Abstract: https://www.ispor.org/research_pdfs/55/pdffiles/PDB14.pdf | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2017 | English | , Epidemiological study, Retrospective database analysis | |
A Retrospective Real-World Study of Incident Comorbidities and Complications Among Acute Myeloid Leukemia Patients and A Retrospective Real-World Study of Incident Comorbidities and Complications Among Acute Myeloid Leukemia Patients and Non-Cancer Comparison Patients in the US | ||||
Aimee Near, Shahed Iqbal, Huan Huang, Neil Dhopeshwarkar, Kathy Lang, Nicola Wallis | ||||
QuintilesIMS | ||||
American Society of Hematology 2017 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Burden of illness, Retrospective database analysis | |
Real-World Adherence and Its Determinants in Patients With Multiple Myeloma Treated With Pomalidomide and Carfilzomib | ||||
Chi-Chang Chen, PhD, MsPharm; KejalParikh, B. Pharm, MS; RolinL. Wade, RPh, MS; Catherine B. McGuiness, MA, MSc; Ali | ||||
QuintilesIMS, Plymouth Meeting, PA Celgene Corporation | ||||
Annual Conference of the Hematology/Oncology Pharmacy Association (HOPA); March 29-April 1, 2017; Anaheim, CA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Retrospective cohort analysis | |
Evaluation of Patient Migration Patterns and Related Health Care Costs Within a National Medicare Advantage Prescription Drug Plan After Implementation of an Oxycodone HCl xtended-elease Access Restriction | ||||
Chi-Chang Chen, MSPharm, PhD; Ajita P. De, MA, MPhil, MS; Brian Sweet, BSPharm, MBA; and Rolin L. Wade, RPh, MS | ||||
QuintilesIMS, Plymouth Meeting, PA | ||||
American College of Cardiology, Washington, DC; March 17–19, 2017 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Pain | 2017 | English | , Cost analysis, Retrospective cohort analysis | |
Outcome Evaluation of a Subcutaneous Immunoglobulin Clinical Management Progra | ||||
Julia Zhu, Gretchen Ayer, Heather S. Kirkham, Chen Chichang, Ron L. Wade, Swapna Karkare, Chet H. Robson, Jordan S. Orange | ||||
Walgreen Co. QuintilesIMS, Plymouth Meeting, PA | ||||
American Journal of Pharmacy Benefits |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2017 | English | , Retrospective cohort analysis | |
Clinical and economic outcomes of a 'high-touch' clinical management program for intravenous immunoglobulin | ||||
Julia Zhu, Heather S. Kirkham, Gretchen Ayer, Chen Chichang, Ron L. Wade, Swapna Karkare, Chet H. Robson, Jordan S. Orange | ||||
Walgreen Co. QuintilesIMS, Plymouth Meeting, PA | ||||
ClinicoEconomics and Outcomes Research |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2017 | English | , Population Based Study, Retrospective cohort analysis | |
Addressing Public Health Challenges -- Opioid Research | ||||
Oliveria, S. | ||||
QuintilesIMS Scientific Forum May 24-25th, 2017 |
||||
, Oral presentation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
2017 | English | , Public Health | ||
Developing a Multi-Phase Claims-Based Algorithm to Facilitate the Study of Drug Exposure During Pregnancy | ||||
Syd Phillips (1); Karin Johnson (1); Sophie Shen (2); Kimberley Woodcroft (3); Susan A Oliveria (4); Teresa Simon (2) | ||||
(1) IQVIA, Epidemiology and Drug Safety, Seattle, WA; (2) Bristol-Myers Squibb, Global Pharmacovigilance and Epidemiology, Hopewell, NJ (3); Henry Ford Health System, Department of Public Health Sciences, Detroit, MI; IQVIA, Epidemiology and Drug Safety, New York, NY | ||||
Conference: 2017 American College of Rheumatology Annual Meeting |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2017 | English | , Retrospective database analysis | |
US Multicenter Study of Time, Operational and Economic Efficiences Associated with Using a New Preloaded IOL Delivery System | ||||
Damien Goldberg, Katharine Coyle, Michael Jones, Stephen Lane, Terry Kim. Michael Keith | ||||
Damien Goldberg, Wolstan and Goldberg Eye Associates, Katharine Coyle, IQVIA | ||||
Conference |
||||
, Oral presentation | ||||
, USA | ||||
Abstract: \plyvnas02heorCLIENT2017_Alcon Lens ObservationalAbstractASCRS PresentationASCRS oral presentation FINAL 05032017.pptx | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2017 | English | , Observational study | |
Utilizing Real World Data to Understand Impact of Patient Support Programs on Adherence and Outcomes: A Case Study. | ||||
Jaganathan S, Burudpakdee C, von Allmen H. | ||||
PMSA |
||||
, Podium presentation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
2017 | English | |||
A Real-World Study of 30-Day Exacerbation Outcomes in Chronic Obstructive Pulmonary Disease (COPD) Patients Managed with Aerobika OPE | ||||
Chakkarin Burudpakdee, Arpamas Seetasith, Patrick Dunne, Garry Kauffman, Brian Carlin, Dom Coppolo, Jason Suggett | ||||
Medical and Scientific Services, Real-World Evidence Solutions, IQVIA | ||||
Pulmonary Therapy |
||||
, Article | ||||
, USA | ||||
Abstract: https://link.springer.com/article/10.1007/s41030-017-0027-5 | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2017 | English | , Population Based Study, Retrospective cohort analysis | |
A Database Cohort Study to Assess the Risk of Angioedema Among Patients with Heart Failure Initiating Angiotensin-Converting Enzyme Inhibitors in the USA | ||||
Thy P. Do, Arpamas Seetasith, Rossella Belleli, Raymond G. Schlienger, Stefano Corda, Chakkarin Burudpakdee, Hendrik J. Streefkerk, Sigrid Behr | ||||
Novartis Pharma AG (at the time of study) AND Medical and Scientific Services, Real-World Evidence Solutions, IQVIA | ||||
Am J Cardiovasc Drugs |
||||
, Article | ||||
, USA | ||||
Abstract: http://rdcu.be/znUq | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Drug safety | 2017 | English | , Epidemiological study, Population Based Study, Retrospective cohort analysis | |
Healthcare costs of patients with Crohn's disease receiving certolizumab pagol with and without home health nurse assistance: results from a retrospective analysis of patient claims data | ||||
Douglas C Wolf, Srihari Jaganathan, Chakkarin Burudpakdee, Arpamas Seetasith, Mohamed Yassine, Jay Gucky, Robert Low, David Schwartz | ||||
Atlanta Gastroenterology Associates; UCB Pharma; Medical and Scientific Services, Real-World Evidence Solutions, IQVIA | ||||
Academy of Managed Care Pharmacy Managed Care & Specialty Pharmacy Annual Meeting |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2017 | English | , Population Based Study, Retrospective cohort analysis | |
The economic impact of delaying brain metastases in ALK-positive non-small cell lung cancer in the commercially insured US population | ||||
William Wong, Chakkarin Burudpakdee, Arpamas Seetasith, Frank A Corvino, Wei-Shi Yeh, Matthew Gubens | ||||
Genentech, Inc.; Medical and Scientific Services, Real-World Evidence Solutions, IQVIA | ||||
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 22nd Annual International Meeting |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Cost of illness, Retrospective cohort analysis | |
Adherence and treatment patterns of early adopters of brexpiprazole with schizophrenia: Results from a retrospective analysis of longitudinal prescription data | ||||
Mallik Greene, Arpamas Seetasith, Ann Hartry, Chakkarin Burudpakdee | ||||
Otsuka Pharmaceutical Development & Commercialization, Inc.; Medical and Scientific Services, Real-World Evidence Solutions, IQVIA | ||||
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 22nd Annual International Meeting |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2017 | English | , Retrospective cohort analysis | |
Brexpiprazole use in patients with major depressive disorder: Results from a retrospective analysis of longitudinal prescription data | ||||
Mallik Greene, Arpamas Seetasith, Ann Hartry, Chakkarin Burudpakdee | ||||
Otsuka Pharmaceutical Development & Commercialization, Inc.; Medical and Scientific Services, Real-World Evidence Solutions, IQVIA | ||||
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 22nd Annual International Meeting |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2017 | English | , Population Based Study, Retrospective cohort analysis | |
Adherence and treatment patterns of brexpiprazole therapy in long-term care patients with schizophrenia: Results from a retrospective analysis of long-term care data | ||||
Mallik Greene, Arpamas Seetasith, Ann Hartry, Chakkarin Burudpakdee | ||||
Otsuka Pharmaceutical Development & Commercialization, Inc.; Medical and Scientific Services, Real-World Evidence Solutions, IQVIA | ||||
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 22nd Annual International Meeting |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2017 | English | , Population Based Study, Retrospective cohort analysis | |
Brexpiprazole use in long-term care patients with major depressive disorder: Results from a retrospective analysis of long-term care data | ||||
Mallik Greene, Arpamas Seetasith, Ann Hartry, Chakkarin Burudpakdee | ||||
Otsuka Pharmaceutical Development & Commercialization, Inc.; Medical and Scientific Services, Real-World Evidence Solutions, IQVIA | ||||
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 22nd Annual International Meeting |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2017 | English | , Population Based Study, Retrospective cohort analysis | |
Healthcare resource use and cost associated with brexpiprazole and quetiapine extended release in major depressive disorder | ||||
Mallik Greene, Arpamas Seetasith, Ann Hartry, Chakkarin Burudpakdee | ||||
Otsuka Pharmaceutical Development & Commercialization, Inc.; Medical and Scientific Services, Real-World Evidence Solutions, IQVIA | ||||
Academy of Managed Care Pharmacy AMCP Nexus 2017 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2017 | English | , Population Based Study, Retrospective cohort analysis | |
Healthcare resource use and cost with brexpiprazole use in patients with major depressive disorder | ||||
Mallik Greene, Arpamas Seetasith, Ann Hartry, Chakkarin Burudpakdee | ||||
Otsuka Pharmaceutical Development & Commercialization, Inc.; Medical and Scientific Services, Real-World Evidence Solutions, IQVIA | ||||
Academy of Managed Care Pharmacy AMCP Nexus 2017 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
2017 | English | , Population Based Study, Retrospective database analysis | ||
Determinants of the relationship between improved glucose control and modelled health outcomes in type 2 diabetes simulation models. | ||||
Foos V1, Lamotte M1, Altrabsheh E2, Sathananthan A2, McEwan P3 | ||||
1 QuintilesIMS, Zaventem, Belgium, 2 QuintilesIMS, London, United Kingdom, 3 Health Economics and Outcomes Research Ltd, Cardiff, United Kingdom | ||||
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual European Congress, 2017, November 4 - 8, Glasgow, Scotland |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Health economics | 2017 | English | , Cost effectiveness | |
Exploration of run-time requirements in probabilistic sensitivity analysis utilizing a patient level based type 2 diabetes simulation model. | ||||
Foos V1, Lamotte M1, Sathananthan A2, Altrabsheh E2, McEwan P3 | ||||
1 QuintilesIMS, Zaventem, Belgium, 2 QuintilesIMS, London, United Kingdom, 3 Health Economics and Outcomes Research Ltd, Cardiff, United Kingdom | ||||
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual European Congress, 2017, Nov 4 - 8, Glasgow, Scotland |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Health economics | 2017 | English | , Cost effectiveness | |
Real-world comparison of femtosecond laser-assisted cataract surgery versus standard phacoemulsification cataract surgery: a retrospective cohort study from an outpatient ophthalmology clinic in France | ||||
Crozafon P1, Griner R2, Bouchet C3, Zignani M3, Ender F3, Keith M, Foster S4, Zou M2, Gardiner G4 | ||||
2 IQVIA, Basel, Switzerland 4 IQVIA, London, UK | ||||
European Society of Cataract and Refractive Surgerons, 35th Congress, 2017, Lisbon, Portugal |
||||
, Oral presentation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2017 | English | , Epidemiological study, Retrospective cohort analysis | |
Healthcare Resource Utilization and Costs Among Psoriasis Patients Treated with Biologics, Overall and by Disease Severity | ||||
Al Sawah S, Anderson A, Casso D, Murage MJ, Oliveria SA, Malatestinic WN, Tanaka Y, Muram TM, Ojeh CK, Zbrozek A, Araujo AB | ||||
Al Sawah S: Eli Lilly and Company; Anderson A: IQVIA; Casso D: IQVIA; Murage MJ: Eli Lilly and Company; Oliveria SA: IQVIA; Malatestinic WN: Eli Lilly and Company; Tanaka Y: Eli Lilly and Company; Muram TM, Ojeh CK: Eli Lilly and Company; Zbrozek A, Araujo AB: Eli Lilly and Company | ||||
The Academy of Managed Care Pharmacy® NEXUS; Dallas, TX |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Drug Utlization Study, Patient Registries & Real-World Study Methods | 2017 | English | , Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis | |
Developing a Multi-Phase Claims-Based Algorithm to Facilitate the Study of Drug Exposure During Pregnancy | ||||
Phillips S, Johnson KJ, Shen SW, Woodcroft KJ, Oliveria SA, Simon TA | ||||
Phillips S: IQVIA; Johnson KJ: IQVIA (formerly); Shen SW: Bristol-Meyers Squibb; Woodcroft KJ: Henry Ford Health System; Oliveria SA: IQVIA; Simon TA: Bristol Meyers Squibb | ||||
American College of Rheumatology Annual Meeting, 3-8 November 2017 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Drug safety, Patient Registries & Real-World Study Methods, Pregnancy | 2017 | English | , Database Study, Epidemiological study, Retrospective database analysis | |
Adherence and Persistence to Biologics Among Psoriasis Patients, Overall and by Disease Severity | ||||
Murage MJ, Anderson A, Oliveria SA, Al Sawah S, Casso D, Malatestinic WN, Tanaka Y, Muram TM, Ojeh CK, Zbrozek A, Araujo AB | ||||
Murage MJ: Eli Lilly and Company; Anderson A: IQVIA; Oliveria SA: IQVIA; Al Sawah S: Eli Lilly and Company; Casso D: IQVIA; Malatestinic WN: Eli Lilly and Company; Tanaka Y: Eli Lilly and Company; Muram TM: Eli Lilly and Company; Ojeh CK: Eli Lilly and Company; Zbrozek A: Eli Lilly and Company, Araujo AB: Eli Lilly and Company | ||||
The Academy of Managed Care Pharmacy® NEXUS; Dallas, TX |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Dermatology, Drug Utlization Study | 2017 | English | , Database Study, Epidemiological study, Retrospective database analysis | |
Demographic Characteristics and Treatment Patterns Among Patients Treated for Hereditary Angioedema in a US Cohort, 2006–2015 | ||||
Tachdjian R, Johnson KE, Casso D, Oliveria SA, Devercelli G, Jain G | ||||
Tachdjian R, Johnson KE, Casso D, Oliveria SA, Devercelli G, Jain G Tachdjian R: UCLA School of Medicine; Johnson KE: IQVIA (formerly); Casso D: IQVIA; Oliveria SA: IQVIA; Devercelli G: Shire; Jain G: Shire | ||||
North American Rhinology & Allergy Conference: Puerto Rico |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rare Diseases | 2017 | English | , Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis | |
The Treatment of Patients with Injectable Opioids for Uncontrolled Postoperative Pain in the Inpatient Setting: Incidence and Impact on Hospital Charges | ||||
Chingcuanco F, Divino V, DeKoven M, Gordon RJ, Meier A, Ben-Joseph R | ||||
Millennium Health, San Diego, USA; IQVIA Fairfax, USA; University of California, San Diego, San Diego, USA | ||||
Pain Week 2017 |
||||
, Poster | ||||
, USA | ||||
Abstract: https://www.tandfonline.com/doi/pdf/10.1080/00325481.2017.1367065?needAccess=true | ||||
Condition | Year | Language | Analysis type | |
, Anesthesiology, perioperative medicine, Pain, Surgery | 2017 | English | , Retrospective database analysis | |
A composite endpoint for clinical trials for new tocolytics: combining data from four U.S. integrated delivery networks. | ||||
Pimenta JM, Brinkley E, Beach KJ, Montague TH, Mack CD. | ||||
Pharmacoepidemiol Drug Saf. 2017;1–8. | ||||
Pharmacoepidemiol Drug Saf. 2017;1–8. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Injuries | 2017 | English | ||
Distal Fibula Fractures in National Football League Athletes. | ||||
Werner BC, Mack C, Franke K, Barnes RP, Warren RF, Rodeo SA. | ||||
Orthop J Sports Med. 2017 Sep 8;5(9):2325967117726515. eCollection 2017 Sept. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Injuries | 2017 | English | ||
Trends in Antibiotic Use by Birth Season and Birth Year. | ||||
Kinlaw AC, Stürmer T, Lund JL, Pedersen L, Kappelman MD, Daniels JL, Frøslev T, Mack CD, Sørensen HT. | ||||
2017 Sep;140(3). Epub 2017 Aug 14. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
2017 | English | |||
Patterns of use of systemic therapies among patients with metastatic melanoma: a retrospective claims database analysis in the United States. | ||||
Ma Q1, Chen YJ2, Hines DM2, Munakata J3, Batty N4, Barber BL1, Zhao Z1. | ||||
1 a Department of Global Health Economics , Amgen Inc , Thousand Oaks , CA , USA. 2 b Health Economics & Outcomes Research, IMS Health , Fairfax , VA , USA. 3 c Real World Evidence Solutions, IMS Health , San Francisco , CA , USA. 4 d Department of Medical Affairs , Amgen Inc , Thousand Oaks , CA , USA. | ||||
J Dermatolog Treat. 2017 Sep;28(6):549-553 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Retrospective database analysis | |
Incidence of Anterior Cruciate Ligament Reconstruction Among Adolescent Females in the United States, 2002 Through 2014 | ||||
Herzog MM, Marshall SW, Lund JL, Pate V, Mack CD, Spang JT | ||||
Gillings School of Global Public Health, Department of Epidemiology, University of North Carolina at Chapel Hill; Injury Prevention Research Center, University of North Carolina; QuintilesIMS Real-World Insights | ||||
JAMA Pediatr. 2017 Aug 1;171(8):808-810 |
||||
, Article | ||||
, USA | ||||
Abstract: ncbi.nlm.nih.gov/pubmed/28604937 | ||||
Condition | Year | Language | Analysis type | |
, Injuries, Orthopedics | 2017 | English | , Epidemiological study, Observational study, Retrospective database analysis | |
Adult Spasticity International Registry Study: methodology and baseline patient, healthcare provider, and caregiver characteristics | ||||
Gerard E Francisco 1, Daniel S Bandari, Ganesh Bavikatte, Wolfgang H Jost, Aubrey Manack Adams, Joan Largent, Alberto Esquenazi | ||||
Francisco: The University of Texas Health Science Center McGovern Medical School and TIRR Memorial Hermann; Largent: IQVIA | ||||
PMID: 28805237 DOI: 10.2340/16501977-2245 |
||||
, Article | ||||
, Asia Pacific, Europe, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/28805237/ | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2017 | English | , Epidemiological study, Observational study | |
Using Certification to Promote Uptake of Real-World Evidence by Payers | ||||
Jodi B. Segal, Joel D. Kallich, Emma R. Oppenheim, Louis P. Garrison Jr., Sheikh Usman Iqbal, Marla Kessler, G. Caleb Alexander | ||||
1Co-director, Center for Drug Safety and Effectiveness, Johns Hopkins University, and Professor of Medicine and Epidemiology, Division of General Internal Medicine, Department of Medicine, Johns Hopkins Medicine/Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 2Principal, Big Health Data, Falmouth, Maine. 3Master’s Student, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 4Professor of Pharmaceutical Outcomes Research and Policy, School of Pharmacy, University of Washington, Seattle. 5Senior Medical Affairs Leader−Neuroscience, Global Medical Affairs, AstraZeneca, Cambridge, Massachusetts. 6Vice President, Global Services and Real-World Evidence Solutions, IMS Health, Plymouth Meeting, Pennsylvania. 7Co-director, Center for Drug Safety and Effectiveness, Johns Hopkins University, and Associate Professor of Medicine and Epidemiology, Division of General Internal Medicine, Department of Medicine, Johns Hopkins Medicine/Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. | ||||
J Manag Care Spec Pharm, 2016 Mar;22(3):191-196. |
||||
, Article | ||||
, USA | ||||
Abstract: http://dx.doi.org/10.18553/jmcp.2016.22.3.191 | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Health policy | 2016 | English | , Review | |
TREATMENT PATTERNS AMONG PATIENTS PRESCRIBED PDE-5 INHIBITOR MONOTHERAPY FOR PULMONARY HYPERTENSION | ||||
Yeaw J, Lickert C, Drake W, De AP, Wade RL | ||||
1IMS Health, San Francisco, CA, USA, 2Actelion Pharmaceuticals, Inc., South San Francisco, CA, USA, 3IMS Health, Plymouth Meeting, PA, USA | ||||
ISPOR 21th, May 2016, Washington DC USA |
||||
, Poster | ||||
, USA | ||||
Abstract: www.ispor.org | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2016 | English | ||
COPD Patients Initiating Roflumilast in Sweden, Germany and the United States: Findings from the Roflumilast PASS Study | ||||
Hoti F, Mushnikov V, Mehtälä J, et al. | ||||
32nd International Conference on Pharmacoepidemiology and Therapeutic Risk Management; 2016; Dublin, Ireland |
||||
, Abstract | ||||
, Germany, Nordic, Sweden, USA | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2016 | English | , Real World Evidence | |
Patterns of Roflumilast Use for the Treatment of COPD Across Three Distinct Populations: Findings from the Roflumilast PASS Study | ||||
Knox C, Mountford W, Kaufman E, et al. | ||||
32nd International Conference on Pharmacoepidemiology and Therapeutic Risk Management; 2016; Dublin, Ireland |
||||
, Abstract | ||||
, Germany, Sweden, USA | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2016 | English | , Epidemiological study, Real World Evidence | |
Integrating the Patient Perspective Into Clinical Research Study Designs: Case Studies and Recommendations. | ||||
David Cameron | ||||
QuintilesIMS | ||||
Journal for Clinical Studies |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Methodology | 2016 | English | ||
Superior Labrum Anterior-Posterior Tears in the National Football League. | ||||
Chambers CC, Lynch TS, Gibbs DB, Ghodasra JH, Sahota S, Franke K, Mack CD, Nuber GW. | ||||
Department of Orthopaedic Surgery, Northwestern University, Chicago, Illinois, USA ‡Center for Shoulder, Elbow and Sports Medicine, Columbia University Medical Center, New York, New York, USA §Department of Orthopaedic Surgery, University of California–Los Angeles, Los Angeles, California, USA ‖Quintiles, Durham, North Carolina, USA ¶Department of Orthopaedic Surgery, NorthShore University, Chicago, Illinois, USA Investigation performed at Northwestern University and at NorthShore University, Chicago, Illinois, USA | ||||
American Journal of Sports Medicine |
||||
, Article | ||||
, USA | ||||
Abstract: http://ajs.sagepub.com/content/early/2016/10/28/0363546516673350.abstract | ||||
Condition | Year | Language | Analysis type | |
, Injuries | 2016 | English | , Epidemiological study, Real World Evidence | |
Real-world glycemic, blood pressure, and weight control in patients with type 2 diabetes mellitus treated with canagliflozin-an electronic health-record-based study. | ||||
Lefebvre P1, Pilon D1, Robitaille MN1, Lafeuille MH1, Chow W2, Pfeifer M2, Duh MS3. | ||||
1a Groupe d'analyse, Ltée , Montréal , Québec , Canada ; 2b Janssen Scientific Affairs, LLC , Raritan , NJ , USA ; 3c Analysis Group, Inc. , Boston , MA , USA. | ||||
Curr Med Res Opin. 2016 Jun;32(6):1151-9 |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.tandfonline.com/doi/full/10.1080/03007995.2016.1183604 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2016 | English | , Retrospective database analysis | |
Evidence generation from healthcare databases: recommendations for managing change | ||||
Alison Bourke, Andrew Bate, Brian C. Sauer, Jeffrey S. Brown and Gillian C. Hall | ||||
IMS Health, London, UK Pfizer, Tadworth, UK University of Utah School of Medicine, Salt Lake City, UT, USA Harvard Medical School, Boston, MA, USA Grimsdyke House, London, UK | ||||
Pharmacoepidemiology and Drug Safety |
||||
, Abstract | ||||
, UK, USA | ||||
Abstract: http://onlinelibrary.wiley.com/doi/10.1002/pds.4004/full | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2016 | English | ||
Leveraging real-world evidence in disease management decision-making with a total cost of care (TCoC) estimator. American drug and health benefits. | ||||
Nguyen TN, Trocio J, Kowal S, Ferrufino C; Munakata J,South D | ||||
American Drug and Health Benefits. 2016 December; 9(9):475-484 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Abstract: http://www.ahdbonline.com/issues/2016/december-2016-vol-9-no-9/2276-leveraging-real-world-evidence-in-disease-management-decision-making-with-a-total-cost-of-care-estimator | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2016 | English | , Cost analysis | |
Estimated budget impact of adopting the affordable care act’s required smoking cessation coverage on united states healthcare payers. | ||||
Baker CL, Ferrufino CP, Bruno M, Kowal S | ||||
Advances in Therapy. 2016 November; 25:1-5 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Abstract: http://link.springer.com/article/10.1007/s12325-016-0446-y | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2016 | English | , Budget impact, Cost analysis | |
Minimizing burden of disease-related hospitalization among pulmonary arterial hypertension patients. | ||||
Li S, Highland K, Cole M, Bilir P, Tsang Y, Graber-Naidich A, Kowal S, Drake W | ||||
Academy of Managed Care Pharmacy (AMCP) Nexus 2016 Conference, 2016, October 3-6, National Harbor, Maryland |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2016 | English | , Budget impact, Cost analysis | |
Budget impact of contrast media choice and contrast induced acute kidney injury in high-risk patients undergoing invasive coronary angiography with or without percutaneous coronary intervention from a us hospital perspective. | ||||
Todoran T, Goldfarb S, Pena CS, Ferrufino CP, Kowal S, De Francesco M, Lamotte M, King A | ||||
International Society for Pharmacoeconomics and Outcomes Research – 21st Annual International Meeting, 2016, May, Washington D.C. |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Nephrology | 2016 | English | , Budget impact | |
Comorbidity Burden in Trial-Aligned Patients with Established Gout in Germany, UK, US, and France: a Retrospective Analysis. | ||||
Nyberg F1,2, Horne L3, Morlock R4, Nuevo J5, Storgard C4, Aiyer L4, Hines DM6, Ansolabehere X7, Chevalier P8 | ||||
1 AstraZeneca, Mölndal, Sweden 2 University of Gothenburg, Gothenburg, Sweden 3 AstraZeneca, Wilmington, USA 4 Ardea Biosciences, San Diego, USA 5 AstraZeneca, Madrid, Spain 6 IMS Health, Alexandria, USA 7 IMS Health, Paris, France 8 IMS Health, Vilvoorde, Belgium | ||||
Advances in Therapy, 2016, 33(7): 1180–1198 |
||||
, Article | ||||
, France, Germany, UK, USA | ||||
Condition | Year | Language | Analysis type | |
2016 | English | |||
Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective Analysis. | ||||
Morlock R1, Chevalier P2, Horne L3, Nuevo J4, Storgard C1, Aiyer L1, Hines DM5, Ansolabehere X6, Nyberg F7,8 | ||||
1 Ardea Biosciences, San Diego, CA, USA 2 IMS Health HEOR, Zaventem, Belgium 3 AstraZeneca, Wilmington, DE, USA 4 AstraZeneca, Madrid, Spain 5 IMS Health HEOR, Fairfax, VA, USA, 6 IMS Health HEOR, Paris, France, 7 AstraZeneca, Mölndal, Sweden 8 University of Gothenburg, Gothenburg, Sweden | ||||
Rheumatol Ther., 2016, 3(1): 53-75 |
||||
, Article | ||||
, France, Germany, UK, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2016 | English | ||
Improving Medication Adherence and Health Care Outcomes in a Commercial Population through a Community Pharmacy. | ||||
Akinbosoye OE1, Taitel MS1, Grana J1, Hill J2, Wade RL2. | ||||
1 Walgreen Co., Health Analysis Research and Reporting , Deerfield, Illinois. 2 IMS Health, Health Economics and Outcomes Research , Real World Solutions, Plymouth Meeting, Pennsylvania. | ||||
Popul Health Manag. 2016 Dec;19(6):454-461 |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5296931/ | ||||
Condition | Year | Language | Analysis type | |
, Medication compliance | 2016 | English | , Budget impact, Retrospective database analysis | |
Orphan Drug Expenditures In The United States: A Historical And Prospective Analysis, 2007-18. | ||||
Divino V1, DeKoven M2, Kleinrock M3, Wade RL4, Kaura S5. | ||||
1 Victoria Divino (vdivino@us.imshealth.com) is a senior consultant at IMS Health in Fairfax, Virginia. 2 Mitch DeKoven is a principal at IMS Health. 3 Michael Kleinrock is director of research development for the IMS Institute for Healthcare Informatics, in Parsippany, New Jersey. 4 Rolin L. Wade is a senior principal at IMS Health. 5 Satyin Kaura is a senior director at Celgene Corporation, in Summit, New Jersey. | ||||
Health Aff (Millwood). 2016 Sep 1;35(9):1588-94 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rare Diseases | 2016 | English | , Budget impact | |
Improving Medication Adherence and Health Care Outcomes in a Commercial Population through a Community Pharmacy. | ||||
Akinbosoye OE1, Taitel MS1, Grana J1, Hill J2, Wade RL2. | ||||
1 Walgreen Co., Health Analysis Research and Reporting , Deerfield, Illinois. 2 IMS Health, Health Economics and Outcomes Research , Real World Solutions, Plymouth Meeting, Pennsylvania. | ||||
Popul Health Manag. 2016 Dec 1; 19(6): 454–461. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Medication compliance | 2016 | English | , Budget impact, Retrospective database analysis | |
Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective Analysis. | ||||
Morlock R, Chevalier P, Horne L, Nuevo J, Storgard C, Aiyer L, Hines DM, Ansolabehere X, Nyberg F. | ||||
Rheumatol Ther. 2016 Jun;3(1):53-75. |
||||
, Article | ||||
, France, Germany, UK, USA | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Health policy, Metabolic Disorders , Public Health | 2016 | English | , Retrospective cohort analysis | |
Clinical effectiveness of ranibizumab for NAMD in UK and Australia: a retrospective cohort study using electronic medical records. | ||||
Johnston R12, Carius HJ3, Ferreira A4, Milnes F4, Freitas R5 | ||||
1 The Royal College of Ophthalmologists' National Ophthalmology Database, London, UK 2 Gloucester Hospitals NHS Foundation Trust, Cheltenham, UK 3 IMS Health Inc., Basel, Switzerland 4 Novartis Pharma AG, Basel, Switzerland | ||||
World Ophthalmology Congress (WOC), 2016, Feb 5-9th, Guadalajara, Mexico |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2016 | English | , clinical setting: Secondary care, Epidemiological study, Retrospective cohort analysis | |
Clinical outcomes of treatment switching in neovascular age-related macular degeneration: a retrospective cohort study in the United States using electronic medical records. | ||||
Milnes F1, Griner R2, Ferreira A3, Skelly A3, Dugel PU4 | ||||
1 Novartis Pharma AG, Basel, Switzerland 2 IMS Health Inc., Burlington, MA, United States 3 Novartis Ireland Limited, Dublin, Ireland 4 Retinal Consultants of Arizona, Phoenix, AZ/USC Eye Institute, Los Angeles, CA, USA | ||||
Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, Research: A Vision of Hope, 2016, May 1-5, Seattle, Washington, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2016 | English | , clinical setting: Secondary care, Epidemiological study, Retrospective cohort analysis | |
Predicting response to anti-vascular endothelial growth factor treatment using electronic medical record data in eyes with neovascular age-related macular degeneration. | ||||
Andrews C1, D'Souza K1, Lacey S1, Rigg J2, Pitcher A2, Milnes F1 | ||||
1 Novartis Pharma AG Basel, Switzerland 2 QuintilesIMS, London, UK | ||||
International Society For Pharmacoeconomics and Outcomes Research (ISPOR) 19th Annual European Congress, 2016, Vienna, Austria |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2016 | English | , clinical setting: Secondary care, Epidemiological study, Observational study | |
Severe ocular inflammation following ranibizumab or aflibercept injections for age-related macular degeneration: a retrospective claims database analysis. | ||||
Souied EH1, Dugel PU2, Ferreira A3, Hashmonay R3, Lu J4, Kelly SP5 | ||||
1 Centre Hospitalier Intercommunal Créteil , Université Paris-Est , Créteil , France 2 Retinal Consultants of Arizona, Phoenix, AZ, USA and USC Eye Institute, Keck School of Medicine , University of Southern California , Los Angeles , CA , USA 3 Novartis Pharma AG , Basel , Switzerland 4 IMS Health , Plymouth Meeting , PA , USA 5 Royal Bolton Hospitals NHS Foundation Trust , Bolton , UK | ||||
Ophthalmic Epidemiology 2016; 23(2): 71-9 |
||||
, Article | ||||
, USA | ||||
Abstract: http://dx.doi.org/10.3109/09286586.2015.1090004 | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2016 | English | , clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective database analysis | |
Dynamic Real World Data Platform Integrating Automated Claims and Registry Data for Pharmacoepidemiologic Studies | ||||
Syd Phillips, Andre B. Araujo, Chrissa Proctor, William N. Malatestinic, Cynthia J. Larmore, Leslie R. Harrold, George W. Reed, Deb Casso, Karin Johnson, Jeremy Stamer, Susan A. Oliveria | ||||
S. Phillips, C. Proctor, D. Casso, J. Stamer, and S.A. Oliveria are employees of QuintilesIMS (formerly IMS Health) KJ was an employee of QuintilesIMS at the time of the study. A. B. Araujo, W. N. Malatestinic, and C. J. Larmore are employees and stock owners of Eli Lilly and Company. | ||||
International Conference on Pharmacoepidemiology and Therapeutic Risk Management. August 25-28; Dublin, Ireland |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Patient Registries & Real-World Study Methods | 2016 | English | , Review | |
Assessing Data Availability for Pharmacoepidemiology Research in 3 US Healthcare Databases Using the OMOP Common Data Model | ||||
Karin Johnson, Deb Casso, Amanda Anderson, Syd Phillips, Christian Reich, Urvi Shah, Mui van Zandt, Susan A. Oliveria | ||||
QuintilesIMS | ||||
OHDSI Symposium, Washington DC, September 23, 2016 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2016 | English | , Database Study | |
Linked Patient-Reported Outcomes Data From Patients With Multiple Sclerosis Recruited on an Open Internet Platform to Health Care Claims Databases Identifies a Representative Population for Real-Life Data Analysis in Multiple Sclerosis | ||||
Risson V, Ghodge B, Bonzani IC, Korn JR, Medin J, Saraykar T, Sengupta S, Saini D, Olson M. | ||||
Novartis Pharma AG, Basel, Switzerland QuintileIMS | ||||
J Med Internet Res. 2016 Sep 22;18(9):e249 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders, Patient Registries & Real-World Study Methods | 2016 | English | , Data linkage, direct to patient research, Methodology, social media | |
Increasing economic burden of tyrosine kinase inhibitor treatment failure by line of therapy in chronic myeloid leukemia. | ||||
McGarry LJ., Chen YJ., Divino V., Pokras S., Taylor CR., Munakata J., Nieset CC., Huang H., Jabbour E., Malone DC. | ||||
ARIAD. IMS authors: Divino V, Munakata J | ||||
Curr Med Res Opin. Curr Med Res Opin. 2016;32(2):289-99 |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/26566171 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Burden of illness | |
REAL-WORLD TREATMENT PATTERNS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS NEWLY INITIATED WITH ANTIHYPERGLYCEMIC MEDICATIONS IN THE UNITED STATES | ||||
Cai J., Burudpakdee C., Divino V. | ||||
Janssen. IMS authors: Burudpakdee C, Divino V | ||||
ISPOR 21st Annual International Meeting |
||||
, Oral presentation | ||||
, USA | ||||
Abstract: https://www.ispor.org/ScientificPresentationsDatabase/Presentation/62486?pdfid=44270 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2016 | English | , Retrospective database analysis | |
GENERIC DRUG VOLUME AND COST SAVINGS IN ONCOLOGY: A 2005-2014 MIDAS ANALYSIS | ||||
Divino V., Coyle K., Kleinrock M., Wade RL., DeKoven M., Kaura S. | ||||
Celgene. IMS authors: Divino V, Coyle K, Kleinrock M, Wade RL, DeKoven M | ||||
ISPOR 19th Annual European Congress |
||||
, Poster | ||||
, USA | ||||
Abstract: https://www.ispor.org/ScientificPresentationsDatabase/Presentation/68602?pdfid=47233 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Retrospective database analysis | |
New and emerging novel therapy combinations for relapsed and refractory multiple myeloma (RRMM) | ||||
Victoria Divino, Kejal Parikh, Mitch DeKoven, Katharine Coyle, Safiya Abouzaid | ||||
Celgene, IMS authors: Divino V, DeKoven M, Katharine Coyle | ||||
2016 AMCP Managed Care & Specialty Pharmacy Annual Meeting |
||||
, Poster | ||||
, USA | ||||
Abstract: http://www.jmcp.org/doi/pdf/10.18553/jmcp.2016.22.4.S1 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Literature Review | |
Characteristics of Patients Approved and Denied Access to PCSK9i Therapy by Payers | ||||
Seth J. Baum, Chi-Chang Chen, Pallavi B. Rane,3 Jeetvan Patel, Juan Maya, David J. Harrison,Nicole Yurgin, Rolin L. Wade | ||||
Preventive Cardiology Inc., Boca Raton, FL QuintilesIMS, Plymouth Meeting, PA | ||||
American College of Cardiology, Washington, DC; March 17–19, 2017 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2016 | English | , Retrospective cohort analysis | |
Time to Approval in Patients Requesting Access to PCSK9i Therapy by Payer Type | ||||
Seth J. Baum, Chi-Chang Chen, Pallavi B. Rane, JeetvanPatel, Juan F. Maya, David J. Harrison, Catherine B. McGuiness, Nicole | ||||
Preventive Cardiology Inc., Boca Raton, FL QuintilesIMS, Plymouth Meeting, PA | ||||
2017 AMCP Managed Care & Specialty Pharmacy Annual Meeting, Denver, CO. March 27-30, 2017 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2016 | English | , Retrospective cohort analysis | |
Mortality and Vascular Events among Elderly Patients with Chronic Myeloid Leukemia: A Retrospective Analysis of Linked SEER-Medicare Data | ||||
Lang K, McGarry L, Huang H, Dorer D, Kaufman E, Knopf K | ||||
Huan Huang is IQVIA author | ||||
Clin Lymphoma Myeloma Leuk |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.sciencedirect.com/science/article/pii/S2152265016000525?via%3Dihub | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Population Based Study, Retrospective database analysis | |
Healthcare resource use and associated costs among patients with seasonal versus perennial allergic rhinitis | ||||
Lang K, Allen-Ramey F, Huang H, Rock M, Kaufman E, Dykewicz M | ||||
Huan Huang is IQVIA author | ||||
Allergy Asthma Proc |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/27657517 | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2016 | English | , Population Based Study, Retrospective database analysis | |
Characterizing treatment pathways at scale using the OHDSI network | ||||
George Hripcsaka,b,c,1, Patrick B. Ryanc,d, Jon D. Dukec,e, Nigam H. Shahc,f, Rae Woong Parkc,g, Vojtech Huserc,h, Marc A. Suchardc,i,j,k, Martijn J. Schuemiec,d, Frank J. DeFalcoc,d, Adler Perottea,c, Juan M. Bandac,f, Christian G. Reichc,l, Lisa M. Schillingc,m, Michael E. Mathenyc,n,o, Daniella Meekerc,p,q, Nicole Prattc,r, and David Madiganc,s | ||||
aDepartment of Biomedical Informatics, Columbia University Medical Center, New York, NY 10032; bMedical Informatics Services, NewYork-Presbyterian Hospital, New York, NY 10032; cObservational Health Data Sciences and Informatics, New York, NY 10032; dEpidemiology Analytics, Janssen Research and Development, Titusville, NJ 08560; eCenter for Biomedical Informatics, Regenstrief Institute, Indianapolis, IN 46205; fCenter for Biomedical Informatics Research, Stanford University, CA 94305; gDepartment of Biomedical Informatics, Ajou University School of Medicine, Suwon, South Korea, 443-380; hLister Hill National Center for Biomedical Communications (National Library of Medicine), National Institutes of Health, Bethesda, MD 20894; iDepartment of Biomathematics, University of California, Los Angeles, CA 90095; jDepartment of Biostatistics, University of California, Los Angeles, CA 90095; kDepartment of Human Genetics, University of California, Los Angeles, CA 90095; lReal World Evidence Solutions, IMS Health, Burlington, MA 01809; mDepartment of Medicine, University of Colorado School of Medicine, Aurora, CO 80045; nDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN 37212; oGeriatric Research, Education and Clinical Center, VA Tennessee Valley Healthcare System, Nashville, TN 37212; pDepartment of Preventive Medicine, University of Southern California, Los Angeles, CA 90089; qDepartment of Pediatrics, University of Southern California, Los Angeles, CA 90089; rDivision of Health Sciences, University of South Australia, Adelaide, SA, Australia 5001; and sDepartment of Statistics, Columbia University, New York, NY 10027 | ||||
Proceedings of the National Academy of Science of the United State of America - PNAS |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.pnas.org/content/113/27/7329 | ||||
Condition | Year | Language | Analysis type | |
, Drug Utlization Study, Observational Health Data Sciences and Informatics (OHDSI) collaboration | 2016 | English | , Database Study, Retrospective database analysis | |
Comparative Assessment of US Healthcare Databases and Linkage Capabilities for Pharmacoepidemiology Studies. | ||||
Deborah Casso, Karin Johnson, Syd Phillips, Amanda Anderson and Susan A Oliveria. | ||||
IMS Health, Plymouth Meeting, PA, United States | ||||
International Conference on Pharmacoepidemiology and Therapeutic Risk Management |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2016 | English | ||
Assessment of Cognitive Impairment, Treatment Adherence, and Healthcare Resource Utilization among Treated Schizophrenia Patients | ||||
Casso D, Phillips S, Woodcroft KJ, Sidovar MF, Oliveria SA, Trudeau JJ. | ||||
Casso D: IQVIA; Phillips S: IQVIA; Woodcroft KJ: Henry Ford Health System; Sidovar MF: Boehringer-Ingelheim Pharmaceuticals; Oliveria SA: IQVIA; Trudeau JJ: Boehringer-Ingelheim Pharmaceuticals | ||||
International Congress on Schizophrenia Research (ICOSR) |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2016 | English | , Epidemiological study, Retrospective database analysis | |
Comparative Assessment of US Healthcare Databases and Linkage Capabilities for Pharmacoepidemiology Studies | ||||
Casso D, Johnson K, Phillips S, Anderson A, Oliveria SA. | ||||
Casso D: IQVIA; Johnson K: IQVIA (formerly), Phillips S: IQVIA; Anderson A: IQVIA; Oliveria SA: IQVIA | ||||
2016 International Conference on Pharmacoepidemiology and Therapeutic Risk Management |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Patient Registries & Real-World Study Methods | 2016 | English | , Database Study, Review | |
Guidelines for Breast Cancer Gene Mutation Testing in Healthy Individuals and Patients Diagnosed with Breast Cancer | ||||
Casso D, Telford C, Oliveria SA, Saggar JK, Tyczynski JE. | ||||
Casso D: IQVIA; Telford C: AstraZeneca; Oliveria SA: IQVIA; Tyczynski JE: AstraZeneca | ||||
6th International Symposium on Hereditary Breast and Ovarian Cancer, Montreal, Canada |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Literature Review, Review | |
Towards an understanding of the Challenges and Opportunities when Studying Emerging Therapies. | ||||
Mack, CD. Gokhale M. | ||||
Current Epidemiology Reports. 2016 Dec. Vol 3 No 4. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
2016 | English | |||
Economic Burden of HIV Antiretroviral Therapy Adverse Events in the United States. | ||||
Dekoven M, Makin C, Slaff S, Marcus M, Maiese EM. | ||||
IMS Health, Fairfax, VA, USA. Yoh Services LLC, Philadelphia, PA, USA. Merck Sharp & Dohme Corp, Whitehouse Station, NJ, USA emaiese@gmail.com | ||||
J Int Assoc Provid AIDS Care. 2016 Jan-Feb;15(1):66-76 |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/26224690 | ||||
Condition | Year | Language | Analysis type | |
, HIV AIDS | 2016 | English | , Retrospective database analysis | |
Real-World Axitinib Use in the United States: A Retrospective Study Using Linked Datasets. | ||||
MacLean E, Cisar L, Mehle K, Eremina D, Quigley JM | ||||
Outcomes and Evidence, Global Health and Value, New York, New York. US Medical Affairs, Oncology, Pfizer, New York, New York. Commercial Effectiveness Services, IMS Health, Plymouth Meeting, Pennsylvania. Statistical Methodology, IMS Health, Plymouth Meeting, Pennsylvania. Commercial Effectiveness Services, IMS Health, Plymouth Meeting, Pennsylvania. | ||||
J Manag Care Spec Pharm. 2016 Jun;22(6):723-732u |
||||
, Abstract | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/27231799 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Retrospective database analysis | |
Axitinib as Subsequent Therapy in Renal Cell Carcinoma: Real-World Treatment Patterns in the United States | ||||
MacLean E1, Mehle K2, Eremina D2, Quigley J2 | ||||
1 Pfizer, New York, US, 2 IMS Health, Plymouth Meeting, US | ||||
American Society of Clinical Oncology, 2014 JMCP; 2015; 21(4):S15 |
||||
, Abstract | ||||
, USA | ||||
Abstract: http://www.amcp.org/mwg-internal/ogf7f4h09szyk7/progress?id=WFRYx0FI68JadqynyZ9ANLnilO3lKxogo0_mDztGEXc,&dl | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Retrospective database analysis | |
THE COST AND LENGTH OF STAY OF HOSPITAL EMERGENCY DEPARTMENT VISITS FOR CHRONIC HEART FAILURE PATIENTS IN CANADA | ||||
Fischer AA1, Liu N1, Borelli R1, Zaour N2, Barbeau M2 | ||||
1IMS Brogan, Mississauga, ON, Canada, 2Novartis Pharmaceuticals Canada Inc., Dorval, QC, Canada | ||||
ISPOR 18th Annual European Congress Milan, Italy November, 2015 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2015 | English | , Cost analysis | |
UTILIZATION AND COST OF SUPPORTIVE CARE AMONG PATIENTS RECEIVING NAB-PACLITAXEL + GEMCITABINE VERSUS FOLFIRINOX FOR METATSTATIC PANCREATIC CANCER | ||||
Patel M1, Parisi M1, Hill JW2, De AP2, Wade RL2 | ||||
Celgene Corporation, Summit, NJ, USA, 2IMS Health, Plymouth Meeting, PA, USA | ||||
ISPOR 21th, May 2016 Washington, DC USA |
||||
, Poster | ||||
, USA | ||||
Abstract: http://www.ispor.org/ | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Cost analysis | |
Chemotherapy treatment patterns, costs, and outcomes of patients with gastric cancer in the United States: a retrospective analysis of electronic medical record (EMR) and administrative claims data. | ||||
Hess L, Michael D,Mytelka D, Beyrer J, Liepa1 A and Nicol S | ||||
Lilly Oncology | ||||
Gastric Cancer |
||||
, Article | ||||
, USA | ||||
Abstract: http://scholar.google.com/scholar_url?url=http://link.springer.com/article/10.1007/s10120-015-0486-z/fulltext.html&hl=en&sa=X&scisig=AAGBfm3--GVI9iCpWS5h2bj0yC44jPhJVQ&nossl=1&oi=scholaralrt | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Retrospective database analysis | |
Axitinib as subsequent therapy in renal cell carcinoma: real world treatment patterns in the United States | ||||
MacLean E, Mehle K, Eremina D, Quigley J | ||||
Pfizer Global Health & Value, New York, NY | ||||
, Poster | ||||
, USA | ||||
Abstract: http://congress-download.pfizer.com/public/download.aspx?docID=my4%2fLzgcvl8%3d | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Retrospective cohort analysis | |
Increased Treatment Cost Associated with Mantle Cell Lymphoma Disease Progression | ||||
Wade R1, Hu X2, Chen Y3, Mahmoud D4, Le Gouill S3 | ||||
IMS Health Global Market Access, Celgene, Summit, NJ, USA, Haematology Department, CHU Nantes and UMR892 INSERM, Nantes, France | ||||
EHA 2015, Congress of the European Hematology Association, June 2015 |
||||
, Abstract, Poster | ||||
, France, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Cost analysis | |
Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugs | ||||
Saine ME, Carbonari DM, Newcomb CW, et al. | ||||
Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania | ||||
BMC Pharmacology and Toxicology 2015, 16:8 doi:10.1186/s40360-015-0007-z |
||||
, Article | ||||
, UK, USA | ||||
Abstract: http://www.biomedcentral.com/2050-6511/16/8 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2015 | English | , Retrospective database analysis | |
Innovations in Oncology: A medical and commercial trend report for marketers of anti-cancer modalities | ||||
IMS Health | ||||
, Book | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
2015 | English | , Retrospective database analysis | ||
Evaluation of Pharmaceutical Transaction Data for Potential Augmentation of SEER Treatment Data | ||||
Cronin, K., Barrett, M., Warren, J., Tran, Q., Annett, D., Pressman, E., Wu, X., Hsieh, M., Pirolli, M., Penberthy, L. | ||||
SEER |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Retrospective database analysis | |
An audit of patients transferred out of The Health Improvement Network (THIN) – A UK primary care database | ||||
Myland M, Ansell D,Bourke A,Hill F,O’Leary C,Waples C,Nasser A | ||||
IMS Health | ||||
31st International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) Boston, USA |
||||
, Poster, Presentation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2015 | English | , Database Study, Retrospective database analysis | |
Exploring innovative methods to identify patient subgroup treatment response | ||||
Rigg J,Hankins, M,Roddam A, Avorn A, Kim J | ||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2015 | English | , Methodology | |
Audit of irreversible monoamine oxidase inhibitors (MAOI) prescription for depression in current clinical practice within the health improvement network (THIN) UK primary care database | ||||
O’Leary C, Nasser A, Myland M, Waples S & Ansell D | ||||
IMS Health | ||||
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual International Meeting Philadelphia, USA |
||||
, Abstract, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2015 | English | , Database Study, Retrospective database analysis | |
Prevalence of bone loss among nonmetastatic breast cancer patients treated with aromatase inhibitors in the United States | ||||
Pirolli M, Hernandez R, Reich A, Liede A | ||||
Amgen | ||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Epidemiological study | |
Estimating the Budget Impact of Switching from Bortezomib Intravenous (IV) to Bortezomib Subcutaneous (SQ) in the Treatment of Relapsed/Refractory Multiple Myeloma (MM) in Mexico | ||||
Wehler EA1, Kowal S2, Hernandez-Garduno A3, Danese de los Santos L3, De Anda, Anaya P5, Munakata J6, Gonzalez-Michaca L7 | ||||
1IMS Health, Plymouth Meeting, PA, USA 2IMS Health, Seattle, WA, USA 3Janssen, Mexico City, Mexico 4IMS Health, Mexico City, Mexico 5IMS Health, Mexico, D.F., Mexico 6IMS Heath, San Francisco, CA, USA 7Janssen, Raritan, NJ, USA | ||||
Value Health, 2015, 18(7); A818 |
||||
, Poster | ||||
, Mexico, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Cost analysis | |
CURRENT TREATMENT PATTERNS IN PATIENTS WITH METASTATIC MELANOMA: A RETROSPECTIVE CLAIMS DATABASE ANALYSIS IN THE UNITED STATES (US) | ||||
Chen Y1, Ma Q2, Hines DM1, Zhao Z2, Munakata J3, Barber BL2 | ||||
1IMS Health, Fairfax, VA, USA, 2Amgen Inc, Thousand Oaks, CA, USA, 3IMS Health, San Francisco, CA, USA | ||||
ISPOR 18th Annual European Congress Milan, Italy November, 201 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
2015 | English | |||
THE BUDGET IMPACT OF ORPHAN DRUGS IN THE US AND CANADA: A 2007-2013 MIDAS SALES DATA ANALYSIS | ||||
Divino V1, DeKoven M1, Kim T2, Kleinrock M1, Wade RL1, Kaura S3 | ||||
1IMS Health, Fairfax, VA, USA, 2Celgene Corporation, Mississauga, ON, Canada, 3Celgene Corporation, Summit, NJ, USA | ||||
ISPOR 18th Annual European Congress Milan, Italy November, 2015 Value in Health, 2015, 18(7): A666 |
||||
, Poster | ||||
, Canada, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/26533734 | ||||
Condition | Year | Language | Analysis type | |
2015 | English | , Budget impact | ||
Drug utilization pattern of Lisdexamfetamine Dimesylate (LDX) in Europe | ||||
Cook M1, Varughese S1, Maxwell T1, Thun B2, Ehlken B2, Bredow D2Keja J2 | ||||
1 Shire, Wayne, PA, USA; 2 IMS HEALTH GmbH & Co. OHG, Real-World Evidence Solutions, Germany | ||||
ISPOR 18th Annual European Congress, 7-11 November 2015, Milan, Italy |
||||
, Poster | ||||
, Germany, USA | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2015 | English | , Database Study | |
Comparative Effectiveness of Oxaliplatin Versus 5-flourouricil in Older Adults: An Instrumental Variable Analysis. | ||||
Mack CD1, Brookhart MA, Glynn RJ, Meyer AM, Carpenter WR, Sandler RS, Stürmer T. | ||||
Department of Epidemiology, UNC Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC | ||||
Epidemiology. 2015 Sep;26(5):690-9. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment, Oncology | 2015 | English | , Retrospective database analysis | |
Economic impact of severe and non-severe hypoglycemia in patients with Type 1 and Type 2 diabetes in the United States. | ||||
Foos V1, Varol N, Curtis BH, Boye KS, Grant D, Palmer JL, McEwan P | ||||
1 IMS Health , Basel , Switzerland | ||||
J Med Econ., 2015, 18(6): 420-32 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2015 | English | , Economic evaluation | |
Adherence and Persistence Patterns in Medication Use Among Men With Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia. | ||||
Shortridge E1, Donatucci C2, Donga P3, Marcus M3, Wade RL3. | ||||
1 Eli Lilly and Company, Indianapolis, IN, USA. 2 Eli Lilly and Company, Indianapolis, IN, USA donatucci_craig_f@lilly.com. 3 IMS Health, Plymouth Meeting, PA, USA. | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Urology | 2015 | English | , Retrospective database analysis | |
Symptom report and treatment experience of hypogonadal men with and without type 2 diabetes in a United States health plan. | ||||
Shortridge EF1, Polzer P2, Donga P3, Wade RL3 | ||||
1 Spine and Biologics, Medtronic Inc., Memphis, TN, USA. 2 Global Health Outcomes, Eli Lilly and Company, Indianapolis, IN, USA. 3 Health Economics and Outcomes Research, IMS Health, Plymouth Meeting, PA, USA. | ||||
Int J Clin Pract. 2015 Jul;69(7):783-90. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Endocrinology | 2015 | English | , Retrospective database analysis | |
Treatment frequency of ranibizumab injections and dexamethasone implants for the management of branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO): a retrospective cohort study using a us claims database. | ||||
Nghiem-Buffet S1, Regnier 2, Freitas R3, Skelly A4, Yu N5 | ||||
1 Centre Ophtalmologique d’Imagerie et de Laser, Paris, France 2 Novartis Pharma AG, Basel, Switzerland 3 Wellmera AG, Basel, Switzerland 4 Novartis Ireland Limited, Dublin, Ireland 5 IMS Health, London, United Kingdom | ||||
15th European School for Advanced Studies in Ophthalmology (ESASO) Retina Academy, 2015, 22-24th October, Barcelona, Spain |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2015 | English | , clinical setting: Secondary care, Epidemiological study, Retrospective cohort analysis | |
Clinical effectiveness of ranibizumab and aflibercept for nAMD: a retrospective cohort study using electronic medical records from the US. | ||||
Dugel PU1, Griner R2, Milnes F3, Ferreira A3, Freitas R4 | ||||
1 Retinal Consultants of Arizona/USC Eye Institute, Arizona/California, USA 2 IMS Health Inc., Massachusetts, USA 3 Novartis Pharma AG, Basel, Switzerland 4 Wellmera AG, Basel, Switzerland | ||||
15th European School for Advanced Studies in Ophthalmology (ESASO) Retina Academy, 2015, 22-24th October, Barcelona, Spain |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2015 | English | , clinical setting: Secondary care, Epidemiological study, Retrospective cohort analysis | |
Clinical effectiveness of ranibizumab and aflibercept for PED: a retrospective cohort study using electronic medical records from the US. | ||||
Dugel PU1, Griner R2, Ferreira A3, Milnes F3, Freitas R4 | ||||
1 Retinal Consultants of Arizona/USC Eye Institute, Arizona/California, USA 2 IMS Health Inc., Massachusetts, USA 3 Novartis Pharma AG, Basel, Switzerland 4 Wellmera AG, Basel, Switzerland | ||||
15th European School for Advanced Studies in Ophthalmology (ESASO) Retina Academy, 2015, 22-24th October, Barcelona, Spain |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2015 | English | , clinical setting: Secondary care, Epidemiological study, Retrospective cohort analysis | |
Economic Burden of Tyrosine Kinase Inhibitor Treatment Failure in Chronic Myeloid Leukemia. | ||||
Knopf KB., Divino V., McGarry L., Chen YJ., Pokras S., Munakata J., Taylor C., Ng D., Nieset C., Huang H. | ||||
ARIAD. IMS authors: Divino V, Munakata J | ||||
Clin Lymphoma Myeloma Leuk |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/26411541 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Burden of illness | |
Clinical and economic burden of breakthrough seizures. | ||||
Divino V., Petrilla AA., Bollu V., Velez F., Ettinger A., Makin C. | ||||
Sunovion. IMS authors: Divino V | ||||
Epilepsy Behav |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/26255884 | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2015 | English | , Retrospective database analysis | |
Real-World Treatment Patterns and Outcomes Among Patients with Hairy Cell Leukemia | ||||
Karve S., Divino V., Gaughan A., DeKoven M., Gao G., Lanasa MC. | ||||
AstraZeneca, MedImmune. IMS authors: Divino V, DeKoven M | ||||
57th ASH Annual Meeting and Exposition |
||||
, Poster | ||||
, USA | ||||
Abstract: https://ash.confex.com/ash/2015/webprogramscheduler/Paper84903.html | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Retrospective database analysis | |
Healthcare Utilization and Costs Among Patients with Hairy Cell Leukemia: Analysis of a Large US Administrative Claims Database | ||||
Divino V., Karve S., Gaughan A., DeKoven M., Gao G., Lanasa MC. | ||||
AstraZeneca, MedImmune. IMS authors: Divino V, DeKoven M | ||||
57th ASH Annual Meeting and Exposition |
||||
, Poster | ||||
, USA | ||||
Abstract: https://ash.confex.com/ash/2015/webprogramscheduler/Paper84933.html | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Retrospective database analysis | |
Montelukast Use and Patterns of Ambulatory Care among Asian versus Non-Asian Adult Patients with Asthma and/or Allergic Rhinitis in the United States | ||||
Vasey J, Bagga S, Huang H, Wang T, Thompson D | ||||
Huan Huang is at IQVIA | ||||
JHEOR |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.jheor.org/respiratory-diseases/212-montelukast-use-and-patterns-of-ambulatory-care-among-asian-versus-non-asian-adult-patients-with-asthma-and-or-allergic-rhinitis-in-the-united-states | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2015 | English | , Population Based Study, Retrospective database analysis | |
Comparative Effectiveness of Oxaliplatin vs. 5-flourouricil in Older Adults: An Instrumental Variable Analysis. | ||||
Mack CD, Brookhart MA, Glynn RJ, Meyer AM, Carpenter WR, Sandler RS, Stürmer T. | ||||
Epidemiology. 2015 Sep;26(5):690-9. | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
2015 | English | |||
Prevention, Examination and Treatment of Missing Data in Nonexperimental Pharmacoepidemiologic Studies. | ||||
Mack CD, Su Z, Mendelsohn A, Dreyer NA. | ||||
Chinese Journal of Pharmacoepidemiology. 2015 Jan. Vol 24 No 1. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
2015 | English | |||
Provider-based research networks may improve early access to innovative colon cancer treatment for African Americans. Cancer. | ||||
Penn DC, Chang YK, Meyer AM, Mack CD, Sanoff HK, Stitzenberg K, Carpenter WR. | ||||
2015 Jan 1;121(1):93-101. Epub 2014 Sep 10. | ||||
2015 Jan 1;121(1):93-101. Epub 2014 Sep 10. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
2015 | English | |||
Non-adherence to antiplatelet therapy after hospitalization for acute coronary syndrome (ACS) increases readmissions, mortality, health care use and costs. | ||||
Hill J1, Pokras S2, Foody J3, Schabert V4, Makin C5, Nelson M2 | ||||
1 IMS Health, Plymouth Meeting, USA 2 IMS Health, Alexandria, USA 3 Brigham and Women’s Hospital, Boston, USA 4 IMS Health, Woodland Hills, USA, 5 IMS Health, Falls Church, USA | ||||
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 19th Annual International Meeting, 2014, May, Montreal, Canada |
||||
, Podium presentation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2014 | English | , Retrospective database analysis | |
Increasing burden of tyrosine kinase inhibitor (TKI) treatment failure with later lines of therapy in chronic myeloid leukemia: a real world retrospective database analysis. | ||||
Chen Y1, Huang H2, Divino V1, Pokras S1, Hallinan S1, Munakata J1, Taylor C2, McGarry L2, Malone D3 | ||||
IMS Health, USA 2 Ariad Pharmaceuticals, Inc, Cambridge, USA 3 University of Arizona College of Pharmacy, Phoenix, USA | ||||
Academy of Managed Care Pharmacy 26th Annual Meeting & Expo, 2014, April, Tampa, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
Building a real world non-small cell lung cancer cohort by linking a claims database to oncology electronic medical records. | ||||
Chen C1, Wade R2, Khan N1, Pokras S3, Semonelli C1, Zeng S1, Marcus M1 | ||||
1 IMS Health, Plymouth Meeting, USA 2 IMS Health, Parsippany, USA, 3 IMS Health, Alexandria, USA | ||||
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 19th Annual International Meeting, 2014, May, Montreal, Canada |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
Selecting ovarian cancer patients for BRCA mutation testing - Findings from guidelines and literature review | ||||
Eccles D1, Garcia E2, Balmana J3, Ehlken B4, Schroeder C4, Clune J5, Hirst C6, Potter D6, Tyczynski J6 | ||||
1 University of Southampton, Southampton, UK 2 Maastricht UMC, Maastricht, Netherlands 3 Familial Cancer Program, Barcelona, Spain 4 IMS Health, München, Germany 5 AstraZeneca, Melbourne, UK 6 AstraZeneca, Gaithersburg, USA | ||||
Conference of The British Society of Genetic Medicine (BSGM), Liverpool, UK, 22–24 September, 2014 (Poster) |
||||
, Abstract | ||||
, Germany, Netherlands, Spain, UK, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Literature Review | |
Description of Cardiovascular Event Rates in Patients Initiating Chronic Opioid Therapy for Noncancer Pain in Observational Cohort Studies in the US, UK, and Germany | ||||
LoCasale R1, Kern DM2, Chevalier P3, Zhou S2, Chavoshi S1, Sostek M | ||||
1 AstraZeneca, Wilmington Delaware, USA 2 HealthCore Inc., Wilmington Delaware, USA 3 IMS Health, Vilvoorde, Belgium | ||||
Adv Ther. 2014 Jul;31(7):708-23 |
||||
, Manuscript in preparation | ||||
, Germany, UK, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Pain | 2014 | English | , Epidemiological study, Retrospective database analysis | |
Persistence with fingolimod versus dimethyl fumarate in patients with multiple sclerosis: Retrospective analysis of US open-source pharmacy data | ||||
Bergvall N1, Lahoz R1, Nazareth T2, Korn JR3 | ||||
Novartis Pharma AG, Basel, Switzerland, 2Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, 3IMS Health, Waltham, MA, USA | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2014 | English | , Compliance | |
Persistence in open and closed data sources: A study of fingolimod versus interferons/glatiramer acetate in patients with multiple sclerosis | ||||
Lahoz R1, Bergvall N1, Nazareth T2, Korn JR3 | ||||
Novartis Pharma AG, Basel, Switzerland, 2Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, 3IMS Health, Waltham, MA, USA | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2014 | English | , Retrospective database analysis | |
Demographic and Comorbidity Characteristics of Newly Diagnosed Multiple Myeloma Patients in the United States: A Real World Data Analysis | ||||
Chen Y, De A, Cong Z, Aggarwal S, Wade R | ||||
Onyx Pharmaceuticals, Inc | ||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Real World Evidence | |
Characterization of HER2 Testing and Treatment Patterns among Gastric Cancer Patients in the United States using the Oncology Services Comprehensive Electronic Records (OSCER) Database | ||||
Lowe K1, Reich A2, Bobiak S2, Chau D1, Quigley J2, Kelsh M1 | ||||
1 Amgen, Inc. 2 IMS Health | ||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Review | |
Validation of Bone Metastases Coding in an Oncology Electronic Medical Records Database and a Commercial Claims Database | ||||
Hernandez, R1, Quach, D2, Wade, S3, Pirolli, M2, Reich, A2, Quigley, J2, Liede, A1 | ||||
1. Center for Observational Research, Amgen Inc., CA 2. IMS Health, Plymouth Meeting, PA 3. Wade Outcomes Research and Consulting, Salt Lake City, UT | ||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
Prevalence of Renal Impairment (RI) and Use of Nephrotoxic Agents Among Patients with Bone Metastases From Solid Tumors in the United States | ||||
Pirolli, M, Quach, D, Quigley, J | ||||
Cancer Medicine |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
Evidence-based insights in oncology: The journey is only just beginning | ||||
Ghai C | ||||
RWE Solutions & HEOR, IMS Health, New York, USA | ||||
AccessPoint, 2014, May; 4(8): 14-20 |
||||
, Article | ||||
, USA | ||||
Abstract: http://issuu.com/ims_heor_publications/docs/ims_rwe_accesspoint_8_-_250514f_iss | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Oncology | 2014 | English | , Real World Evidence | |
Cost-effectiveness models for chronic obstructive pulmonary disease: cross-model comparison of hypothetical treatment scenarios. | ||||
Hoogendoorn M1, Feenstra TL2, Asukai Y3, Borg S4, Hansen RN5, Jansson SA6, Samyshkin Y3, Wacker M7, Briggs AH8, Lloyd A3, Sullivan SD5, Rutten-van Mölken1 MP. | ||||
1Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The Netherlands. 2Department for Prevention and Health Services Research, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; Department of Epidemiology, University Medical Centre Groningen, The Netherlands.3IMS Health, Health Economics and Outcomes Research, Real-World Evidence Solutions, London, UK 4The Swedish Institute for Health Economics, Lund, Sweden 5Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington, Seattle, WA, USA 6The OLIN Studies, Luleå, Sweden 7Helmholtz Zentrum München, Institute of Health Economics and Health Care Management, Comprehensive Pneumology Center Munich, Neuherberg, Germany. 8Institute of Health & Wellbeing, University of Glasgow, UK. | ||||
Value Health. 2014 Jul;17(5):525-36. |
||||
, Article | ||||
, Germany, Netherlands, Sweden, UK, USA | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2014 | English | , Cost effectiveness | |
Prevalence of women with early-stage breast cancer receiving active management using electronic health records from oncology clinics in the United States. | ||||
Hernandez RK1, Quach D, Wade SW, Pirolli M, Quigley J, Narod SA, Liede A. | ||||
1Center for Observational Research, Amgen Inc, IMS Health Plymouth, | ||||
Breast Cancer Res Treat. 2014 Aug;146(3):637-46 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
Estimating the annual medical costs for newly treated dupuytren’s contracture patients in the real world. | ||||
Kowal S, Ferrufino C, Munakata J, Tursi J | ||||
Academy of Managed Care Pharmacy (AMCP) 26th annual Meeting & Expo, 2014 April, Tampa, FL |
||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2014 | English | , Cost analysis | |
Consequences of patient access restrictions to branded oxycodone hydrochloride extended-release tablets on healthcare utilization and costs in US health plans | ||||
Ben-Joseph R1, Chen CC, De AP, Wade RL, Shah D. | ||||
IMS Health, Plymouth Meeting, PA, USA Purdue Pharma L.P. , Stamford, CT , USA. | ||||
J Med Econ. 2014 Oct;17(10):708-18. |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.tandfonline.com/doi/pdf/10.3111/13696998.2014.925464?needAccess=true | ||||
Condition | Year | Language | Analysis type | |
, Pain | 2014 | English | , Retrospective database analysis | |
Implementation of a pharmacy-based adult vaccine benefit: recommendations for a commercial health plan benefit. | ||||
Ko KJ1, Wade RL2, Yu HT, Miller RM, Sherman B, Goad J. | ||||
1 Cerner Research, 600 Corporate Pointe, Ste. 320, Culver City, CA 90230, USA. 2 IMS Health, Parsippany, New Jersey; | ||||
J Manag Care Spec Pharm. 2014 Mar;20(3):273-82 |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.jmcp.org/doi/pdf/10.18553/jmcp.2014.20.3.273 | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2014 | English | , Literature Review, Public Health | |
Comparative assessment of adherence measures and resource use in SSRI/SNRI-treated patients with depression using second-generation antipsychotics or L-methylfolate as adjunctive therapy. | ||||
Wade RL1, Kindermann SL, Hou Q, Thase ME. | ||||
IMS Health, 11 Waterfront Blvd., Parsippany, NJ 07054, USA | ||||
, Article | ||||
, USA | ||||
Abstract: http://www.jmcp.org/doi/pdf/10.18553/jmcp.2014.20.1.76 | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2014 | English | , Retrospective database analysis | |
Treatment patterns of ranibizumab and aflibercept for the management of wet age-related macular degeneration in routine clinical practice in the United States. | ||||
Ferreira A1, Sagkriotis A1, Milnes F1, Olson M1, Hill J2, Lu J2, Makin C2 | ||||
1 Novartis Pharma AG, Basel, Switzerland 2 IMS Health, Plymouth Meeting, PA, USA | ||||
International Society For Pharmacoeconomics and Outcomes Research (ISPOR) 16th Annual European Congress, 2013, Dublin, Ireland |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2014 | English | , clinical setting: Secondary care, Epidemiological study, Retrospective database analysis | |
Treatment patterns for patients starting anti-VEGF therapy for retinal vein occlusion in US clinical practice. | ||||
Lotery AJ1, Bleier J2, Regnier S3 | ||||
1 Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK 2 IMS Health, London, UK 3 Novartis Pharma AG, Basel, Switzerland | ||||
Annual Meeting of American Academy of Ophthalmology (AAO), 2014 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2014 | English | , Clinical setting: hospital, clinical setting: Secondary care, Epidemiological study, Observational study | |
Treatment patterns of ranibizumab and aflibercept in neovascular age-related macular degeneration- evidence from two large US claims databases. | ||||
Dugel P, Kiss S, Makin C, Johnston SS, Turpcu A | ||||
14th annual Congress of the European Society of Retina Specialists (EURETINA), 2014, London, UK |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2014 | English | , clinical setting: Secondary care, Epidemiological study, Observational study | |
Frequency of ophthalmologist visits for patients starting ranibizumab treatment for visual impairment due to macular edema secondary to central retinal vein occlusion- an analysis of US clinical practice data. | ||||
Bleier J1, Regnier S2 | ||||
1 IMS Health, London, UK 2 Novartis Pharma AG, Basel, Switzerland | ||||
14th annual Congress of the European Society of Retina Specialists (EURETINA), 2014, London, UK |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2014 | English | , clinical setting: Secondary care, Epidemiological study, Retrospective cohort analysis | |
Endophthalmitis following ranibizumab or aflibercept treatment in patients with neovascular age-related macular degeneration- a retrospective US database analysis. | ||||
Kelly S, Ferreira A, Hashmonay R, Lu J, Souied E | ||||
14th annual Congress of the European Society of Retina Specialists (EURETINA) 2014, London, UK |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2014 | English | , clinical setting: Secondary care, Epidemiological study, Retrospective database analysis | |
A real-world comparison of the frequency of patient visits for patients starting treatment for wet age-related macular degeneration with ranibizumab or aflibercept. | ||||
Ferreira A1, Milnes F1, Olson M2, Lu J2, Makin C2 | ||||
1 Novartis Pharma AG, Basel, Switzerland 2 IMS Health, Plymouth Meeting, USA | ||||
World Ophthalmology Congress, 2014, Tokyo, Japan |
||||
, Oral presentation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2014 | English | , clinical setting: Secondary care, Epidemiological study, Observational study | |
A real-world comparison of the frequency of patient visits for patients starting treatment for wet age-related macular degeneration with ranibizumab or aflibercept. | ||||
Ferreira A1, Milnes F1, Olson M2, Lu J2, Makin C2 | ||||
1 Novartis Pharma AG, Basel, Switzerland 2 IMS Health, Plymouth Meeting, USA | ||||
World Ophthalmology Congress, 2014, Tokyo, Japan |
||||
, Oral presentation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
2014 | English | , clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective database analysis | ||
Interventional differences among Huntington's disease patients by disease progression in commercial and medicaid | ||||
Anderson KE., Divino V., DeKoven M., Langbehn D., Warner JH., Giuliano J., Lee WC. | ||||
CHDI. IMS authors: Divino V, DeKoven M | ||||
J Huntingtons Dis. |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/25575957 | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2014 | English | , Burden of illness, Retrospective database analysis | |
The Budget Impact of Orphan Drugs in the U.S.: A 2007-2013 MIDAS Sales Data Analysis | ||||
Victoria Divino, Mitch Dekoven, Weiying Wang, Michael Kleinrock, R. Donald Harvey, Rolin L Wade, and Satyin Kaura | ||||
Celgene, IMS authors: Victoria Divino, Mitch Dekoven, Michael Kleinrock, Rolin L Wade | ||||
2014 American Society of Hematology (ASH) Annual Meeting |
||||
, Oral presentation | ||||
, USA | ||||
Abstract: http://www.bloodjournal.org/content/124/21/736 | ||||
Condition | Year | Language | Analysis type | |
, Rare disease | 2014 | English | , Budget impact | |
Economic burden of tyrosine kinase inhibitor (TKI) treatment failure in patients with chronic myeloid leukemia (CML). | ||||
Yaozhu J Chen, Hui Huang, Victoria Divino, Shibani Pokras, Shawn Hallinan, Julie Munakata, Catherine Taylor, Lisa McGarry, Daniel Ng, Christopher Nieset, Kevin B. Knopf | ||||
ARIAD; IMS authors: Victoria Divino, Julie Munakata | ||||
2014 ASCO Annual Meeting |
||||
, Poster | ||||
, USA | ||||
Abstract: http://meetinglibrary.asco.org/record/92488/abstract | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
Comparison of Health Care Resource Utilization and Costs in Treatment-Adherent Patients with Epilepsy with and without Breakthrough Seizures in A U.S. Managed Care Population | ||||
Charles Makin, Allison Petrilla, Victoria Divino, Vamsi Bollu, Fulton Velez, Shawn Hallinan and Alan Ettinger | ||||
Sunovion; IMS authors: Victoria Divino | ||||
American Academy of Neurology 66th Annual Meeting |
||||
, Poster | ||||
, USA | ||||
Abstract: http://www.neurology.org/content/82/10_Supplement/P5.069 | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2014 | English | , Retrospective database analysis | |
Real-World Persistence and Treatment Failure Associated with First Line Use of Antiepileptic Drug Treatment in a Large U.S. Managed Care Population | ||||
Victoria Divino, Allison Petrilla, Shawn Hallinan, Vamsi Bollu, Fulton Velez, Alan Ettinger and Charles Makin | ||||
Sunovion; IMS authors: Victoria Divino | ||||
American Academy of Neurology 66th Annual Meeting |
||||
, Poster | ||||
, USA | ||||
Abstract: http://www.neurology.org/content/82/10_Supplement/P5.072 | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2014 | English | , Retrospective database analysis | |
The disease burden of pertussis in adults 50 years old and older in the United States: a retrospective study | ||||
McGuiness Balderston C1, Hill J1, Fonseca E1, Hess G1, Hitchcock W2, Krishnarajah G3 | ||||
1 IMS Health, Plymouth Meeting, USA 2 La Jolla Pediatrics, San Diego, USA 3 GlaxoSmithKline, Pennsylvania, USA | ||||
BMC Infectious Diseases.2013, 13:32 |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23343438 | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2013 | English | , Retrospective database analysis | |
Dabigatran Etexilate is Associated with Shorter Hospital Length of Stay and Lower Hospital Costs Compared to Warfarin in Treatment-Naïve, Newly-Diagnosed Non-Valvular Atrial Fibrillation Patients | ||||
Fonseca E1, Walker DR2, Hess G1 | ||||
1IMS Health, Plymouth Meeting, USA 2 Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, USA | ||||
AHA QCOR Cardiovascular Disease and Stroke 2013 Scientific Conference. Baltimore, MD, May 15-17, 2013 |
||||
, Poster | ||||
, USA | ||||
Abstract: http://circoutcomes.ahajournals.org/cgi/content/meeting_abstract/6/3_MeetingAbstracts/A258 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2013 | English | , Cost benefit | |
Non-Valvular Atrial Fibrillation Emergency Department Encounters where Dabigatran Etexilate was Administered are Associated with Lower Admission Rate Compared to Encounters where Warfarin was Administered. | ||||
Fonseca E1, Walker DR2, Hess G1 | ||||
1 IMS Health, Plymouth Meeting, USA 2 Boehringer Ingelheim Pharmaceuticals, Ridgefield, USA | ||||
American Heart Association (AHA) Quality of Care and Outcomes Research (QCOR) Cardiovascular Disease and Stroke 2013 Scientific Conference. Baltimore, MD, May 15-17, 2013 |
||||
, Poster | ||||
, USA | ||||
Abstract: http://circoutcomes.ahajournals.org/cgi/content/meeting_abstract/6/3_MeetingAbstracts/A95 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2013 | English | , Cost benefit | |
Treatment Patterns: Targeted Therapies Indicated for First-Line Management of Metastatic Renal Cell Carcinoma in a Real-World Setting | ||||
Hess G1, Borker R2, Fonseca E1 | ||||
1 IMS Health, Plymouth Meeting, USA 2 GlaxoSmithKline, Philadelphia, USA | ||||
Poster presented at ASCO 2012 Genitourinary Cancers Symposium. San Francisco, CA, February 2-4, 2012 |
||||
, Poster | ||||
, USA | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23267717 | ||||
Condition | Year | Language | Analysis type | |
, Urology | 2013 | English | , Observational study | |
Use of Hospital Claim Data to Estimate the Clinical and Economic Burden of ACS Re-Hospitalizations in Real-World Clinical Practice | ||||
Hess, GP1, Bhandary MS2, Gandhi S2, Kumar D1, Fonseca E1, Gold A2 | ||||
1 IMS Health, Plymouth Meeting, USA 2 AstraZeneca Pharmaceuticals LP, Wilmington, USA | ||||
AHA QCOR Cardiovascular Disease and Stroke 2011 Scientific Conference. Washington, DC, May 12-14, 2011 |
||||
, Poster | ||||
, USA | ||||
Abstract: http://circoutcomes.ahajournals.org/cgi/content/meeting_abstract/4/6_MeetingAbstracts2011/AP11 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2013 | English | , Cost consequence | |
The Prevalence of Comorbid Conditions in US Patients with COPD | ||||
Hess G1, Fonseca E1 | ||||
1 IMS Health, Plymouth Meeting, USA | ||||
ISPOR 15th Annual International Meeting. Atlanta, GA, May 15-19, 2010 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2013 | English | , Observational study | |
Treatment Patterns: Targeted Therapies Indicated for First-Line Management of Metastatic Renal Cell Carcinoma in a Real-World Setting | ||||
Hess G1, Borker R2, Fonseca E1 | ||||
1 IMS Health, Plymouth Meeting, USA 2 GlaxoSmithKline, Research Triangle Park, USA | ||||
Clinical Genitourinary Cancer. 2012 Dec 22. pii: S1558-7673(12)00234-0 2011 Impact Factor: 2.6 |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23267717 | ||||
Condition | Year | Language | Analysis type | |
, Urology | 2013 | English | ||
Cost of palliative radiation to the bone for patients with bone metastases secondary to breast or prostate cancer | ||||
Hess G1, Barlev A2, Chung K2, Hill JW1, Fonseca E1 | ||||
1 IMS Health, Plymouth Meeting, USA 2 Amgen Inc, Thousand Oaks, USA | ||||
Radiation Oncology. 2012, 7:168. Impact Factor: 2.3. Published October 12, 2012 |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561237/ | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Cost analysis | |
Treatment patterns after castration resistant prostate cancer (CRPC) diagnosis: A European physician survey | ||||
Pokras SM1, Zyczynski T2, Lees M2, Powers J3, Jiao X1, Blanchette CM4 | ||||
1 IMS Health, Alexandria, VA, 2 Bristol-Myers Squibb, Lawrenceville, NJ, 3 University of Colorado, Denver, Colorado 4 University of North Carolina, Charlotte, NC | ||||
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 18th Annual International Meeting. May 20, 2013 |
||||
, Oral presentation | ||||
, USA | ||||
Abstract: http://www.ispor.org/awards/18meet/CA3%20Presentation.pdf | ||||
Condition | Year | Language | Analysis type | |
, Vascular disease | 2013 | English | , Observational study | |
The economic burden of dasatinib and nilotinib treatment failure in chronic myeloid leukemia (CML) patients: a real-world analysis | ||||
Pokras SM1, Divino V1, Ferrufino C1, Arnold RJA1, Huang H2 | ||||
1 IMS Health, Alexandria, USA 2 ARIAD Pharmaceuticals, Cambridge, USA | ||||
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 18th Annual International Meeting. May 20, 2013 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2013 | English | , Economic evaluation | |
Cost per treated patient for biologics for rheumatoid arthritis (RA) using US claims data. | ||||
Schabert VF1, Korn JR1, Bilir SP1, DeKoven M1, Harrison DJ2, Joseph G2 | ||||
1 IMS Health, Alexandria, USA, 2 Amgen Inc, Thousand Oaks, USA | ||||
European League Against Rheumatism 2013 Congress, Madrid, Spain |
||||
, Poster | ||||
, Spain, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2013 | English | , Cost analysis | |
Algorithm-based estimation of biologic effectiveness for rheumatoid arthritis | ||||
Yun H1, Schabert VF2, Yeaw J2, Korn JR3, Quach C4, Harrison DJ5, Joseph G5, Collier D5 | ||||
1 University of Alabama at Birmingham, Birmingham, USA 2 IMS Health, Alexandria, USA 3 IMS Health, Waltham, USA 4 University of North Carolina at Chapel Hill, Chapel Hill, USA 5 Amgen Inc, Thousand Oaks, USA | ||||
International Society for Pharmacoeconomics and Outcomes Research 18th International Meeting, New Orleans, LA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2013 | English | , Cost effectiveness | |
Effectiveness of second line biologic use in rheumatoid arthritis after switching from first-line biologics | ||||
Schabert VF1, Yeaw J1, Korn J2, Quach C3, Harrison DJ4, Yun H5, Joseph G4, Collier D4, Curtis J5 | ||||
1 IMS Health, Alexandria, VA, USA, 2 IMS Health, Waltham, MA, USA, 3 University of North Carolina at Chapel Hill, Chapel Hill, NC, USA, 4 Amgen Inc, Thousand Oaks, CA, USA, 5 University of Alabama, at Birmingham, Birmingham, AL, USA | ||||
International Society for Pharmacoeconomics and Outcomes Research 18th International Meeting, New Orleans, LA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2013 | English | , Review | |
Cost per treated patient for biologics across adult indications using claims data | ||||
Schabert VF1, Yeaw J1, Korn J2, Quach C3, Harrison DJ4, Yun H5, Joseph G4, Collier D4, Curtis J5 | ||||
1 IMS Health, Alexandria, VA, USA, 2 IMS Health, Waltham, MA, USA, 3 University of North Carolina at Chapel Hill, Chapel Hill, NC, USA, 4 Amgen Inc, Thousand Oaks, CA, USA, 5 University of Alabama, at Birmingham, Birmingham, AL, USA | ||||
International Society for Pharmacoeconomics and Outcomes Research 18th International Meeting, New Orleans, LA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2013 | English | , Cost analysis | |
Using a validated, claims data based algorithm to evaluate the effectiveness of self-injected vs. infused biologics for rheumatoid arthritis claims data | ||||
Schabert VF1, Yeaw J1, Korn J2, Quach C3, Harrison DJ4, Yun H5, Joseph G4, Collier D4, Curtis J5 | ||||
Academy of Managed Care Pharmacy 25th Annual Meeting, San Diego, CA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2013 | English | , Observational study | |
Costs of tumor necrosis factor blockers per treated patient with psoriatic disease using real-world drug utilization data in a U.S. managed care population | ||||
Schabert VF, Watson C, Burudpakdee C, Joseph G, Iverson P, Harrison DJ | ||||
71st American Academy of Dermatology Annual Meeting, Miami Beach, FL |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2013 | English | , Cost analysis | |
Estimating effectiveness and cost of biologics for rheumatoid arthritis: application of a validated algorithm to commercial insurance claims. | ||||
Curtis JR1, Schabert VF2, Harrison DJ3, Yeaw J2, Korn JR2, Quach C4, Yun H5, Joseph GJ3, Collier DH6. | ||||
1Division of Clinical Immunology and Rheumatology, University of Alabama, Birmingham, Alabama; Department of Epidemiology, University of Alabama, Birmingham, Alabama. Electronic address: jcurtis@uab.edu. 2IMS Health, Alexandria, Virginia. 3Global Health Economics, Amgen Inc, Thousand Oaks, California. 4Health Policy and Management, University of North Carolina, Chapel Hill, North Carolina. 5Department of Epidemiology, University of Alabama, Birmingham, Alabama. 6Inflammation/Development, Amgen Inc, Thousand Oaks, California. | ||||
Clin Ther. 2014 Jul 1;36(7):996-1004. |
||||
, Spain, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2013 | English | , Cost effectiveness | |
Risk Of Exacerbations In Chronic Obstructive Pulmonary Disease Patients Treated With Nebulized LABA Versus Nebulized SABA Treatments | ||||
Yeaw J1, Bollu V2, Karafilidis J2, Cen J, Hines D1, Makin C1 | ||||
1 IMS Health, Alexandria, USA 2 Sunovion Pharmaceuticals, Marlborough, USA | ||||
International Conference of the American Thoracic Society, May 17-22, 2013 in Philadelphia, Pennsylvania |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2013 | English | , Burden of illness | |
Direct medical costs for complications among adults with type 2 diabetes in a US commercial payer setting | ||||
Yeaw J1, Halinan S1, Hines D1, DeLozier A2, Perez M2, Boye M2, Boye KS2, Blanchette CM1 | ||||
1 IMS Health, Alexandria, USA 2 Eli Lilly and Company, Indianapolis, USA | ||||
Society for Pharmacoeconomics and Outcomes Research 18th Annual International Meeting, May 18-22, 2013 in New Orleans, LA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2013 | English | , Cost of illness | |
The efficacy and tolerability of perampanel and other recently approved/third generation anti-epileptic drugs for the treatment of refractory partial onset seizure: A systematic review and Bayesian network meta-analysis. | ||||
Khan N1, Shah D2, Tongbram V2, Verdian L3, Hawkins N2 | ||||
1 IMS Health, New York, USA 2 Oxford Outcomes, Morristown, USA 3 Eisai Inc., Hatfield, UK | ||||
Curr Med Res Opin. 2013 May 9 |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23659562 | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2013 | English | , Meta analysis | |
Utilization of Central Muscle Relaxants (CMRs) in patients initiating Butrans® (buponorphin transdermal system) | ||||
Hess G, Pergolizzi J, Chang CL, Ben-Joseph R, Pierz K. | ||||
The 32nd Annual Scientific Meeting of the American Pain Society |
||||
, Abstract, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Pain | 2013 | English | ||
Utilization of Central Muscle Relaxants (CMRs) in Patients initiating Butrans® (Buponorphin Transdermal System) | ||||
Hess G, Pergolizzi J, Chang CL, Ben-Joseph R, Pierz K | ||||
The 32nd Annual Scientific Meeting of the American Pain Society. New Orlean, LA. May 8-11, 2013 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Pain | 2013 | English | , Retrospective cohort analysis | |
Dosing of Patients Newly Treated with Butrans® (Buprenorphine Transdermal System) | ||||
Pergolizzi J, Hess G, Chang CL, Ben-Joseph R, Pierz K | ||||
The 32nd Annual Scientific Meeting of the American Pain Society. New Orlean, LA. May 8-11, 2013 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Pain | 2013 | English | , Retrospective database analysis | |
Factors predicting medication persistence among patients initiating buprenorphine transdermal system | ||||
Pergolizzi J, Hess G, Chang CL, Shah D, Pierz K, Ben-Joseph R | ||||
The 18th Annual International Meeting of the International Society of Pharmacoeconomics and Outcomes Research. New Orlean, LA. May 20-22, 2013 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Pain | 2013 | English | , Retrospective database analysis | |
Impact of dosage strength on medication persistence among patients treated with buprenorphine transdermal system | ||||
Pergolizzi J, Ben-Joseph R, Chang CL, Pierz K, Shah D, Hess G | ||||
The 18th Annual International Meeting of the International Society of Pharmacoeconomics and Outcomes Research. New Orlean, LA. May 20-22, 2013 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Pain | 2013 | English | , Observational study, Retrospective database analysis | |
Synchronization of administrations of chemotherapy and erythropoiesis-stimulating agents and frequency of associated healthcare visits | ||||
Hill J1, Shreay S2, McGarvey N3, Hess GP4, Corey-Lisle P2 | ||||
1 IMS Health, PA, USA 2 Amgen Inc., CA, USA 3 University of California, CA, USA 4 Leonard Davis Institute UPenn, PA, USA | ||||
, Article | ||||
, USA | ||||
Abstract: http://link.springer.com/article/10.1007/s00520-013-1830-7 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective cohort analysis | |
Persistence and adherence of fingolimod compared with other disease modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis. | ||||
Bergvall N1, Lahoz R1, Agashivala N2, Pradhan A2, Capkun-Niggli G1, Korn JR3, Petrilla AA3, Karkare SU3, Balderston McGuiness C3, Makin C3 | ||||
1Novartis Pharma AG, Basel, CH, 2Novartis Pharmaceuticals Corporation, East Hanover, US, 3IMS Health,Plymouth Meeting, US | ||||
29th Congree of European Committee for Treatment and Research in Multiple Sclerosis. 18th Annual Conference of Rehabilitation in MS. 2-5th October 2013, Copenhagen, Denmark. |
||||
, Abstract | ||||
, USA | ||||
Abstract: http://registration.akm.ch/einsicht.php?XNABSTRACT_ID=179263&XNSPRACHE_ID=2&XNKONGRESS_ID=195&XNMASKEN_ID=900 | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2013 | English | , Retrospective database analysis | |
Relapse rates among patients with multiple sclerosis who switch from interferon therapy to fingolimod or glatiramer acetate: a retrospective US claims database analysis | ||||
Bergvall N1, Lahoz R1, Agashivala N2, Pradhan A2, Capkun-Niggli G1, Korn JR3, Petrilla AA3, Karkare SU3, Balderston McGuiness C3, Makin C3 | ||||
1Novartis Pharma AG, Basel, CH, 2Novartis Pharmaceuticals Corporation, East Hanover, US, 3IMS Health,Plymouth Meeting, US | ||||
29th Congree of European Committee for Treatment and Research in Multiple Sclerosis. 18th Annual Conference of Rehabilitation in MS. 2-5th October 2013, Copenhagen, Denmark. |
||||
, Abstract | ||||
, USA | ||||
Abstract: http://registration.akm.ch/einsicht.php?XNABSTRACT_ID=179276&XNSPRACHE_ID=2&XNKONGRESS_ID=195&XNMASKEN_ID=900 | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2013 | English | , Retrospective database analysis | |
• Relapse rates among patients with a history of relapses treated with fingolimod compared with interferons or glatiramer acetate for the treatment of multiple sclerosis: a retrospective US claims database analysis | ||||
Bergvall N1, Lahoz R1, Agashivala N2, Pradhan A2, Capkun-Niggli G1, Korn JR3, Petrilla AA3, Karkare SU3, Balderston McGuiness C3, Makin C3 | ||||
1Novartis Pharma AG, Basel, CH, 2Novartis Pharmaceuticals Corporation, East Hanover, US, 3IMS Health,Plymouth Meeting, US | ||||
29th Congree of European Committee for Treatment and Research in Multiple Sclerosis. 18th Annual Conference of Rehabilitation in MS. 2-5th October 2013, Copenhagen, Denmark. |
||||
, Abstract | ||||
, USA | ||||
Abstract: http://registration.akm.ch/einsicht.php?XNABSTRACT_ID=179267&XNSPRACHE_ID=2&XNKONGRESS_ID=195&XNMASKEN_ID=900 | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2013 | English | , Retrospective database analysis | |
Comparative effectiveness of fingolimod versus interferons or glatiramer acetate for relapse rates in multiple sclerosis: a retrospective US claims database analysis | ||||
Bergvall N1, Lahoz R1, Agashivala N2, Pradhan A2, Capkun-Niggli G1, Korn JR3, Petrilla AA3, Karkare SU3, Balderston McGuiness C3, Makin C3 | ||||
1Novartis Pharma AG, Basel, Switzerland, 2Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, 3IMS Health, Plymouth Meeting, USA | ||||
Current Medical Research and Opinion, December 2013, Vol. 29, No. 12 : Pages 1647-1656 |
||||
, Abstract | ||||
, USA | ||||
Abstract: http://informahealthcare.com/doi/abs/10.1185/03007995.2013.847411 | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2013 | English | , Retrospective database analysis | |
Prevalence of renal impairment among cancer patients with bone metastases in the United States. | ||||
Shahinian V1, Chen K2, Hernandez R2, Quigley J3, Pirolli M3, Quach D3, Liede A2, Arellano J2 | ||||
1 Univ of Michigan Medical School, Ann Arbor, USA 2 Amgen, Inc, Thousand Oaks, USA 3 IMS Health, Plymouth Meeting, USA | ||||
American Society of Nephrology Kidney Week, 2013, November 5-10, Atlanta, USA (abstr TH-PO295, 171-A) |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Prevalence of renal insufficiency (RI) in cancer (Ca) patients (pts) with bone metastases (BM). | ||||
Chen K1, Hernandez R1, Quigley J2, Pirolli M2, Quach D2, Liede A3, Arellano J3 | ||||
1 Amgen Inc., Thousand Oaks, USA 2 IMS Health, USA (Formerly SDI Health) 3 Amgen, Inc., South San Francisco, USA | ||||
2013 ASCO Annual Meeting; Citation: J Clin Oncol 31, 2013 (suppl; abstr e12508) |
||||
, Abstract | ||||
, USA | ||||
Abstract: http://meetinglibrary.asco.org/content/112069-132 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Prevalence of hypercalcemia of malignancy in the United States. | ||||
Gastanaga V1, Jain R1, Pirolli M2, Quach D2, Quigley J2, Stryker S1, Liede A1 | ||||
1 Amgen, USA 2 IMS, Plymouth Meeting, USA | ||||
Thirty-Fifth Annual Meeting of the American Society for Bone and Mineral Research, 2013, October 4-7, Baltimore, USA (abstr MO0172, S384) |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Projection Methods Using Oncology Electronic Health Records to Produce Nationally Representative Estimates | ||||
Quach D1, Liede A2, Byekwaso S1, Eremina D1, Kossar B1, Zhou L1, Quigley J1, Kallich J2, Adams J3, Smith P1 | ||||
1 Oncology Marketing Analytics and Services, IMS Health, Plymouth Meeting, PA, United States 2 Center for Observational Research, Amgen Inc., Thousand Oaks, CA, United States 3 Kaiser Permanente, Pasadena, CA, United States | ||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Review | |
Prevalence of Hypercalcemia of Malignancy in the United States | ||||
Gastanaga V1, Jain R1, Pirolli M2, Quach D2, Quigley J2, Stryker S1, Liede A1 | ||||
1 Amgen Inc., Thousand Oaks, CA 2 IMS Health, Plymouth Meeting, PA | ||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Real World Data | |
Patterns of Treatment (tx) with Bone-Modifying Agents (BMA) in Patients with Bone Metastases (mets) | ||||
Quigley J1, Hernandez R2, Cetin K2, Pirolli M1, Quach D1, Liede A3 | ||||
1 IMS Health, Plymouth Meeting, USA 2 Amgen, Inc., Thousand Oaks, USA 3 Amgen, Inc., South San Francisco, USA | ||||
2013 ASCO Annual Meeting; Citation: J Clin Oncol 31, 2013 (suppl; abstr e20690) |
||||
, Abstract | ||||
, USA | ||||
Abstract: http://meetinglibrary.asco.org/content/115636-132 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Prevalence of Renal Insufficiency (RI) in Cancer (Ca) Patients (pts) with Bone Metastases (BM) | ||||
Chen K1, Hernandez R1, Quigley J2, Pirolli M2, Quach D2, Liede A3, Arellano J3 | ||||
1 Amgen Inc., Thousand Oaks, USA 2 IMS Health, USA (Formerly SDI Health) 3 Amgen, Inc., South San Francisco, USA | ||||
2013 ASCO Annual Meeting; Citation: J Clin Oncol 31, 2013 (suppl; abstr e12508) |
||||
, Abstract | ||||
, USA | ||||
Abstract: http://meetinglibrary.asco.org/content/112069-132 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Estimating Prevalence of Stage II-III Breast Cancer in the United States by Treatment and Biologic Subtypes Using Oncology Clinic Data | ||||
Quigley J1, Hernandez R2, Pirolli M1, Quach D1, Liede A3 | ||||
1 IMS Health, Plymouth Meeting, USA 2 Amgen, Inc., Thousand Oaks, USA 3 Amgen, Inc., South San Francisco, USA | ||||
San Antonio Breast Cancer Symposium, 2013, December 10-14, San Antonio, USA |
||||
, Abstract | ||||
, USA | ||||
Abstract: http://sabcs.org/ | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Prevalence of Renal Impairment among Cancer Patients with Bone Metastases in the United States | ||||
Shahinian V1, Chen K2, Hernandez R2, Quigley J3, Pirolli M3, Quach D3, Liede A2, Arellano J2 | ||||
1 University of Michigan Medical School, Ann Arbor, USA 2 Amgen, Inc., Thousand Oaks, USA 3 IMS Health, Plymouth Meeting, USA | ||||
American Society of Nephrology Kidney Week, 2013, November 5-10, Atlanta, USA (abstr TH-PO295, 171-A) |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Prevalence of Hypercalcemia of Malignancy in the United States | ||||
Gastanaga V1, Jain R1, Pirolli M2, Quach D2, Quigley J2, Stryker S1, Liede A1 | ||||
1 Amgen, USA 2 IMS, Plymouth Meeting, USA | ||||
Thirty-Fifth Annual Meeting of the American Society for Bone and Mineral Research, 2013, October 4-7, Baltimore, USA (abstr MO0172, S384) |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Patterns of Treatment with Bone-Modifying Agents in Patients with Bone Metastases in the US | ||||
Quigley, J., Hernandez, R., Cetin, K., Pirolli, M., Quach, D., Arellano, J., Liede, A. | ||||
MASCC/ISOO International Symposium on Supportive Care in Cancer, 2013, June 27-29, Berlin, Germany |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Projection Methods Using Oncology Electronic Health Records to Produce Nationally Representative Estimates | ||||
Quach, D., Liede, A., Byekwaso, S., Eremina, D., Kossar, B., Zhou, L., Quigley, J., Kallich, J., Adams, J., Smith, P. | ||||
International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 2013. |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Charateristics of Patients Included in the Myelofibrosis Real-World Practice-Based Network Research (ENRiCH) Data Platform | ||||
Hess, G1, Fonseca, E2, Lee, A3, Wang, H3, Dhawan, R3, Thompson, S4, Iqbal, S3, Redmond, S2 | ||||
1 Symphony Health Solutions, Horsham, PA 2 IMS Health, Plymouth Meeting, PA 3 Sanofi, Cambridge, MA 4 Sanofi, Bridgewater, NJ | ||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Patients with bone metastases from solid tumors initiating treatment with a bone-targeted agent in 2011: a descriptive analysis using oncology clinic data in the US. | ||||
Hernandez RK1, Quigley J, Pirolli M, Quach D, Chen KS, Arellano J, Liede A. | ||||
1Center for Observational Research, Amgen, IMS Health, One IMS Drive, Global Health Economics, Amgen Inc | ||||
Support Care Cancer. 2014 Oct;22(10):2697-705 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | ||
The direct medical costs of Huntington's disease by stage. A retrospective commercial and Medicaid claims data analysis. | ||||
Divino V., Dekoven M., Warner JH., Giuliano J., Anderson KE., Langbehn D., Lee WC. | ||||
CHDI. IMS authors: Divino V, DeKoven M | ||||
J Med Econ |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/23789925 | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2013 | English | , Burden of illness, Retrospective database analysis | |
Administration burden associated with recombinant human growth hormone treatment: perspectives of patients and caregivers. | ||||
Kremidas D, Wisniewski T, Divino VM, Bala K, Olsen M, Germak J, Aagren M, Holot N, Lee WC. | ||||
Novo Nordsik; IMS authors: Divino V | ||||
J Pediatr Nurs |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/22300524 | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2013 | English | , Survey research | |
Administration burden associated with recombinant human growth hormone treatment: perspectives of patients and caregivers. | ||||
Kremidas D, Wisniewski T, Divino VM, Bala K, Olsen M, Germak J, Aagren M, Holot N, Lee WC. | ||||
Novo Nordsik; IMS authors: Divino V | ||||
J Pediatr Nurs |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/22300524 | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2013 | English | , Survey research | |
Alternative outcome definitions and their effect on the performance of methods for observational outcome studies | ||||
Christian G. Reich • Patrick B. Ryan • Martijn J. Schuemie | ||||
C. G. Reich (&) AstraZeneca PLC, 35 Gatehouse Drive, Waltham, MA 02451, USA e-mail: reich@omop.org P. B. Ryan Janssen Research and Development LLC, Titusville, NJ, USA M. J. Schuemie Department of Medical Informatics, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands C. G. Reich P. B. Ryan M. J. Schuemie Observational Medical Outcomes Partnership, Foundation for the National Institutes of Health, Bethesda, MD, USA | ||||
Drug Saf. |
||||
, Article | ||||
, USA | ||||
Abstract: DOI 10.1007/s40264-013-0111-1 | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Observational Health Data Sciences and Informatics (OHDSI) collaboration | 2013 | English | , Database Study, Real World Data | |
Calendar Time-Specific Propensity Score Estimation to Address Channeling Bias in Comparative Effectiveness Research of Second Generation Antipsychotics. | ||||
Dusetzina S, Mack CD, Stürmer T. | ||||
PLoS One. 2013 May 7;8(5):e63973. | ||||
PLoS One. 2013 May 7;8(5):e63973. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
2013 | English | |||
Calendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapy. Pharmacoepidemiology and Drug Safety. | ||||
Mack CD, Glynn RJ, Brookhart MA, Carpenter WR, Meyer AM, Sandler RS, Stürmer T. | ||||
2013 Aug;22(8):810-8. doi: 10.1002/pds.3386. Epub 2013 Jan 7. | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
2013 | English | |||
Burden of unintended pregnancy in the United States: A role for increased use of long-acting reversible contraceptive methods | ||||
Trussell J1, Henry N2, Hassan F2, Prezioso A3, Law A3, Filonenko A4 | ||||
1 Princeton University, USA 2 IMS Health, London, UK 3 Bayer Pharma – USA 4 Bayer AG – Global | ||||
140th Annual Meeting & Exposition of the American Public Health Association San Francisco, California, USA October 27-31, 2012 |
||||
, Abstract, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Womens Health | 2012 | English | , Burden of illness | |
Modeling cost−savings through increase utilization of intrauterine contraception and implant | ||||
Pocoski J1, Henry N2, Hassan F2, Filonenko A3, Law A4,Trussell J5 | ||||
1 Bayer Pharma – USA 2 IMS Health, London, UK 3 Bayer AG – Global 4 Bayer Pharma – USA 5 Princeton University, USA | ||||
68th Annual Meeting of the American Society for Reproductive Medicine San Diego, California, USA October 20-24, 2012 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Womens Health | 2012 | English | , Burden of illness | |
Patient out-of-pocket payments for oral oncolytic therapies: results from a U.S. claims data analysis. | ||||
Raborn ML1, Pelletier EM2, Smith DB2, Reyes CM1 | ||||
1Genentech, Inc., South San Francisco, CA, USA, 2IMS Consulting Group, Watertown, MA, USA | ||||
Am J Manag Care 2012;18(2 Spec No.):SP57-SP64 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Cost analysis, Retrospective database analysis | |
The cost-effectiveness of pregabalin in the treatment of fibromyalgia: US perspective | ||||
Lloyd A1, Boomershine CS2, Choy E3, Chandran A4, Zlateva G4 | ||||
1 IMS Health, London, UK 2 Vanderbilt University, Nashville, TN, USA 3 Cardiff University School of Medicine, Cardiff, UK 4 Pfizer Inc., New York, NY, USA | ||||
Journal of Medical Economics 15(3):481-492 |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=j+med+econ%5BJour%5D+AND+Lloyd+A%5Bfirst+author%5D+AND+pregabalin&TransSchema=title&cmd=detailssearch | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2012 | English | , Cost effectiveness | |
Medication adherence and medical costs associated with exenatide BID versus liraglutide: A retrospective database analysis. | ||||
Pelletier EM1, Pawaskar M2, Chapman R3 | ||||
1IMS Health, Watertown, MA, USA, 2Eli Lilly and Company and Lilly USA, LLC, Indianapolis, IN, USA, 3IMS Health, Alexandria, VA, USA | ||||
International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 17th Annual International Meeting, 2012, June, Washington, DC, USA |
||||
, Abstract, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2012 | English | , Cost analysis, Retrospective cohort analysis, Retrospective database analysis | |
Long-term cost-consequence analysis of exenatide once weekly versus sitagliptin or pioglitazone for the treatment of type 2 diabetes patients in the United States. | ||||
Guillermin AL1, Lloyd A1, Best JH2, Beth Deyoung M2, Samyshkin Y1, Aledort Gaebler J2. | ||||
1 IMS Health, London, UK 2 1Amylin Pharmaceuticals, Inc., San Diego, CA, USA | ||||
J Med Econ. 2012 Mar 12. [Epub ahead of print] |
||||
, Manuscript in preparation | ||||
, USA | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=Guillermin+A%5Bfirst+author%5D+AND+exenatide&TransSchema=title&cmd=detailssearch | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2012 | English | , Cost consequence | |
Long-term clinical and economic benefit associated with liraglutide versus sitagliptin therapy when added to metformin in the treatment of type 2 diabetes: a Core Diabetes Model study. | ||||
Lee WC1, Samyshkin Y2, Langer J3, Palmer J4 | ||||
1IMS Health, Alexandria, VA, USA, 2IMS Health, London, UK, 3Novo Nordisk, Inc., Princeton, NJ, USA, 4IMS Health, Allschwil, Basel, Switzerland | ||||
ISPOR 17th Annual International Meeting. June 2-6, 2012 Washington, DC, USA. |
||||
, Abstract, Poster | ||||
, USA | ||||
Abstract: http://www.ispor.org/meetings/washingtondc0512/Posters4.aspx | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2012 | English | , Cost benefit | |
Risk of treatment failure after first-line sunitinib therapy in patients with metastatic renal cell carcinoma | ||||
Chen CC1, Hess GP1, Liu Z2, Gesme DH3, Agarwala SS4, Garay CA4, Hill JW1, Guo MA4 | ||||
1 IMS Health (formerly SDI), Plymouth Meeting, PA 2 Novartis Pharmaceuticals, East Hanover, NJ 3 Minnesota Hem Onc, Minneapolis, MN 4 St. Luke's Hospital and Health Network, Bethlehem, PA | ||||
Genitourinary Cancers Symposium 2012 |
||||
, Poster, Symposium | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Nephrology, Oncology | 2012 | English | , Retrospective database analysis | |
Descriptive Analysis of Attendance to Dialysis Sessions Among In-Center Hemodialysis Patients | ||||
Blume S, Lee A, Pan F, Chuang C, Hess G | ||||
American Journal of Kidney Diseases; April 2012 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Urology | 2012 | English | , Retrospective database analysis | |
Economic outcomes of exenatide versus liraglutide in type 2 diabetes patients in the United States: results from a retrospective claims database analysis. | ||||
Pelletier EM1, Pawaskar M2, Smith PJ1, Best JH3, Chapman RH4 | ||||
1IMS Health Inc., Watertown, MA, USA, 2Eli Lilly and Company and Lilly USA, LLC, Indianapolis, IN, USA, 3Amylin Pharmaceuticals Inc., San Diego, CA, USA, 4IMS Health Inc., Alexandria, VA, USA | ||||
J Med Econ 2012 [in press]; 2012 Apr 26 [Epub ahead of print] |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2012 | English | , Cost analysis, Retrospective cohort analysis, Retrospective database analysis | |
Are physicians adhering to US Public Health Service smoking cessation guidelines? | ||||
Pokras SM, Chapman RH, Galaznik A | ||||
IMS Health, Pfizer Pharmaceuticals | ||||
Poster presentation at the Society of General Internal Medicine (SGIM), 35th Annual Meeting, Orlando, FL. |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Mental health, Miscellaneous | 2012 | English | , Compliance, Observational study, Prospective study, Survey research | |
Economic burden of toxicities associated with metastatic colorectal cancer treatment regimens containing monoclonal antibodies. | ||||
Burudpakdee C1, Zhao Z2, Munakata J1, Gao S2, Trochlil K1, Barber B2 | ||||
1 IMS Health, Alexandria, VA, US 2 Amgen, Thousand Oaks, CA, US | ||||
J Med Econ, 2012, 15(2):371-7 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Cost analysis | |
Cost-effectiveness of real-time continuous glucose monitoring (RT-CGM) in type 2 diabetes (T2DM) | ||||
Fonda SJ, Graham C, Samyshkin Y, Munakata J, Powers J, Vigersky RA | ||||
American Diabetes Association, 2012, June 8-12, Philadelphia, PA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2012 | English | , Cost effectiveness | |
Disability outcomes and dose escalation with etanercept, adalimumab, and infliximab in rheumatoid arthritis patients: a US-based retrospective comparative effectiveness study | ||||
Schabert VF, Bruce B, Ferrufino CF, Globe DR, Harrison DJ, Lingala B, Fries JF | ||||
1,3 IMS Health, Falls Church, VA. 2,6-7 Stanford University School of Medicine. 4-5 Amgen | ||||
Curr Med Res Opin |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2012 | English | , Observational study | |
Annual costs of tumor necrosis factor inhibitors using real-world data in a commercially insured population in the United States | ||||
Schabert VF, Watson C, Gandra SR, Goodman S, Fox KM, Harrison DJ | ||||
1,4 IMS Health, Falls Church, VA, US, 2-3,6 Amgen, 5 Strategic Healthcare Solutions | ||||
J Med Econ |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2012 | English | , Budget impact | |
Long-Term Cost-utility analysis of Exenatide once weekly versus insulin Glargine for the treatment of Type 2 diabetes patients in the United States. | ||||
Samyshkin Y1, Guillermin A-L1, Best JH2, Brunell SC2, Lloyd A1 | ||||
1 IMS Health, London, UK 2 Amylin Pharmaceuticals, San Diego, CA, USA | ||||
Journal of Medical Economics, 2012;15(6):1-8 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2012 | English | , Cost utility | |
Cost of self-monitoring of blood glucose in the United States among patients on an insulin regimen for diabetes | ||||
Yeaw J1, Lee WC1, Aagren M2, Christensen T2 | ||||
1 IMS Health, Redwood City, CA, US 2 Novo Nordisk, Copenhagen, Denmark | ||||
J Manag Care Pharm. 2012 Jan-Feb;18(1):21-32. |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22235952 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2012 | English | , Retrospective database analysis | |
Burden of unintended pregnancy in the United States: A role for increased use of long-acting reversible contraceptive | ||||
Trussell J1, Henry N2, Hassan F2, Prezioso A3, Law A3, Filonenko A4 ( | ||||
1 Princeton University, USA 2 IMS Health, London, UK 3 Bayer Pharma – USA 4 Bayer AG – Global | ||||
Contraception, in press |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Womens Health | 2012 | English | , Burden of illness | |
Health economic evidence in support of a low-dose contraceptive levonorgestrel intrauterine system (LNG-IUS 12) | ||||
Trussell J1, Hassan F2, Henry N2, Law A3, Pocoski J3, Filonenko Anna4 | ||||
1 Princeton University, USA 2 IMS Health, London, UK 3 Bayer Pharma – USA 4 Bayer AG – Global | ||||
ISPOR 15th Annual European Congress Berlin, Germany November 3-7, 2012 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Womens Health | 2012 | English | , Cost effectiveness | |
Evaluation of long-acting somatostatin analog injection devices by nurses: a quantitative study. | ||||
Adelman DT1, Burgess A, Davies PR. | ||||
1Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. | ||||
Med Devices (Auckl). 2012;5:103-9. doi: 10.2147/MDER.S37831. Epub 2012 Dec 14. |
||||
, Article | ||||
, France, Germany, UK, USA | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23293542 | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous | 2012 | English | , Survey research | |
Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies. | ||||
Lo Re V 3rd, Haynes K, Ming EE, Wood Ives J, Horne LN, Fortier K, Carbonari DM, Hennessy S, Cardillo S, Reese PP, Reddy KR, Margolis D, Apter A, Kimmel SE, Roy J, Freeman CP, Razzaghi H, Holick CN, Esposito DB, Van Staa TP, Bhullar H & Strom BL. | ||||
Cegedim | ||||
Pharmacoepidemiol Drug Saf. 2012 Nov;21(11):1202-15. doi: 10.1002/pds.3318. Epub 2012 Jul 5. |
||||
, Article | ||||
, UK, USA | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22763953 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Diabetes | 2012 | English | , Retrospective database analysis | |
Development and validation of the self-completed ascites impact measure to understand patient motivation for requesting a paracentesis. | ||||
Crawford B1, Piaut E2, Gotlieb W3, Joulain F4 | ||||
1 Mapi Values, Tokyo, Japan 2 2Mapi Values, Boston, MA, USA 3 McGill University, Montreal, Quebec, Canada 4Sanofi, Paris, France | ||||
Patient Relat Outcome Meas. 2012 Jul; 3: 21–30. Published online 2012 Jun 21. doi: 10.2147/PROM.S28179 |
||||
, Article | ||||
, Canada, USA | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417936/ | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2012 | English | , Patient questionnaire | |
Hemoglobin Decline in Cancer Patients Receiving Chemotherapy Without An Erythropoiesis-Stimulating Agent | ||||
Pirker R1, Pirolli M2, Quigley J2, Hulnick S2, Legg J3, Collins H3, Vansteenkiste J4 | ||||
1 Medical University Vienna, Vienna, AT 2 IMS Health, USA (Formerly SDI Health) 3 Amgen, Inc., Thousand Oaks, USA | ||||
Support Care Cancer DOI 10.1007/s00520-012-1617-2. September 2012. |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584249/ | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2012 | English | , Burden of illness | |
Prevalence of Non-Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors in the United States | ||||
Liede A1, Pirolli M2, Hernandez R1, Quigley J2, Quach D2 | ||||
1 Amgen, Inc., Thousand Oaks, USA 2 IMS Health, Plymouth Meeting, USA | ||||
San Antonio Breast Cancer Symposium, 2012, December 4-8, San Antonio, USA (abstr P2-13-03, 275s) |
||||
, Abstract | ||||
, USA | ||||
Abstract: http://www.sabcs.org/UserPortal/Documents/SABCS_2012_Abstract_Book.pdf | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Retrospective database analysis | |
Castration Resistance and High-Risk Disease among Non-Metastatic (M0) Prostate Cancer (PC) Patients on Androgen Deprivation Therapy (ADT) | ||||
Pirolli M1, Hernandez R2, Cetin K2, Quigley J1, Grant-Huerta Y2, Stryker S2, Smith P1, Adams J3, Liede A2 | ||||
1 IMS Health, USA (Formerly SDI Health) 2 Amgen, Inc, Thousand Oaks, USA 3 RAND Corporation, Santa Monica, USA | ||||
J Clin Oncol., 30, 2012 (suppl; abstr 1581) |
||||
, Abstract | ||||
, USA | ||||
Abstract: http://meetinglibrary.asco.org/content/94833-114 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Retrospective database analysis | |
FOLFIRINOX Treatment of Metastatic Pancreatic Cancer in an Electronic Health Records Warehouse in the US | ||||
Gastanaga, V., Lethen, J., Barlev, A., Wang, S., Kelsh, M. | ||||
Annals of Oncology, vol. 23 s4, p. iv63, 2012 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Retrospective database analysis | |
Risk of Significant Hemoglobin (Hb) Declination in Chemotherapy Patients Prior To and After Policy Changes Affecting Use of Erythropoiesis -Stimulating Agents (Esa's): 2006-2009 | ||||
Hill, J. W., Cong, Z., Hess, G. P., McGarvey, N., Nordyke, R. J. | ||||
International Journal of Medical Research |
||||
, Abstract | ||||
, USA | ||||
Abstract: http://www.medscape.com/medline/abstract/22971506 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Retrospective database analysis | |
Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050. PLoS One. | ||||
Granich R, Kahn JG, Bennett R, Holmes CB, Garg N, Serenata C, Sabin ML, Makhlouf-Obermeyer C, De Filippo Mack C, Williams P, Jones L, Smyth C, Kutch KA, Ying-Ru L, Vitoria M, Souteyrand Y, Crowley S, Korenromp EL, Williams BG. | ||||
2012;7(2):e30216. Epub 2012 Feb 13. | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
2012 | English | |||
Impact of persistence with infliximab on hospitalizations in ulcerative colitis. | ||||
Carter CT1, Leher H1, Smith P2, Smith DB2, Waters HC1 | ||||
1Janssen Scientific Affairs, LLC., Horsham, PA, USA, 2IMS Consulting Group, Watertown, MA, USA | ||||
Am J Manag Care 2011;17(6):385-392. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2011 | English | , Retrospective database analysis | |
Evaluation of the GETQUIT clinics for smoking cessation. | ||||
Pokras SM, Ferrufino CP, Galaznik A, Zou K, Chapman RH. | ||||
HEOR IMS Consulting Group, USA; Pfizer Global Pharmaceuticals, USA. | ||||
International Society for Pharmacoeconomics & Outcomes Research (ISPOR) 14th Annual European Congress, Madrid, Spain. November 8, 2011. |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous, Neurological disorders, Respiratory disease | 2011 | English | , Observational study, Prospective study, Survey research | |
The economics of inpatient on-demand treatment for haemophilia with high-responding inhibitors: a US retrospective data analysis | ||||
Pokras SM, Petrilla AA, Weatherall J, Lee WC. | ||||
IMS Consulting Group, USA. Novo Nordisk Denmark | ||||
Haemophilia |
||||
, Article | ||||
, USA | ||||
Abstract: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2516.2011.02623.x/full | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2011 | English | , Retrospective database analysis | |
Cost of all-cause and cardiovascular disease-related hospitalization in patients with type 2 diabetes treated with exenatide BID, sulfonylureas, or insulin: a retrospective analysis of the LifeLink™ Database. | ||||
Best JH1, Pelletier EM2, Smith DB2 | ||||
1Amylin Pharmaceuticals, Inc., San Diego, CA, USA, 2IMS Health, Watertown, MA, USA | ||||
International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 16th Annual International Meeting, 2011, May, Baltimore, MD, USA |
||||
, Abstract, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2011 | English | , Cost analysis, Retrospective cohort analysis, Retrospective database analysis | |
Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the GLP-1 receptor agonist exenatide twice daily or other glucose-lowering therapies: a retrospective analysis of the LifeLink™ database. | ||||
Best JH1, Hoogwerf BJ2, Herman WH3, Pelletier EM4, Smith DB4, Wenten M1, Hussein MA5 | ||||
1Amylin Pharmaceuticals, Inc., San Diego, CA, USA, 2Eli Lilly and Company, Indianapolis, IN, USA, 3University of Michigan, Ann Arbor, MI, USA, 4IMS Health, Watertown, MA, USA, 5IMS Health, Falls Church, VA, USA | ||||
Diabetes Care 2011;34(1):90-95; 2012 Oct 7 (Epub ahead of print) |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2011 | English | , Cost analysis, Retrospective cohort analysis, Retrospective database analysis | |
Caregiver experience among congenital hemophilia with inhibitor patients. | ||||
Wisniewski T1, Petrilla A2, DeKoven M2, Lee WC2, Cooper D3, Holot N3, von Mackensen S4 | ||||
1 Health Economics and Outcomes Research, Novo Nordisk Inc., Princeton, NJ, USA 2 IMS Health, Health Economics and Outcomes Research, Falls Church, Virginia, USA 3 Clinical Development and Medical Affairs, Novo Nordisk Inc., Princeton, NJ, USA 4 Institute and Policlinics of Medical Psychology, Centre of Psychosocial Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany | ||||
ISPOR 16th Annual International Meeting, 2011, May 21-25, Baltimore, USA |
||||
, Abstract | ||||
, USA | ||||
Abstract: http://www.ispor.org/Events/Index.aspx?eventId=35 | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous | 2011 | English | , Survey research | |
Human growth hormone treatment: Synthesis of literature on product delivery systems and administration practices. | ||||
Bhosle MJ1, Klingman D1, Aagren M2, Wisniewski T2 Lee WC1 | ||||
1 IMS Health, Falls Church, VA, USA 2 Novo Nordisk, Princeton, NJ, USA | ||||
Journal of Specialists in Pediatric Nursing. 2011 Jan;16(1):50-63. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Pediatrics | 2011 | English | , Literature Review | |
Cost-effectiveness of liraglutide versus rosiglitazone, both in combination with glimepiride in treatment of type 2 diabetes in the US. | ||||
Lee WC1, Conner C2, Hammer M3. | ||||
1 Health Economics & Outcomes Research, IMS Health, Falls Church, VA, USA 2 Novo Nordisk Inc., Princeton, New Jersey, USA 3 Novo Nordisk A/S, Soborg, Denmark | ||||
Curr Med Res Opin. 2011 Feb 25. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2011 | English | , Cost effectiveness | |
Venlafaxine xr, Duloxetine, and Escitalopram among commercially insured patients | ||||
Whiteley J1, Makin C2, Klingman D2, Alvir J1, Harnett J1 | ||||
1Pfizer, Inc., New York, NY, USA, 2IMS Health, Falls Church, VA, USA | ||||
ISPOR 16th Annual International Meeting, May 21-25 2011, Baltimore, USA |
||||
, Poster | ||||
, USA | ||||
Abstract: http://www.ispor.org/meetings/baltimore0511/Posters3.aspx | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2011 | English | ||
New patient-level data from Sentinel, ACA and recent commercial endeavours: implications for outcomes research | ||||
Hess G1, Benner J2, Schabert V3 | ||||
1 SDI, 2 Brookings Institute, 3 IMS Health, USA | ||||
ISPOR 16th Annual International Meeting, May 21-25 2011, Baltimore, USA |
||||
, Symposium | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Medication compliance | 2011 | English | , Workshop | |
Baseline characteristics and pre–index total health care and rheumatoid arthritis-related costs in patients receiving Golimumab therapy | ||||
Carter C1, Tandon N1, Smith D2 | ||||
1Centocor Ortho Biotech Services, LLC, Horsham, PA, USA, 2IMS Health Incorporated, Watertown, MA, USA | ||||
ISPOR 16th Annual International Meeting, May 21-25 2011, Baltimore, USA |
||||
, Poster | ||||
, USA | ||||
Abstract: http://www.ispor.org/meetings/baltimore0511/Posters1.aspx | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2011 | English | , Cost of illness | |
Biologic experience and dosing of Golimumab patients in managed care | ||||
Carter C1, Tandon N1, Smith D2 | ||||
1Centocor Ortho Biotech Services, LLC, Horsham, PA, USA, 2IMS Health Incorporated, Watertown, MA, USA | ||||
ISPOR 16th Annual International Meeting, May 21-25 2011, Baltimore, USA |
||||
, Poster | ||||
, USA | ||||
Abstract: http://www.ispor.org/meetings/baltimore0511/Posters1.aspx | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2011 | English | , Observational study | |
Cost and quality of life benefits of faster bleed resolution with an rFVIIa analogue: a mathematical simulation study for the German population. | ||||
Pokras SM. Petrilla AA. Weatherall J. Lee WC. | ||||
HEOR, IMS Consulting Group, USA; Novo Nordisk, Denmark | ||||
International Society for Pharmacoeconomics & Outcomes Research (ISPOR) 14th Annual European Congress, Madrid, Spain. November 7, 2011. |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2011 | English | , Cost effectiveness, Economic evaluation | |
A comparative effectiveness analysis of trastuzumab persistence between two adjuvant breast cancer treatment regimens among US health plan enrollees. | ||||
Lalla D1, Pelletier EM2, Goodman S2, Brammer M1, Schabert VF3 | ||||
1Genentech, Inc., South San Francisco, CA, USA, 2IMS Consulting Group, Watertown, MA, USA, 3IMS Consultin Group, Woodland Hills, CA, USA | ||||
34th Annual San Antonio Breast Cancer Symposium, December 2011, San Antonio, TX, USA |
||||
, Abstract, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective cohort analysis, Retrospective database analysis | |
Are out-of-pocket payments for oral oncologic therapies too high? Updated results from a U.S. claims data analysis. | ||||
Raborn ML1, Pelletier EM2, Smith DB2, Reyes CM1 | ||||
1Genentech, Inc., South San Francisco, CA, USA, 2IMS Consulting Group, Watertown, MA, USA | ||||
International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 14th Annual European Meeting, November 2011, Madrid, Spain |
||||
, Abstract, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Cost analysis, Retrospective database analysis | |
Trastuzumab persistence between two adjuvant breast cancer treatment regimens among US health plan enrollees: a comparative effectiveness analysis. | ||||
Lalla D1, Pelletier EM2, Goodman S2, Brammer M1, Schabert VF3 | ||||
1Genentech, Inc., South San Francisco, CA, USA, 2IMS Consulting Group, Watertown, MA, USA, 3IMS Consulting Group, Woodland Hills, CA, USA | ||||
16th European Cancer Organisation (ECCO) – 36th European Society for Medical Oncology (ESMO) Multidisciplinary Cancer Congress, September 2011, Stockholm, Sweden |
||||
, Abstract, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective cohort analysis, Retrospective database analysis | |
Cost and outcomes associated with rivaroxaban vs enoxaparin for the prevention of postsurgical venous thromboembolism from a US payer’s perspective | ||||
Duran A1, Sengupta N2, Diamantopoulos A3, Forster F1, Kwong4, Lees M5 | ||||
1 IMS Health, London, UK 2 Worldwide Market Access, Janssen Global Services, Raritan, NJ, USA 3 Symmetron Ltd, London, UK 4 Harbor-UCLA Medical Center and UCLA David Geffen School of Medicine, Los Angeles, CA, USA 5 Bayer HealthCare, Uxbridge, UK | ||||
Journal of Medical Economics Vol. 14, No. 6, 2011, 824–834 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2011 | English | , Cost effectiveness | |
Determining initial and follow-up costs of cardiovascular events in a US managed care population. | ||||
Chapman RH, Liu LZ, Girase PG, Straka RJ. | ||||
IMS Health, Pfizer Inc. | ||||
BMC Cardiovascular Disorders 2011; 11:11ff. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2011 | English | , Cost analysis | |
Healthcare costs associated with treatment modification in type 2 diabetes mellitus patients taking oral anti-diabetic drugs. | ||||
Krishnarajah G, Bhosle M, Chapman R. | ||||
Bristol Myers Squibb, IMS Health | ||||
Managed Care 2011; 20(6):42-48 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2011 | English | , Cost analysis | |
Evaluation of the GETQUIT clinics for smoking cessation. | ||||
Pokras SM, Ferrufino CP, Chapman RH. | ||||
IMS Health | ||||
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 14th Annual European Congress, Madrid, Spain, November 5-8, 2011. |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous | 2011 | English | , Observational study | |
Costs of tumor necrosis factor blockers per treated rheumatoid arthritis patient using real-world drug data in US commercially-insured population. | ||||
Schabert VF, Gandra S, Watson C, Yeaw J, Goodman S, Fox KM, Milev S, Harrison DJ. | ||||
ACR/ARHP Annual Scientific Meeting |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2011 | English | ||
New patient-level data from SENTINEL, ACA and recent commercial endeavours: implications for outcomes research. | ||||
Hess G1, Benner JS2, Schabert VF3. | ||||
1 SDI Health LLC, Plymouth Meeting, PA, USA 2 University of Pennsylvania School of Medicine, Philadelphia, PA, USA 3 IMS Consulting Group, Falls Church, VA, USA | ||||
16th Annual International Meeting, International Society of Pharmacoeconomics and Outcomes Research (ISPOR) |
||||
, Symposium | ||||
, USA | ||||
Abstract: http://www.ispor.org/meetings/baltimore0511/Educational-Symposia_052311.asp | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous | 2011 | English | ||
Next steps for patient adherence. | ||||
Schabert VF. | ||||
IMS Consulting Group, Falls Church, VA, USA | ||||
RxAdherence 2011 |
||||
, Invited speaker | ||||
, USA | ||||
Abstract: http://www.hcpconline.org/rxadherence-2011.html | ||||
Condition | Year | Language | Analysis type | |
, Medication compliance | 2011 | English | , Compliance | |
Opportunities and risks associated with Real-World Evidence. | ||||
Schabert VF, Resnick J. | ||||
2011 IMS Market Access Conference |
||||
, Oral presentation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous | 2011 | English | ||
Indications using real-world data in United States commercially-insured population | ||||
Schabert V1, Gandra SR2, Watson C2, Fox KM3, Yeaw J4, Goodman S4, Milev S5, Harrison DJ2 | ||||
1IMS Health, Falls Church, VA, USA, 2Amgen, Inc., Thousand Oaks, CA, USA, 3Strategic Healthcare Solutions, LLC, Monkton, MD, USA, 4IMS Health, Watertown, MA, USA, 5IMS Brogan, A unit of IMS, Ottawa, ON, Canada | ||||
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Pricing and reimbursement | 2011 | English | , Economic evaluation | |
Relative Risk of Acute Pancreatitis in Initiators of Exenatide BID Compared to Other Antidiabetic Medication: A Follow-up Study. | ||||
Wenten M1, Gaebler JA1, Hussein M2, Pelletier EM2, Smith DB2, Girase P2, Noel RA3, Braun DK3, Bloomgren GL1 | ||||
1Amylin Pharmaceuticals, Inc., San Diego, CA, USA, 2IMS Health Incorporated, Watertown, MA, USA, 3Eli Lilly and Company, Indianapolis, IN, USA | ||||
Diabet Med 2012 [in press]; 2012 Mar 12 [Epub ahead of print] |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2011 | English | , Retrospective cohort analysis, Retrospective database analysis | |
Cost Effectiveness of Rivaroxaban versus Enoxaparin for Prevention of Post-Surgical Venous Thromboembolism from a US Payer's Perspective | ||||
Duran A1, Sengupta N2, Diamantopoulos A3, Forster F1, Kwong L4, Lees M5. | ||||
1 IMS Health, London, UK 2 Janssen Global Services, Raritan, NJ, USA 3 Symmetron Ltd, London, UK 4 Harbor-UCLA Medical Center and UCLA David Geffen School of Medicine, Los Angeles, CA, USA 5 Bayer HealthCare, Uxbridge, UK | ||||
Pharmacoeconomics. 2011 Dec 21. p87 |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22187932 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2011 | English | , Cost effectiveness | |
Patient characteristics, biologic experience, and real-world dosing of golimumab. | ||||
Carter CT1, Tandon N1, Smith DB2 | ||||
1Centocor Ortho Biotech Inc., Horsham, PA, USA, 2IMS Consulting Group, Watertown, MA, USA | ||||
The European League Against Rheumatism (EULAR) Annual European Congress of Rheumatology, London, UK, May 25-28, 2011. |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2011 | English | , Retrospective database analysis | |
Biologic experience and systemic medication use among commercially insured psoriasis patients receiving ustekinumab. | ||||
Carter CT1, Martin S1, Denny L1, Smith D2 | ||||
1Janssen Scientific Affairs, LLC., Horsham, PA, USA, 2IMS Consulting Group, Watertown, MA, USA | ||||
Society for Medical Decision Making (SMDM), October 23-26, 2011, Chicago, IL, USA |
||||
, Abstract, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2011 | English | , Retrospective database analysis | |
Impact of infliximab adherence on Crohn’s disease-related healthcare utilization and inpatient costs | ||||
Carter CT1, Waters HC1, Smith DB2 | ||||
1Janssen Scientific Affairs, LLC., Horsham, PA, USA, 2IMS Consulting Group, Watertown, MA, USA | ||||
Adv Ther 2011;28(8):671-683; Epub 2011 Aug 3. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2011 | English | , Cost analysis, Retrospective database analysis | |
Metastatic renal cell carcinoma: patient characteristics, treatment patterns, and schedule compliance in clinical practice | ||||
Hess GP1, Chen CC1, Hill JW1, Liu Z2, Gesme DH3, Agarwala SS4 | ||||
1 IMS Health (formerly SDI), Plymouth Meeting, PA; SDI, 2 Novartis Pharmaceuticals, East Hanover, NJ 3 Minnesota Hem Onc, Minneapolis, MN 4 St. Luke's Hospital and Health Network, Bethlehem, PA | ||||
Kidney Cancer Journal 2011; 9(3) |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Clinical burden of illness in patients with neuroendocrine tumors | ||||
Hess GP1, Chen CC1, Liu Z2, Yao JC3, Phan AT3, Hill JW1. | ||||
1 IMS Health (formerly SDI), Plymouth Meeting, US 2 Novartis Pharmaceuticals, East Hanover, NJ 3 Department of GI Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX | ||||
Pancreas. 2012 Apr 17 In press |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Burden of illness | |
Risk of hepatic and gastrointestinal events in patients with neuroendocrine tumors | ||||
Hess GP1, Chen CC1, Liu Z2, Yao JC3, Phan AT3, Hill JW1 | ||||
1 IMS Health (formerly SDI), Plymouth Meeting, PA, USA 2 Novartis Pharmaceuticals, East Hanover, NJ, USA 3 Department of GI Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA | ||||
Neuroendocrinology 2011;94(Suppl.1;abstract) |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2011 | English | , Retrospective database analysis | |
Metastatic renal cell carcinoma: patient characteristics and recent treatment patterns in real-world practice. | ||||
Hess GP1, Chen CC1, Liu Z2, Gesme DH3, Agarwala SS4 | ||||
1 IMS Health (formerly SDI), Plymouth Meeting, PA, USA 2 Novartis Pharmaceuticals, East Hanover, NJ, USA 3 Minnesota Hem Onc, Minneapolis, MN, USA 4 St. Luke's Hospital and Health Network, Bethlehem, PA, USA | ||||
JMCP April 2011;17(3):232-272 (suppl: abstract) |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Patient compliance with metastatic renal cell carcinoma treatments. | ||||
Hess GP1, Chen CC1, Liu Z2, Gesme DH3, Agarwala SS4 | ||||
1 IMS Health (formerly SDI), Plymouth Meeting, PA, USA 2 Novartis Pharmaceuticals, East Hanover, NJ, USA 3 Minnesota Hem Onc, Minneapolis, MN, USA 4 St. Luke's Hospital and Health Network, Bethlehem, PA, USA | ||||
JMCP April 2011;17(3):232-272 (suppl: abstract) |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Risk of treatment failure after first-line tyrosine kinase inhibitors (TKI) therapy in patients with metastatic renal cell carcinoma | ||||
Hess GP1, Chen CC1, Liu Z2, Gesme DH3, Agarwala SS4, Hill JW1 | ||||
1 IMS Health (formerly SDI), Plymouth Meeting, PA, USA 2 Novartis Pharmaceuticals, East Hanover, NJ, USA 3 Minnesota Hem Onc, Minneapolis, MN, USA 4 St. Luke's Hospital and Health Network, Bethlehem, PA, USA | ||||
J Clin Oncol 29: 2011 (suppl; abstr e15114) |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Risk of anxiety/depression events in patients newly diagnosed with neuroendocrine tumors | ||||
Chen CC1, Hess GP1, Liu Z2, Yao JC3, Phan AT3, Hill JW1 | ||||
1 IMS Health (formerly SDI), Plymouth Meeting, PA, USA 2 Novartis Pharmaceuticals, East Hanover, NJ, USA 3 Department of GI Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA | ||||
J Clin Oncol 29: 2011 (suppl; abstr e16591) |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2011 | English | , Retrospective database analysis | |
Risk of osteoporosis/osteopenia events in patients newly diagnosed with neuroendocrine tumors. | ||||
Hill JW1, Chen CC1, Hess GP1, Satram-Hoang S2, Reyes CM2 | ||||
1 IMS Health (formerly SDI), Plymouth Meeting, PA, USA 2 Genentech, South San Francisco, USA | ||||
J Clin Oncol 29: 2011 (suppl; abstr e16602) |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2011 | English | , Retrospective cohort analysis | |
Comparative antibiotic failure rates in the treatment of community-acquired pneumonia (CAP): results from a claims analysis. | ||||
Hess GP, Hill JW, Raut MK, Fisher AC, Mody SM, Schein JR, Chen CC. | ||||
1 IMS Health (formerly SDI), Plymouth Meeting, PA, USA | ||||
Advances in Therapy. 2010 Oct: 27(10): 743-755. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2011 | English | , Retrospective database analysis | |
Patient Compliance with Metastatic Renal Cell Carcinoma Treatments | ||||
Hess GP, Chen C, Liu Z, Gesme DH, Agarwala SS | ||||
IMS Health (formerly SDI Health),Plymouth Meeting, PA,USA | ||||
AMCP's 23rd Annual Meeting April 27-29, 2011. |
||||
, Abstract | ||||
, USA | ||||
Abstract: http://www.amcp.org/WorkArea/DownloadAsset.aspx?id=8975 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Metastatic Renal Cell Carcinoma: Patient Characteristics and Recent Treatment Patterns in Real-World Practice | ||||
Hess GP, Chen C, Liu Z, Gesme DH, Agarwala SS | ||||
IMS Health (formerly SDI Health), Plymouth Meeting, PA, USA | ||||
AMCP's 23rd Annual Meeting April 27-29, 2011 |
||||
, Abstract | ||||
, USA | ||||
Abstract: http://www.amcp.org/WorkArea/DownloadAsset.aspx?id=8975 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Use of Hospital Claims Data to Estimate the Clinical and Economic Burden of Acute Coronary Syndrome Rehospitalizations in Real-World Clinical Practice | ||||
Hess G1, Bhandary D2, Gandhi S2, Kumar D1, Fonseca E1, Gold A2 | ||||
1 IMS Health (formerly SDI), Plymouth Meeting, PA, USA 2 AstraZeneca Pharmaceuticals LP, Wilmington, DE, USA | ||||
Circulation: Cardiovascular Quality and Outcomes, Fall 2011 |
||||
, Abstract | ||||
, USA | ||||
Abstract: http://circoutcomes.ahajournals.org/cgi/content/short/4/6_MeetingAbstracts2011/AP11?rss=1 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2011 | English | , Retrospective database analysis | |
Estimating the economic burden of gastric cancer. | ||||
Knopf KB1, Smith DB2, Doan JF3, Munakata J4 | ||||
1 California Pacific Medical Center, San Francisco, CA, US 2 IMS Consulting Group, Watertown, MA, US 3 Genentech Inc., South San Francisco, CA, US 4 IMS Consulting Group, Redwood City, CA, US | ||||
J Clini Oncol, 2011, 29:(suppl; abstr e16589) |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Adherence to Medications with Once-a-Day (QD) and Twice-a-Day (BID) Dosing Formulations in Acute Coronary Syndrome patients | ||||
Hess G1, Bhandary D2, Fonseca E1, Kumar D1, Potter D2, Smith D2, Gandhi SK2 | ||||
1 IMS Health, Plymouth Meeting, USA 2 AstraZeneca Pharmaceuticals LP, Wilmington, USA | ||||
Poster presented at ISPOR 16th Annual International Meeting. Baltimore, MD, May 21-25, 2011 |
||||
, Poster | ||||
, USA | ||||
Abstract: http://www.ispor.org/meetings/baltimore0511/Posters1.aspx | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2011 | English | , Real World Evidence | |
Rate of hemoglobin decline in patients receiving chemotherapy without an erythropoiesis-stimulating agent in the United States community setting. | ||||
Pirolli M, Collins H2, Quigley J1, Hulnick S1 | ||||
1 IMS Health, USA (Formerly SDI Health) 2 Amgen, Inc., Thousand Oaks, USA | ||||
European Journal of Cancer, 2011 |
||||
, Abstract | ||||
, USA | ||||
Abstract: http://obroncology.com/imshealth/content/ESMO%202011_pPirolli_1669-A-2_v2%20copy.pdf | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2011 | English | , Retrospective database analysis | |
Chemotherapy Relative Dose Intensity Among Older (>65) and Younger (<65) Patients with Non-Hodgkin Lymphoma Recieving CHOP+R | ||||
Whittaker, S., Abella, S., Schwartzberg, L., Saleh, M. | ||||
Blood, 2011 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
The Problem of Missing Data: Using Imputation Methods to Facilitate Oncology Outcomes Research | ||||
Lau, E.C., Legg, J.C., Watson, H.N., Steffey, D.L., Mowat, F.S., Kelsh, M.A. | ||||
ICPE, 2011 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Assessing the Comparability of EMR Information to Patient Registry and Health Claims Data | ||||
Mowat, F.S., Lau, E.C., Kelsh, M.A., Legg, J.C., Engel-Nitz, N.M., Watson, H.N., Collins, H.L., Nordyke, R.J., Whyte, J.L. | ||||
ICPE, 2011 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
A Validation Study of Algorithms for Identifying Metastatic Breast, Lung, or Colorectal Cancer in Administrative Claims Data | ||||
Whyte, J.L., Engel-Nitz, N., Teitelbaum, A., Gomez-Rey, G., Kallich, J. | ||||
Value in Health, 14(3):A6, 2011 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Use of Electronic Medical Records (EMR) for Oncology Outcomes Research: Assessing the Comparability of EMR Information to Patient Registry and Health Claims Data | ||||
Lau, E. L., Mowat, F. S., Kelsh, M. A., Legg, J., Enge-Nitz, N. M., Watson, H. N., Collins, H., Nordyke, R. J., Whyte, J. L. | ||||
Clinical Epidemiology |
||||
, Abstract | ||||
, USA | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224632/ | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Hemoglobin Trends and Anemia Treatment Due To Concomitant Chemotherapy in Community Oncology Clinics | ||||
Feinberg, B., Gilmore, A., Haislip, S., Gilmore, J., Jain, G., Whyte, J. | ||||
Journal of Oncology Practice |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Chemotherapy Relative Dose Intensity Among Older (>65) and Younger (<65) Patients with Non-Hodgkin Lymphoma Receiving CHOP+/-R | ||||
Whittaker, S., Abella, S., Schwartzberg, L., Saleh, M. | ||||
Blood |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Rate of Hemoglobin Decline in Patients Receiving Chemotherapy Without an Erythropoiesis-Stimulating Agent in the United States Community Setting | ||||
Pirolli, M., Collins, H., Quigley, J., Hulnick, S. | ||||
European Journal of Cancer |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
The Problem of Missing Data: Using Imputation Methods to Facilitate Oncology Outcomes Research | ||||
Lau, E. C., Legg, J. C., Watson, H. N., Steffey, D. L., Mowat, F. S., Kelsh, M. A. | ||||
ICPE |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Assessing the Comparability of EMR Information to Patient Registry and Health Claims Data | ||||
Mowat, F. S., Lau, E. C., Kelsh, M. A., Legg, J. C., Engel-Nitz, N. M., Watson, H. N., Collins, H. L., Nordyke, R. J., Whyte, J. L. | ||||
ICPE |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Rate of Hemoglobin Decline from <10 G/Dl to <9 G/Dl by Electronic Medical-Record (EMR) Evaluation in Community Oncology Patients Receiving Chemotherapy in the Absence of ESA Treatment | ||||
Pirolli, M., Collins, H., Quigley, J., Hulnick, S. | ||||
ASCO |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Synchronization of Administrations of Chemotherapy and Erythropoiesis-Stimulating Agents and Frequency of Associated Health Care Visits | ||||
Hill, J., Shreay, S., McGarvey, N., De, A. P., Hess, G., Corey-Lisle, P. | ||||
Value in Health, 14(3):A75 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Use of Electronic Medical Records (EMR) for Oncology Outcomes Research: Assessing the Comparability of EMR Information to Patient Registry and Health Claims Data | ||||
Lau, E. L., Mowat, F. S., Kelsh, M. A., Legg, J., Engel-Nitz, N. M., Watson, H. N., Collins, H., Nordyke, R. J., Whyte, J. L. | ||||
Value in Health, 14(3):A178 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
A Validation Study of Algorithms for Identifying Metastatic Breast, Lung, or Colorectal Cancer in Administrative Claims Data | ||||
Whyte, J. L., Engel-Nitz, N., Teitelbaum, A., Gomez-Rey, G., Kallich, J. | ||||
Value in Health, 14(3):A6 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Development of Algorithms to Identify Metastatic Cancer in Claims Data, Using Oncology EMR Data | ||||
Nordstrom, B., Whyte, J., Kallich, J. | ||||
AHRQ Symposium on Research Methods for Comparative Effectiveness and Patient-Centered Outcomes Research |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Validation of a common data model for active safety surveillance research. | ||||
J Marc Overhage,1,2 Patrick B Ryan,2,3,4 Christian G Reich,2 Abraham G Hartzema,2,5 Paul E Stang2,3 | ||||
1Regenstrief Institute, Indiana University, School of Medicine, Indianapolis, Indiana, USA 2Observational Medical Outcomes Partnership, Foundation for the National Institutes of Health, Bethesda, Maryland, USA 3Johnson & Johnson Institute, Department of Pharmaceutical Research and Development LLC, Titusville, New Jersey, USA 4UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, USA 5College of Pharmacy, University of Florida, Gainesville, Florida, USA | ||||
J Am Med Inform Assoc |
||||
, Article | ||||
, USA | ||||
Abstract: doi:10.1136/amiajnl-2011-000376 | ||||
Condition | Year | Language | Analysis type | |
, Drug safety, Methodology | 2011 | English | , Database Study, Real World Data | |
Racial disparities in receipt and comparative effectiveness of oxaliplatin for stage III colon cancer in older adults. Cancer. | ||||
Mack CD, Carpenter W, Meyer AM, Sanoff H, Stürmer T. | ||||
2012 Jun 1;118(11):2925-34. Epub 2011 Nov 9. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
2011 | English | |||
Costing Human Rights and Community Support Interventions as a Part of Universal Access to HIV Treatment and Care in a Southern African Setting. Curr HIV Res. | ||||
Jones L, Akugizibwe P, Clayton M, Amon JJ, Sabin M, Bennett R, Stegling C, Baggaley R, Kahn JG, Holmes CB, Garg N, Makhlouf-Obermeyer C, DeFilippo Mack C, Williams P, Smyth C, Vitoria M, Crowley S, Williams B, McClure C, Granich R, Hirnschall G. | ||||
2011 Sep;9(6):416-28. | ||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
2011 | English | |||
Pregabalin is cost effective for FM: US and UK comparison | ||||
Chandran AB1, Lui J1, Choy E2, Boomershine C2, Castelnuovo E3, Lloyd A3, Zlateva G1 | ||||
1 Pfizer Inc, US 2 Vanderbilt University, US 3 IMS Health, London, UK | ||||
American Academy of Pain Management, 21st Annual Clinical Meeting, September 21-24, 2010, Caesars Palace, Las Vegas, Nevada, US |
||||
, Poster | ||||
, UK, USA | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2010 | English | , Cost effectiveness | |
The cost-effectiveness of Pregabalin (lyrica®) in the treatment of severe fibromyalgia in the United States. | ||||
Lloyd A1, Castelnuovo E1, Boomershine CS2, Choy E3, Chandran A4, Zlateva G4 | ||||
1IMS Health, London, UK, 2Division of Rheumatology and Immunology, Vanderbilt University, Nashville, TN, USA, 3King's Musculoskeletal Clinical Trials Unit, King's College, London, UK, 4Pfizer Inc., New York, NY, USA | ||||
ISPOR 15th Annual International Meeting May 15-19, 2010 Hilton Atlanta, Atlanta, GA, USA |
||||
, Poster | ||||
, USA | ||||
Abstract: http://www.ispor.org/meetings/atlanta0510/Posters2.aspx | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2010 | English | , Cost effectiveness | |
Risk of cardiovascular events in patients with diabetes treated with exenatide or thiazolidinediones: a retrospective analysis of the pharmetrics database. | ||||
Best JH1, Pelletier EM2, Hoogwerf BJ3, Herman WH4, DeYoung MB1, Smith DB2, Yushmanova I1, Hussein M5 | ||||
1Amylin Pharmaceuticals, Inc., San Diego, CA, USA, 2IMS Health, Watertown, MA, USA, 3Eli Lilly and Company, Indianapolis, IN, USA, 4University of Michigan, Ann Arbor, MI, USA, 5IMS Health, Falls Church, VA, USA | ||||
ISPOR 15th Annual International Meeting, May 15-19, 2010, Atlanta, GA, USA |
||||
, Poster | ||||
, USA | ||||
Abstract: http://www.ispor.org/meetings/atlanta0510/Posters1.aspx | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2010 | English | , Retrospective cohort analysis, Retrospective database analysis | |
Direct health care costs among patients with bipolar disorder who initiated therapy with Aripiprazole or Quetiapine XR. | ||||
Pelletier EM1, Smith DB1, Hassan M2, Kim J2, Alemayehu B1 | ||||
1IMS Health, Watertown, MA, USA, 2AstraZeneca Pharmaceuticals LP, Wilmington, DE, USA | ||||
ISPOR 15th Annual International Meeting, May 15-19, 2010, Atlanta, GA, USA |
||||
, Poster | ||||
, USA | ||||
Abstract: http://www.ispor.org/meetings/atlanta0510/Posters2.aspx | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2010 | English | , Cost analysis, Retrospective cohort analysis, Retrospective database analysis | |
Methods for interpreting tumor necrosis factor (TNF) blocker dosing and treatment patterns from pharmacy and professional claims. | ||||
Makin C1, Schabert V2, Harrison DJ3, Goodman S4 | ||||
1IMS Health, Plymouth Meeting, PA, USA, 2IMS Health, Santa Barbara, CA, USA, 3Amgen, Newbury Park, CA, USA, 4IMS Health, Watertown, MA, USA | ||||
ISPOR 15th Annual International Meeting, May 15-19, 2010, Atlanta, GA, USA |
||||
, Poster | ||||
, USA | ||||
Abstract: http://www.ispor.org/meetings/atlanta0510/Posters2.aspx | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2010 | English | , Methodology | |
Cost-effectiveness of switching to biphasic insulin aspart from human premix insulin in a US setting. | ||||
Palmer JL1, Knudsen MS2, Aagren M3, Thomsen TL4. | ||||
1 IMS Health, Basel, Switzerland 2 IMS Health, London, UK 3 Novo Nordisk Inc., Princeton, NJ, USA 4 Novo Nordisk A/S, Virum, Denmark | ||||
J Med Econ. 2010;13(2):212-20. |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.ncbi.nlm.nih.gov/sites/entrez | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2010 | English | , , Cost effectiveness | |
Persistence with Infliximab maintenance therapy decreases hopitalizations in patients with ulcerative colitis | ||||
Waters H1, Carter C1, Smith P2, Smith D2 | ||||
1 Centocor Ortho Biotech Services, LLC, Horsham, PA, USA, 2 IMS Health, Watertown, MA, USA | ||||
ISPOR 15th Annual International Meeting, May 15-19, 2010, Atlanta, GA, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2010 | English | , Retrospective cohort analysis | |
Comparison of hospitalizations and costs among bipolar patients who switched to extended-release quetiapine from immediate-release quetiapine. | ||||
Hassan M1, Pelletier EM2, Smith DB2, Alemayehu B1, Kim J1 | ||||
1AstraZeneca Pharmaceuticals LP, Wilmington, DE, USA, 2IMS Health, Watertown, MA, USA | ||||
American Psychiatric Association (APA) 163rd Annual Meeting, 2010, May, New Orleans, LA, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2010 | English | , Cost analysis, Retrospective cohort analysis, Retrospective database analysis | |
Risk of cardiovascular events in patients with diabetes treated with exenatide or other glucose-lowering therapies: a retrospective analysis of the PharMetrics database. | ||||
Best JH1, Pelletier EM2, Herman WH3, Hoogwerf BJ4, Smith DB2, Wenten M1, Hussein MA2 | ||||
1Amylin Pharmaceuticals, Inc., San Diego, CA, USA, 2IMS Health, Watertown, MA, USA, 3University of Michigan, Ann Arbor, MI, USA, 4Eli Lilly and Company, Indianapolis, IN, USA, 5IMS Health, Falls Church, VA, USA | ||||
American Diabetes Association (ADA) 70th Scientific Sessions, June 25-29, 2010, Orlando, FL, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2010 | English | , Retrospective cohort analysis, Retrospective database analysis | |
Prescribing patterns and out-of-pocket expenses among bipolar disorder patients receiving extended-release quetiapine or aripiprazole. | ||||
Pelletier EM1, Smith DB1, Hassan M2, Kim J2 | ||||
1IMS Health, Watertown, MA, USA, AstraZeneca Pharmaceuticals LP, Wilmington, DE, USA | ||||
American Psychiatric Association (APA) 163rd Annual Meeting, 2010, May, New Orleans, LA, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2010 | English | , Retrospective cohort analysis, Retrospective database analysis | |
Cost analysis in commercial managed care plans for patients with bipolar depression who initiated therapy with quetiapine XR and aripiprazole. | ||||
Pelletier EM1, Smith DB1, Hassan M2, Kim J2, Alemayehu B2 | ||||
1IMS Health, Watertown, MA, USA, 2AstraZeneca Pharmaceuticals LP, Wilmington, DE, USA | ||||
College of Psychiatric and Neurologic Pharmacists (CPNP) 13th Annual Meeting, 2010, April, San Antonio, TX, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2010 | English | , Cost analysis, Retrospective cohort analysis, Retrospective database analysis | |
A retrospective cohort study to assess the relative risk of acute pancreatitis among initiators of exenatide compared to initiators of other anti-diabetic medication: a follow-up study. | ||||
Wenten M1, Gaebler JA1, Pelletier EM2, Smith DB2, Girase P2, Noel R3, Braun D3, Bloomgren G1, Hussein MA4 | ||||
1Amylin Pharmaceuticals, Inc., San Diego, CA, USA, 2IMS Health, Watertown, MA, USA, 3Eli Lilly and Company, Indianapolis, IN, USA, 4IMS Health, Falls Church, VA, USA | ||||
ISPE 26th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, August 19-22, 2010, Brighton, England, UK |
||||
, Podium presentation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2010 | English | , Retrospective cohort analysis, Retrospective database analysis | |
Retrospective cohort studies of the risk of acute pancreatitis: initiators of exenatide compared to other antidiabetic drugs in two commercial US health insurance databases. | ||||
Bloomgren G1, Wenten M1, Dore D2, Hussein M3, Pelletier E4, Smith D4, Noel R5, Braun D5, Seeger J2 | ||||
1Amylin Pharmaceuticals, Inc., San Diego, CA, USA, 2i3 Drug Safety, Waltham, MA, USA, 3IMS Health, Falls Church, VA, USA, 4IMS Health, Watertown, MA, USA, 5Eli Lilly and Company, Indianapolis, IN, USA | ||||
EASD 46th Annual Meeting, September 20-24, 2010, Stockholm, Sweden. |
||||
, Podium presentation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2010 | English | , Retrospective database analysis | |
Risk of cardiovascular events in patients with type 2 diabetes treated with exenatide or other glucose-lowering therapies: a retrospective analysis of the LifeLinkTM database. | ||||
Best JH1, Hoogwerf BJ2, Pelletier EM3, Smith DM3, Wenten M1, Hussein MA3 | ||||
1Amylin Pharmaceuticals, Inc., San Diego, CA, USA, 2Eli Lilly and Company, Indianapolis, IN, USA, 3IMS Health, Watertown, MA, USA, 4IMS Health, Falls Church, VA, USA | ||||
EASD 46th Annual Meeting, September 20-24, 2010, Stockholm, Sweden. |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2010 | English | , Retrospective database analysis | |
A retrospective cohort study to assess the relative risk of acute pancreatitis among initiators of exenatide compared to initiators of other anti-diabetic medication: a follow-up study. | ||||
Wenten M1, Gaebler J1, Hussein M2, Pelletier E3, Smith D3, Girase P3, Noel R4, Braun D4, Bloomgren G1 | ||||
1Amylin Pharmaceuticals, Inc., San Diego, CA, USA, 2IMS Health, Falls Church, VA, USA, 3IMS Health, Watertown, MA, USA, 4Eli Lilly and Company, Indianapolis, IN, USA | ||||
American Diabetes Association (ADA) 70th Scientific Sessions, June 25-29, 2010, Orlando, FL, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2010 | English | , Retrospective database analysis | |
Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in managed care enrollees? | ||||
Hussein MA, Chapman RH, Benner JS, Tang SSK, Solomon HA, Joyce A, Foody JM | ||||
American Journal of Cardiovascular Drugs 2010; 10(3):193-202 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2010 | English | , Compliance, Retrospective cohort analysis | |
Association between adherence to calcium-channel blocker and statin medications and likelihood of cardiovascular events among US managed care enrollees. | ||||
Chapman RH, Yeaw J, Roberts CS | ||||
BMC Cardiovascular Disorders 2010; 10:29ff |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2010 | English | , Retrospective cohort analysis | |
Subacute lack of asthma control and acute asthma exacerbation history as predictors of subsequent acute asthma exacerbations: Evidence from managed care data | ||||
O’Connor RD, Bleecker ER, Long A, Tashkin D, Peters S, Klingman D, Gutierrez, B | ||||
Department of Quality Management, Sharp Rees-Stealy Medical Group, San Diego, California, CA 92101, USA. roconnor1@cox.net | ||||
Journal of Asthma, 2010, 47(4):422-8 |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20528597 | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2010 | English | , Retrospective database analysis | |
Risk of cardiovascular events in patients with type 2 diabetes treated with exenatide BID or other glucose-lowering therapies: a retrospective analysis of the LifeLinkTM Database. | ||||
Pelletier EM1, Hoogwerf BJ2, Smith DB1, Best JH3 | ||||
1IMS Health, Watertown, MA, USA, 2Eli Lilly and Company, Indianapolis, IN, USA, 3Amylin Pharmaceuticals, Inc., San Diego, CA, USA | ||||
American Heart Association (AHA) Scientific Sessions, November 13-17, 2010, Chicago, IL, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2010 | English | , Retrospective cohort analysis, Retrospective database analysis | |
Long-Term cost-consequence analysis of Exenatide once weekly versus Sitagliptin or Pioglitazone in Type 2 Diabetes patients in the United States | ||||
Aledort Gaebler J1, Samyshkin Y2, Guillermin ALG2, Lloyd A2 | ||||
1Amylin Pharmaceuticals, Inc., San Diego, CA, USA, 2IMS Health, London, UK | ||||
ISPOR 13th Annual European Congress, 6-9 November 2010, Prague, Czech Republic |
||||
, Poster | ||||
, USA | ||||
Abstract: http://www.ispor.org/congresses/Prague1110/posters1.aspx | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2010 | English | , Cost consequence | |
Systemic lupus erythematosus (SLE) is costly for the Health care system and workplace: a systematic literature review | ||||
Doria A1, Grandfils N2, Maurel F2, Rudge H3 | ||||
1 University of Padova, Padova, Italy 2 IMS Health, Paris, France 3 GlaxoSmithKline, Uxbridge, UK | ||||
ISPOR 13th Annula European Congress to be held 6-9 November 2010 at the Prague Congress Centre in Prague, Czech Republic |
||||
, Abstract, Poster | ||||
, Canada, Germany, UK, USA | ||||
Condition | Year | Language | Analysis type | |
, Dermatology | 2010 | English | , Literature Review | |
The modeled lifetime cost-effectiveness of published adherence-improving interventions for antihypertensive and lipid-lowering medications. | ||||
Chapman RH,1 Kowal SL,1 Cherry SB,1 Ferrufino CP,1 Roberts CS,2 Chen L.2 | ||||
1. IMS Health, 2. Pfizer Inc. | ||||
Value in Health 2010; 13(6):685-694. |
||||
, Article | ||||
, USA | ||||
Abstract: http://onlinelibrary.wiley.com/doi/10.1111/j.1524-4733.2010.00774.x/abstract | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2010 | English | , Cost effectiveness | |
A Large Observational Study of Cardiovascular Outcomes Associated With Atorvastatin or Simvastatin Therapy in Hypertensive Patients Without Prior Cardiovascular Disease. | ||||
Foody JM, Joyce AT, Jeffers BW, Liu LZ, Benner JS. | ||||
1Division of Cardiovascular Medicine, Department of Internal Medicine, Harvard Medical School, Boston, MA; 2PharMetrics, Watertown, MA; 3Global Health Economics & Outcomes Research, Pfizer, New York, NY; 4Weill Medical College of Cornell University, New York, NY; 5IMS, Falls Church, VA; and 6University of Pennsylvania School of Medicine, Philadelphia, PA. | ||||
Am J Ther. 2010 Mar 8. [Epub ahead of print] |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2010 | English | , Retrospective database analysis | |
Comparison of hospitalizations and costs among bipolar patients who switched to extended-release quetiapine from immediate-release quetiapine. | ||||
Hassan M1, Pelletier E2, Smith D2, Alemayehu B1, Kim J1 | ||||
1AstraZeneca Pharmaceuticals LP, Wilmington, DE, USA, 2IMS Health, Watertown, MA, USA | ||||
Institute on Psychiatric Services (IPS) 62nd Annual Meeting, 2010, October, Boston, MA, USA |
||||
, Abstract, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2010 | English | , Cost analysis, Retrospective cohort analysis, Retrospective database analysis | |
Prescribing patterns and out-of-pocket expenses among bipolar disorder patients receiving extended-release quetiapine or aripiprazole. | ||||
Pelletier E1, Smith D1, Hassan M2, Kim J2 | ||||
1IMS Health, Watertown, MA, USA, 2AstraZeneca Pharmaceuticals LP, Wilmington, DE, USA | ||||
Institute on Psychiatric Services (IPS) 62nd Annual Meeting, 2010, October, Boston, MA, USA |
||||
, Abstract, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2010 | English | , Retrospective cohort analysis, Retrospective database analysis | |
The economic consequences of ineffective inpatient on-demand treatment for haemophilia with inhibitors: a US retrospective data analysis. | ||||
Pokras SM1. Weatherall J2. Petrilla AA1. Lee WC1. | ||||
1 IMS Health, Alexandria, US 2 Novo Nordisk | ||||
World Federation of Hemophilia Congress 2010, Buenos Aires, Argentina, July 2010 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2010 | English | , Retrospective database analysis | |
Cost-effectiveness of liraglutide versus exenatide added to metformin, sulfonylurea or both for the treatment of type 2 diabetes in the U.S. | ||||
Lee WC1, Conner C2, Hammer M. | ||||
1 Health Economics & Outcomes Research, IMS Health, Falls Church, Virginia, USA 2 Novo Nordisk Inc., Princeton, New Jersey, USA 3 Novo Nordisk A/S, Soborg, Denmark | ||||
Clinical Therapeutics. 2010 Sep;32(10):1756-67. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2010 | English | , Cost effectiveness | |
Clinical and economic burden of toxicities associated with monoclonal antibodies for metastatic colorectal cancer (MCRC). | ||||
Burudpakdee C, Zhao Z, Trochlil K, Gao S, Munakata J, Barber B | ||||
The 35th ESMO Congress, 2010, October 8-12, Milan |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | English | , Cost analysis | |
Potential cost savings associated with faster bleeding resolution in the inpatient treatment of haemophilia with inhibitors. | ||||
Weatherall J1, Munakata J2, Lee WC2 | ||||
1 Novo Nordisk A/S, Soborg, Denmark 2 IMS Health, Falls Church VA, US | ||||
ISPOR 4th Asia-Pacific Conference, 2010, September 5-7, Phuket, Thailand |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2010 | English | , Cost analysis | |
Optimizing treatment strategies for acute bleeds in haemophilia with inhibitors: long-term impact of early treatment decisions. | ||||
Munakata J1, Kowal S1, Weatherall J2, Lee WC1 | ||||
1 IMS Health, Falls Church, VA 2 Novo Nordisk A/S, Soborg, Denmark | ||||
The XXIX International Congress of the World Federation of Hemophilia, 2010, July 10-14, Buenos Aires, Argentina |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2010 | English | , Economic evaluation | |
Medical cost savings associated with a reduced need for re-treatment and fewer infusions required per bleed in the management of on-demand bleeds in haemophilia patients with inhibitors. | ||||
Kowal S1, Munakata J1, Weatherall J2, Lee WC1 | ||||
1 IMS Health, Falls Church, VA 2 Novo Nordisk A/S, Soborg, Denmark | ||||
The XXIX International Congress of the World Federation of Hemophilia, 2010, July 10-14, Buenos Aires, Argentina |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2010 | English | , Economic evaluation | |
Impact of faster bleeding resolution on health-related quality of life (HRQoL) and quality adjusted life years (QALYs) in haemophilia patients with inhibitors. | ||||
Kowal S1, Munakata J1, Weatherall J2, Lee WC1 | ||||
1 IMS Health, Falls Church, VA, US 2 Novo Nordisk A/S, Soborg, Denmark | ||||
The XXIX International Congress of the World Federation of Hemophilia, 2010, July 10-14, Buenos Aires, Argentina |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2010 | English | , Economic evaluation | |
Switching From Atorvastatin to Simvastatin in Patients at High Cardiovascular Risk: Effects on Low-Density Lipoprotein Cholesterol | ||||
Aronow HD, Hess G, Hill J, Kuznik A, Liu LZ. | ||||
Am J Ther. 2010 Mar-Apr;17(2):167-75 |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19770794 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2010 | English | , Burden of illness, Epidemiological study, Prospective study, Quality of life | |
Use of Electronic Medical Records (EMRs) in Oncology Outcomes Research | ||||
Kanas, G., Morimoto, L., Mowat, F., O'Malley, C., Fryzek, J., Nordyke, R. | ||||
ClinicoEconomics and Outcomes, 2:1-14 |
||||
, USA | ||||
Condition | Year | Language | Analysis type | |
2010 | English | , Retrospective database analysis | ||
Systematic Therapy for Metastatic Colorectal Cancer: Patterns of Chemotherapy and Biologic Therapy Use in US Medical Oncology Practice | ||||
Hess, G. P., Wang, P. F., Quach, D., Barber, B., Zhao, Z. | ||||
Journal of Oncology Practice, 6(6):301-307 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | English | , Retrospective database analysis | |
Effect of Reimbursement Changes on Erythropoiesis-Stimulating Agent Utilization and Transfusions | ||||
Hess, G., Nordyke, R. J., Hill, J., Hulnick, S. | ||||
American Journal of Hematology |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2010 | English | , Retrospective database analysis | |
Real-World Use of Granulocyte Colony-Stimulating Factor Support with CHOP+/-R Therapy for Non-Hodgkin's Lymphoma | ||||
Campomayor, C., Jurss, L. | ||||
The Journal of Supportive Oncology, 8(5):A12 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | English | , Retrospective database analysis | |
Clinical Practice Use of Absolute Neutrophil Count Monitoring with Chemotherapy | ||||
Barron, R. L., Pirolli, M., Hess, G., Quach, D., Quigley, J. M., Hill, J. | ||||
JMCP |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | English | , Retrospective database analysis | |
Hemoglobin Trends Among Patients with Anemia with Concomitant Chemotherapy in the Community Oncology Clinic Setting | ||||
Feinberg, B., Gilmore, A., Haislip, S., Gilmore, J., Jain, G., Whyte, J. | ||||
Supportive Care in Cancer, 18:S138 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | English | , Retrospective database analysis | |
Trends in Erythropoiesis-Stimulating Agents (ESAs) Utilization and Hemoglobin (Hb) Levels Among Cancer Patients Undergoing Chemotherapy (2006-2008) | ||||
Hill, J., Cong, Z., Hess, G., Nordyke, R. | ||||
Supportive Care in Cancer, 18:S138-9 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | English | , Retrospective database analysis | |
Comparing the cost of treatment for peripheral artery disease and coronary artery disease in US managed care enrollees. | ||||
Jaff MR1, Chapman RH2, Ferrufino C2, Kowal S2, Smith D, Girase P, Rosen E3, Engelhart L3. | ||||
1 Massuchesetts General Hospital, Boston, MA, USA 2 IMS Health, Falls Church, VA, USA 3 Cordis, Warren, NJ, USA | ||||
American College of Cardiology 58th Annual Scientific Session, 2009, March 29-31, Orlando, FL, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2009 | English | , Retrospective cohort analysis | |
The burden of migraine in the United States: current and emerging perspectives on disease management and economic analysis | ||||
Hazard E1, Munakata J2, Bigal ME, Rupnow MFT, Lipton RB | ||||
1IMS Health, Falls Church, VA, USA, 2IMS Health, San Francisco,CA USA | ||||
Value in Health 2009;12(1):55-64; (epub 2008 Jul 30). |
||||
, Manuscript in preparation | ||||
, USA | ||||
Abstract: http://cat.inist.fr/?aModele=afficheN&cpsidt=21104743 | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2009 | English | , Burden of illness, Cost analysis | |
Suboptimal Rates of Cervical Testing Among Women With Inflammatory Bowel Disease. | ||||
Long M, Porter C, Sandler R, Kappelman M | ||||
Clinical Gastroenterology and Hepataology, 2009, 7(5): 549-53 |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B7GGW-4TP49P8-7&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&_docanchor=&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=7f1199d34338f25a2e6ad83030c3dde7 | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2009 | English | , Retrospective database analysis | |
Partial Compliance with Antipsychotics Increases Mental Health Hospitalizations in Schizophrenic Patients: Analysis of a National Managed Care Database. | ||||
Kozma C, Weiden P | ||||
American Health & Drug Benefits, 2009, 2(1): 31-38 |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.cnsforum.com/commenteditem/92a04e88-7adc-4065-9e78-29ba80fbd766/default.aspx | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2009 | English | , Retrospective database analysis | |
Developing a successful strategy for medication adherence interventions. | ||||
Schabert VF1, Alibocus K2, Frenzel A3 | ||||
1 IMS Health, Inc., Falls Church, VA, USA 2 IMS Health, Inc., London, UK 3 IMS Health Inc., Frankfurt, DE | ||||
Eyeforpharma Patient Relationship Marketing and Adherence Conference, 2009, London, UK |
||||
, Oral presentation | ||||
, UK, USA | ||||
Condition | Year | Language | Analysis type | |
, Medication compliance | 2009 | English | , Meta analysis | |
A cost-effectiveness analysis of pioglitazone plus metformin compared with rosiglitazone plus metformin from a third-party payer perspective in the US. | ||||
St. Charles M, Minshall M, Pandya B, Baran R, Tunis S | ||||
Current Medical Research and Opinion, 2009, 25(6): 1343-53 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2009 | English | , Cost effectiveness | |
Are high-risk hypertensive patients prescribed concomitant statin therapy? A retrospective cohort study. | ||||
Chapman RH1, Petrilla AA1, Berman L, Benner J2, Tang SS | ||||
1 IMS Health, Falls Church, VA, US 2 Formerly of IMS Health, Falls Church, VA, US | ||||
American Journal of Cardiovascular Drugs 2009; 9(5):299-308 |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.ingentaconnect.com/content/adis/acv/2009/00000009/00000005/art00003 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2009 | English | , Retrospective cohort analysis | |
Cost of hospital admission for antiarrhythmic drug initiation in atrial fibrillation | ||||
Kim M1, Klingman D2, Lin J3, Pathak P2, Battleman D2 | ||||
1 Northwestern University, Chicago, IL, USA 2 IMS Health, Falls Church, VA, US 3 Sanofi-aventis, Bridgewater, NJ, US | ||||
Ann Pharmacother. 2009 May;43(5):840-8. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19417111?ordinalpos=&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.SmartSearch&log$=citationsensor | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2009 | English | , Cost effectiveness | |
Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy. | ||||
Benner JS1, Chapman RH2, Petrilla AA2, Tang SSK, Rosenberg N, Schwartz JS | ||||
1 Formerly of IMS Health, Falls Church, VA, US 2 IMS Health, Falls Church, VA, US | ||||
American Journal of Hralth-System Pharmacy 2009; 66(16):1471-1477 |
||||
, Article | ||||
, USA | ||||
Abstract: http://archinte.ama-assn.org/cgi/content/abstract/165/10/1147 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2009 | English | , Retrospective cohort analysis | |
Incidence and temporal pattern of hospital readmissions for atrial fibrillation in managed care patients following prior hospitalization for this condition | ||||
Kim M, Lin J1, Hussein M2, Battleman D2 | ||||
1 Sanofi-Aventis, Bridgewater, NJ, US 2 IMS Health, Falls Church, VA, US | ||||
Current Medical Research Opinion. 2009; In press |
||||
, Manuscript in preparation | ||||
, USA | ||||
Abstract: http://informahealthcare.com/doi/abs/10.1185/03007990902869235 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2009 | English | , Burden of illness | |
Economic outcomes associated with microvascular complications of diabetes mellitus: results from a US claims data analysis. | ||||
Pelletier EM1, Shim B1, Ben-Joseph R2, Caro JJ3 | ||||
1IMS Health, Watertown, MA, USA, 2sanofi-aventis, Bridgewater, NJ, USA, 3United BioSource Corp, Concord, MA, USA | ||||
Pharmacoeconomics, 2009, 27(6): 479-490 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Abstract: http://ideas.repec.org/a/wkh/phecon/v27y2009i6p479-490.html | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2009 | English | , Retrospective database analysis | |
Mobilization with chemotherapy compared to G-CSF alone: an analysis of resource use and cost in autologous stem cell transplant patients. | ||||
Pelletier EM1, Smith PJ1, Dembek CJ2. | ||||
1IMS Health, Watertown, MA, USA, 2Genzyme Corporation, Cambridge, MA, USA | ||||
BMT Tandem Meeting, 2009, February 11-15, Tampa, FL, US |
||||
, Abstract, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2009 | English | , Cost analysis | |
Patient perspectives on taking vitamin K antagonists: a qualitative study in the UK, USA and Spain | ||||
Wild D1, Murray M2, Donatti2, | ||||
1 Oxford Outcomes Ltd, Oxford, UK 2 Health Protection Agency, London, UK 3 IMS Health, London, UK | ||||
Expert Review of Pharamacoeconomics and Outcomes Research October 2009, Vol. 9, No. 5, Pages 467-474 |
||||
, Article | ||||
, Spain, UK, USA | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=Wild+D%5Bfirst+author%5D+AND+vitamin&TransSchema=title | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2009 | English | , Observational study | |
Patient out-of-pocket payments for second-line non-small-cell lung cancer oncologic therapies: results from a U.S. claims data analysis. | ||||
Pelletier EM1, Tierce J2, Reyes CM3 | ||||
1IMS Health, Watertown, MA, USA, 2IMS Health, Falls Church, VA, USA, 3Genentech Inc., South San Francisco, CA, USA | ||||
International Association for the Study of Lung Cancer (IASLC) 13th World Conference on Lung Cancer (WCLC), 2009, August, San Francisco, CA, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2009 | English | , Cost of illness | |
Patient characteristics and patterns of therapy use among newly diagnosed patients with early breast cancer: results from a U.S. claims data analysis. | ||||
Pelletier EM1, Smith DB1, Kaura S2, Zelt S2, Battleman DS3 | ||||
1IMS Health, Watertown, MA, USA, 2Novartis Pharmaceuticals, East Hanover, NJ, USA, 3IMS Health, Falls Church, VA, USA | ||||
32nd Annual San Antonio Breast Cancer Symposium, 2009, December, San Antonio, TX, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2009 | English | , Retrospective database analysis | |
Patient out-of-pocket payments for oral oncologic therapies: updated results from a U.S. claims data analysis. | ||||
Pelletier EM1, Tierce J2, Yim YM3, Reyes C3 | ||||
1IMS Health, Watertown, MA, USA, 2IMS Health, Falls Church, VA, USA, 3Genentech Inc., South San Francisco, CA, USA | ||||
American Society of Clinical Oncology (ASCO) 45th Annual Meeting, 2009, May, Orlando, FL, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2009 | English | , Cost analysis | |
Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis. | ||||
Pelletier EM1, Ogale S2, Yu E2, Brunetta P2, Garg J2 | ||||
1IMS Health, Watertown, MA, USA, 2Genentech Inc., South San Francisco, CA, USA | ||||
Clinical Therapeutics, 2009, 31(11): 2653-2664 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2009 | English | , Cost analysis | |
Can adherence to antihypertensive therapy be used to promote adherence to statin therapy? | ||||
Chapman RC1, Pelletier EM2, Smith PJ2, Roberts CS3 | ||||
1IMS Health, Falls Church, VA, USA, 2IMS Health, Watertown, MA, USA, 3Pfizer Inc., New York NY, USA | ||||
Patient Preference and Adherence, 2009, 3: 265-275 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2009 | English | , Compliance | |
Pharmacotherapy adherence and costs versus nonpharmacologic management in overactive bladder. | ||||
Pelletier EM1, Vats V2, Clemens JQ3 | ||||
1IMS Health, Watertown, MA, USA, 2Pfizer Inc., New York, NY, USA, 3University of Michigan, Ann Arbor, MI, USA | ||||
American Journal of Managed Care, 2009, 15(Suppl 4): S108-S114 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Overactive bladder | 2009 | English | , Compliance, Cost analysis | |
Incremental cardiovascular costs and resource use associated with diabetes: an assessment of 29,863 patients in the US managed-care setting. | ||||
Robert J Straka1, Larry Z Liu2, Prafulla S Girase3, Allyson DeLorenzo4 and Richard H Chapman5 | ||||
1 University of Minnesota College of Pharmacy, Minneapolis, MN, USA, 2 Pfizer Inc, New York, NY, USA, 3 IMS Health, Watertown, MA, USA, 4 Columbia University, New York, NY, USA and 5 IMS Health, Falls Church, VA, USA | ||||
Cardiovascular Diabetology 2009; 8:53-63 |
||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Diabetes | 2009 | English | , Cost analysis, Retrospective cohort analysis | |
Health economic review of non-small cell lung cancer (NSCLC) treatment in the United States. | ||||
Munakata J1, Trochlil K1, Battleman D1, Foley D2 | ||||
1IMS Health, Falls Church, VA, USA, 2Boehringer Ingelheim Ltd, Ridgefield, CT, USA | ||||
ISPOR 12th Annual Europena Congress, Paris, France 24-27 October 2009 PCN145 |
||||
, Poster | ||||
, USA | ||||
Abstract: http://www.ispor.org/congresses/paris1009/posters1.aspx | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2009 | English | , Literature Review | |
Publication trends of budget impact analyses over the past six years. | ||||
Pathak P, Kowal-Podmore S, Munakata J | ||||
ISPOR 14th International Meeting |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2009 | English | , Literature Review | |
Patterns and predictors of discontinuation of rhythm-control drug therapy in patients with newly diagnosed atrial fibrillation. | ||||
Kim MH, Klingman D, Lin J, Battleman DS. | ||||
Division of Cardiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA. Michael.Kim@nmff.org | ||||
Pharmacotherapy. 2009 Dec;29(12):1417-26. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2009 | English | , Retrospective database analysis | |
Rates of venous thromboembolism occurrence in medical patients among the insured population. | ||||
Spyropoulos AC, Hussein M, Lin J, Battleman D. | ||||
McMaster University, Hamilton General Hospital, Hamilton, ON L8L 2X2, Canada. spyropa@mcmaster.ca | ||||
Thromb Haemost. 2009 Nov;102(5):951-7. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2009 | English | , Retrospective database analysis | |
Rates of symptomatic venous thromboembolism in US surgical patients: a retrospective administrative database study. | ||||
Spyropoulos AC, Hussein M, Lin J, Battleman D. | ||||
University of New Mexico Health Sciences Center, Albuquerque, NM, USA. aspyropoulos2787@msn.com | ||||
J Thromb Thrombolysis. 2009 Nov;28(4):458-64. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2009 | English | , Retrospective database analysis | |
Antidepressant switching among adherent patients treated for depression. | ||||
Marcus SC, Hassan M, Olfson M. | ||||
School of Social Policy and Practice, University of Pennsylvania, Philadelphia, PA, USA. | ||||
Psychiatr Serv. 2009 May;60(5):617-23. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2009 | English | , Retrospective database analysis | |
Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA. | ||||
Joyce AT, Smith P, Khandker R, Melin JM, Singh A. | ||||
PharMetrics, Inc., 311 Arsenal Street, Watertown, MA 02472, USA. ajoyce@us.imshealth.com | ||||
J Rheumatol. 2009 Apr;36(4):743-52. Epub 2009 Feb 17. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2009 | English | , Retrospective database analysis | |
Cost-effectiveness of Rivaroxaban for prevention of venous thromboembolism (VTE) after total hip or knee replacement (THR, TKR) in the USA | ||||
Kwong L1, Duran A2, Diamantopoulos A2, Sengupta N3, Lees M4. | ||||
1Dept of Orthopaedic Surgery, Harbor-UCLA Medical Center, Torrance, USA 2IMS Health, London, UK 3 Johnson & Johnson, California, USA 4Bayer HealthCare, London, UK | ||||
Journal of Thrombosis and Haemotosis, Volume 7 Supplement 2, July 2009, Abstracts from the XXII ISTH Congress |
||||
, Poster | ||||
, USA | ||||
Abstract: http://www.blackwellpublishing.com/isth2009/abstract.asp?id=78214 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2009 | English | , Cost effectiveness | |
Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy. | ||||
Benner JS1, Chapman RH1, Petrilla AA1, Tang SSK2, Rosenberg N2, Schwartz JS. | ||||
1 IMS Health, Falls Church, VA, USA 2 Pfizer Inc., New York, NY, USA 3 University of Pennsylvania, Philadelphia USA | ||||
Am J Health Syst Pharm. 2009 Aug 15;66(16):1471-7 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2009 | English | , Burden of illness | |
Relation of headache frequency to resource utilization, work productivity, and total costs: results from the American Migraine Prevalence and Prevention (AMPP) Study | ||||
Munakata J1, Serrano D, Klingman D, Hazard E, Rupnow MFT, Tierce J, Reed M, Stewart WF, Lipton RB | ||||
ISPOR 14th Annual International Meeting, 2009, May 16-20, Orlando, FL |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2009 | English | , Cost analysis | |
Effects of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Therapy After Hospital Discharge on Subsequent Rehospitalization for Acute Myocardial Infarction and Heart Failure | ||||
Hess G1,2, Preblick R3, Hill J1, Plauschinat C1, Yaskin J4 | ||||
1IMS Health, Former SDI, Plymouth Meeting, PA, USA, 2Leonard Davis Institute for Health Economics and Policy, University of Pennsylvania, Philadelphia, PA, 3Novartis Pharmaceuticals Corporation, East Hanover, NJ, 4Department of Health Policy, Jefferson Medical College, Philadelphia, PA | ||||
Congest Heart Fail. 2009 Jul-Aug;15(4):170-5 |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19627290 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Respiratory disease | 2009 | English | , Burden of illness, Quality of life | |
The Importance of Clinical Variables in Comparative Analyses Using Propensity Score Matching: the Case of ESA Costs for the Treatment for Chemotherapy-Induced Anemia | ||||
Polsky, D., Eremina, D., Hess, G., Hill, J., Hulnick, S., Roumm, A., Whyte, J. L., Kallich, J. | ||||
Pharmacoeconomics, 27(9):755-765 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2009 | English | , Retrospective database analysis | |
Review: Use of Electronic Medical Records for Health Outcomes Research: A Literature Review | ||||
Dean, B. B., Lam, J., Natoli, J. L., Butler, Q., Aguilar, D., Nordyke, R. J. | ||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2009 | English | , Retrospective database analysis | |
Erythropoiesis Stimulating Agent (ESA) Administration at Hb<10 G/Dl for Chemotherapy-Induced Anemia (CIA) Following the National Coverage Decision (NCD) | ||||
Hulnick, S. A., Hess, G., Hill, J., Viswanathan, H. N., Nordyke, R. J. | ||||
Journal of Clinical Oncology, 27(suppl; abstract e20627): Pub only abstract for ASCO |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2009 | English | , Retrospective database analysis | |
Trajectory of Hemoglobin (Hb) in Patients Receiving Erythropoiesis-Stimulating Agents (ESAs) for Anemia Due to Concomitantly Administered Myelosuppressive Chemotherapy (CIA) (2006~2008) | ||||
Hill, J., Cong, Z., Hess, G. P., Nordyke, R. | ||||
Blood |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2009 | English | , Retrospective database analysis | |
Drug titration patterns and HbA1c levels in type 2 diabetes. | ||||
Maclean JR1, Chapman RH2, Ferrufino CP2, Krishnarajah S1 | ||||
1 IMS Health, Falls Church, VA, USA | ||||
International Journal of Clinical Practice |
||||
, Manuscript in preparation | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2984545/ | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2009 | English | , Retrospective cohort analysis | |
Long-term cost-effectiveness of pioglitazone versus placebo in addition to existing diabetes treatment: a US analysis based on proactive | ||||
1Valentine WJ, 1Tucker D, 1Palmer AJ, 2Minshall ME, 1Foos V, 3Silberman C | ||||
1IMS-Health, Allschwil, Switzerland; 2IMSHealth, Noblesville, IN, USA; 3Takeda Global Research and Development, Ltd., Deerfield, IL, USA | ||||
Value in Health - Published Online: 24 Jul 2008 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2008 | English | , Cost effectiveness | |
Direct medical costs for type 2 diabetes mellitus complications in the U.S. commercial payer setting: a resource for economic research. | ||||
Pelletier EM1, Smith P1, Boye KS2, Misurski DA2, Tunis SL3, Minshall ME3 | ||||
1IMS Health, Watertown, MA, USA, 2Eli Lilly & Company, Indianapolis, IN, USA, 3IMS Health, Noblesville, IN, USA | ||||
Diabetologia, 2008, 51(Suppl 1): S538 European Association for the Study of Diabetes (EASD) 44th Annual Meeting, 2008, September, Rome, Italy |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2008 | English | , Retrospective database analysis | |
Adherence to single−pill amlodipine/atorvastatin compared to other branded and generic CCB + statin combinations among US managed care enrollees | ||||
Chapman R1, Hussein M,1 Benner J1,1 Roberts C | ||||
1 IMS Health, Falls Church, VA, US | ||||
American Society of Hypertension 23rd Annual Scientific Meeting & Exposition, New Orleans, LA, May 14-17, 2008 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2008 | English | , Retrospective cohort analysis | |
Adherence to single−pill amlodipine/ atorvastatin compared to other branded and generic CCB + statin combinations among U.S. managed care enrollees. | ||||
Chapman R, Hussein M, Benner J, Roberts C. | ||||
1 IMS Health, Falls Church, VA, US 2 IMS Health, Falls Church, VA, US 3 Formerly of IMS Health, Falls Church, VA, US 4 Pfizer, Inc, New York, NY, US | ||||
Journal of Clinical Hypertension 2008;10(5 Suppl A):A113. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2008 | English | , Retrospective cohort analysis | |
Pioglitazone versus rosiglitazone treatment in patients with type 2 diabetes and dyslipidemia: cost-effectiveness in the US. | ||||
Tunis SL, Minshall ME, St. Charles M, Pandya BJ, Baran RW | ||||
1 IMS Health, Falls Church, VA, US 2 Formerly of IMS Health, Falls Church, VA, US 3 Formerly of IMS Health, Falls Church, VA, US 4 Takeda, Deerfield, IL, USA 5 Takeda, Deerfield, IL, US | ||||
Current Medical Research and Opinion 2008;24(11):3085-3096. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2008 | English | , Cost effectiveness | |
Self-monitoring of Blood Glucose in Type 2 Diabetes: Cost-effectiveness in the United States | ||||
Tunis SL1, Minshall ME1 | ||||
1 IMS Health, Falls Church, VA, US | ||||
Am J Manag Care. 2008;14(3):131-140 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2008 | English | , Cost effectiveness | |
Standardized type 2 diabetes complication costs from US commercial payers to be used in modeling the long-term economic outcomes of diabetes complications. | ||||
Minshall ME1, Pelletier EM2, Smith PJ2, Forma FM3 | ||||
1IMS Health, Noblesville, IN, USA, 2IMS Health, Watertown, MA, USA 3Novo Nordisk, Princeton, NJ, USA | ||||
International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 11th Annual European Meeting, 2008, November 8-11, Athens, Greece |
||||
, Oral presentation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2008 | English | , Retrospective database analysis | |
Cross-cultural comparisons of the overweight/obese population in the US and Europe | ||||
Annunziata K, Gupta S, Chapnick J, Pokras S, Klingman D | ||||
ISPOR 2008 13th Annual International Congress |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK, USA | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2008 | English | , Retrospective database analysis | |
Five-Year Routine Cervical Cancer Screening Rates and Intervals in a United States Health Plan | ||||
Schabert VF, Ye X, Insinga RP, Singhal PK, Riedel AA | ||||
Current Medical Research and Opinion 2008; 24(9):2429-2435. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Observational study | |
Frequency of Provider Contact After FDA Advisory on Risk of Pediatric Suicidality With SSRIs. | ||||
Morrato E, Libby A, Orton H, deGruy III F, Brent D, Allen R, Valuck R | ||||
American Journal Psychiatry, 2008, 165: 42-50 |
||||
, Article | ||||
, USA | ||||
Abstract: http://ajp.psychiatryonline.org/cgi/content/abstract/165/1/42 | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2008 | English | , Retrospective database analysis | |
Direct Health Care Costs of Crohn's Disease and Ulcerative Colitis in US Children and Adults. | ||||
Kappelman M, Rifas-Shimanh S, Porter C, Ollendorf D, Sandler R, Galanko J, Finkelstein J | ||||
Gastroenterology, 2008, 135(6): 1907-13 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2008 | English | , Retrospective database analysis | |
Can adherence to antihypertensive therapy be used to promote adherence to statin therapy? | ||||
Chapman R1, Pelletier EM2, Benner J1, Moller R3, Roberts C3 | ||||
1IMS Health, Falls Church, VA, USA, 2IMS Health, Watertown, MA, USA, 3Pfizer Inc., New York, NY, USA | ||||
American Heart Association (AHA) 9th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, 2008, April 30-May 2, Baltimore, MD, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2008 | English | , Retrospective cohort analysis | |
Comparison of self-reported survey (SHIELD) versus NHANES data in estimating prevalence of dyslipidemia. | ||||
Bays H, Chapman R1, Fox K, Grandy S, SHIELD Study Group | ||||
1 IMS Health, Falls Church, VA, USA | ||||
Current Medical Research and Opinion 2008;24(4):1179-86 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2008 | English | , Survey research | |
Economic burden of transformed Migraine (TM): results from the American Migraine Prevalence and Prevention (AMPP) Study. | ||||
Munakata J1, Hazard E1, Serrano D, Klingman D1, Rupnow M, Tierce J1, Reed M, Lipton R | ||||
1 IMS Health, Falls Church, VA, US | ||||
American Academy of Neurology 60th Annual Meeting 2008, Chicago, IL, April 12-19, 2008 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Vascular disease | 2008 | English | , Economic evaluation | |
In patients use of low-molecular-weight heparin maintains quality but reduces hospital-based treatment cost associated with venous thromboembolism prophylaxis. | ||||
Ferrufino C1, Merli G2, Lin J3, Hussein M1 | ||||
1 IMS Health, Falls Church, VA, US 2 Thomas Jefferson Hospital, Philadelphia, PA, US 3 Sanofi Aventis, Bridgewater, NJ, US | ||||
J Gen Int Med 2007;22(Suppl 1):60 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2008 | English | , Economic evaluation | |
Inpatient enoxaparin reduces hospital-based costs associated with VTE prophylaxis. | ||||
Merli G1, Ferrufino C2, Lin J3, Hussein M2, Battleman D2 | ||||
1 Thomas Jefferson Hospital, Philadelphia, PA, US 2 IMS Health, Falls Church, VA, US 3 Sanofi Aventis, Bridgewater, NJ, US | ||||
AHA-QCOR annual meeting, Washington, DC, May 9-11, 2008 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2008 | English | , Economic evaluation | |
Patterns and Predictors of Overactive Bladder-specific Quality of Life. | ||||
Benner J1, Brubaker L, Bavendam T, Fanning F, Goldberg E2, Trocio J3, Jumadilova Z | ||||
1 Formerly of IMS Health, Falls Church, VA, US 2 IMS Health, Falls Church, VA 3 Pfizer, New York, NY, US | ||||
Journal of Pelvic Medicine & Surgery;2007 Sept/Oct;13(5):302-303(#91P) |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Overactive bladder | 2008 | English | , Quality of life | |
Patterns of Use, Outcomes, and Costs of Selected Viscosupplementation Agents in Health Plan Administrative Data. | ||||
Yeaw J1, DeKoven MP2, Mozaffari E, Tierce J2 | ||||
1 IMS Health, Watertown, MA, US 2 IMS Health, Falls Church, VA, US | ||||
J Manag Care Pharm;2008;14(2):239 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2008 | English | , Cost analysis | |
Testing and control among type 2 diabetes mellitus patients on oral anti-diabetes drugs. | ||||
Chapman RH1, Ferrufino CP1, Maclean JR, Krishnarajah S | ||||
1 IMS Health, Falls Church, VA, US | ||||
American Diabetes Association’s 68th Scientific Sessions, San Francisco, CA, June 6-10, 2008 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2008 | English | , Retrospective cohort analysis | |
The cost and effectiveness of adherence-improving interventions for lipid-lowering and antihypertensive drugs. | ||||
Chapman R1, Ferrufino C1, Kowal-Podmore S1, Classi P2, Roberts C2 | ||||
1 1 IMS Health, Falls Church, VA, US 2 Pfizer, New York, NY, US | ||||
ISPOR 13th Annual International Meeting, Toronto, ON, Canada, May 3-7, 2008 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2008 | English | , Cost effectiveness | |
Long-Term Economic Value of a Hypothetical DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus: The Potential Impact of the Preservation of Beta-Cell Function. | ||||
Tunis S1, Minshall M2, Bron M, Baran R, Pandya B | ||||
1 IMS Health, Falls Church, VA, US 2 Formerly of IMS Health, Falls Church, VA, US | ||||
American Diabetes Association, 2008, June 6 - 10, San Francisco, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2008 | English | , Cost utility | |
The Impact of Clinical Trial Design on Cost-Effectiveness Analyses: Illustration from a Published Study of the One-Touch® Ultrasmart® Blood Glucose Meter for Insulin-Using Diabetes Patients. | ||||
Tunis SL1, Minshall ME1 | ||||
1 IMS Health, Falls Church, VA, USA | ||||
Diabetes Technology & Therapeutics, 2008;10(3): 227-31 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Abstract: http://www.liebertonline.com/doi/abs/10.1089/dia.2007.0270 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2008 | English | , Cost effectiveness | |
Estimating healthcare burden of illness of hypertension among women using menopausal hormone therapy. | ||||
Pelletier EM1, Chang J2, Mittapally R1, Nahum GG2, Gricar JA3 | ||||
1IMS Health, Watertown, MA, USA, 2Bayer HealthCare Pharmaceuticals, Wayne, NJ, USA, 3Independent Health Care Consultant, New York, NY, USA | ||||
ISPOR 13th Annual International Meeting, 2008, May, Toronto, Ontario, Canada |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2008 | English | , Burden of illness | |
Hospital-based costs associated with VTE treatment regimens | ||||
Merli G1, Ferrufino C2, Lin J3, Hussein M2, Battleman D2 | ||||
1 Thomas Jefferson Hospital, Philadelphia, PA, US 2 IMS Health, Falls Church, VA, US 3 Sanofi Aventis, Bridgewater, NJ, US | ||||
J Thromb Haemost, 2008,6(7):1077-86. Epub 2008 Jul 1. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2008 | English | , Economic evaluation | |
Predictors of adherence to concomitant antihypertensive and lipid-lowering medications in older adults: A retrospective, cohort study. | ||||
Chapman RH, Petrilla AA, Benner JS, Schwartz JS, Tang SSK. | ||||
1 IMS Health, Falls Church, VA, USA 2 IMS Health, Falls Church, VA, USA 3 Formerly of IMS Health, Falls Church, VA, USA | ||||
Drugs & Aging 2008;25(10):885-892. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2008 | English | , Retrospective database analysis | |
Cost-Effectiveness Analysis of Continuous Subcutaneous Insulin Injection vs. Multiple Daily Injections in Type 1 Diabetes Patients: an International Comparison. | ||||
Graham C, Lynch P, St. Charles M, Minshall M | ||||
Value in Health, 2008; 11(3):A224. Value in Health, 2008; 11(3):A224. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2008 | English | , Cost effectiveness | |
Cost-effectiveness of blood glucose monitoring is controversial. Reply to Aspinall SL and Glassman PA | ||||
Tunis SL, Minshall ME | ||||
1 IMS Health, Falls Church, VA, US 2 Formerly of IMS Health, Falls Church, VA, US | ||||
American Journal of Managed Care, 2008;14(6):399-400. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2008 | English | , Cost effectiveness | |
Quality of life and depression of people living with type 2 diabetes mellitus and those at low and high risk for type 2 diabetes: findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD) | ||||
Grandy S1, Chapman RH2, Fox KM3, for the SHIELD Study Group | ||||
(1) AstraZeneca LP, Wilmington, DE, USA (2) IMS Health -US HEOR, Falls Church, VA, USA (3) Strategic Healthcare Solutions, LLC, Monkton, MD, USA | ||||
International Journal of Clinical Practice 2008; 62(4):562-568 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2008 | English | , Survey research | |
Quality of life and depression of people living with type 2 diabetes mellitus and those at low and high risk for type 2 diabetes: findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD). | ||||
Grandy S, Chapman RH, Fox KM, for the SHIELD Study Group. | ||||
2 IMS Health, Falls Church, VA, USA | ||||
International Journal of Clinical Practice 2008; 62(4):562-568. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2008 | English | , Survey research | |
Treatment failures in type 2 diabetes patients taking oral anti-diabetes drugs | ||||
Chapman R, Ferrufino C, Maclean JR, Krishnarajah G | ||||
1 IMS Health, Falls Church, VA, US 2 IMS Health, Falls Church, VA, US 3 Bristol-Myers Squibb, Princeton, NJ, US 4 Bristol-Myers Squibb, Princeton, NJ, US 4 | ||||
American Diabetes Association’s 68th Scientific Sessions, 2008, June San Francisco, CA, US |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2008 | English | , Retrospective cohort analysis | |
Costs of a prior authorization on lubiprostone for elderly (age > 65) patients with chronic constipation in a medicare part D population | ||||
Lobo F, Pokras S1, Smith TW1, Thomas S, Sill B, Baum C | ||||
1 IMS Health, Falls Church, VA, US | ||||
ISPOR 2008 13th Annual International Congress |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2008 | English | , Burden of illness | |
Financial impact of lifting a prior authorization on lubiprostone for chronic constipation patients in a commercial managed care population (age < 65 years) | ||||
Lobo F, Pokras S1, Smith TW1, Thomas S, Sill B, Baum C | ||||
1 IMS Health, Falls Church, VA, US | ||||
ISPOR 2008 13th Annual International Congress |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2008 | English | , Cost analysis | |
Raising the Bar in the USA: The Impact of Heightened Awareness of the Need for Health-Economic Data in the Absence of a Regulatory Mandate. | ||||
Minshall ME, Watkins J | ||||
ISPOR Connections, 2008; 14(1):9-12. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2008 | English | , Methodology | |
Oseltamivir and influenza-related complications, hospitalization and healthcare expenditure in healthy adults and children. | ||||
Gums JG1, Pelletier EM2, Blumentals WA3 | ||||
1University of Florida, Gainesville, FL, USA, 2IMS Health, Watertown, MA, USA, 3Roche Laboratories, Nutley, NJ, USA | ||||
Expert Opinion on Pharmacotherapy, 2008, 9(2): 1-11 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Abstract: http://www.curehunter.com/public/pubmed18201141.do | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease, Respiratory disease | 2008 | English | , Retrospective database analysis | |
An Evidence-based Approach to Improving Medication Compliance and Persistence Programs | ||||
Goldberg E1, Benner J2 | ||||
1 IMS Health, Falls Church, VA, US 2 Formerly IMS Health, Falls Church, VA, US | ||||
The Pharmaceutical Business Intelligence and Research Group - 2008 PBIRG Annual General Meeting, Washington, DC, May 18-21, 2008 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Medication compliance | 2008 | English | , Compliance | |
Medication Compliance and Persistence: Terminology and Definitions | ||||
Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, Wong PK | ||||
Value in Health 11 (1), 44–47. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Medication compliance | 2008 | English | , Cost effectiveness | |
Methods for medication compliance studies: an overview of the ISPOR medication compliance SIG guidelines | ||||
Manias E, Gwadry-Sridhar F, Benner JS, Peterson AM | ||||
ISPOR 2008 13th Annual International Congress |
||||
, Workshop | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Medication compliance | 2008 | English | , Compliance | |
Health behavior change: leading models and their practical application. | ||||
Schabert VF1, Drane A | ||||
1 IMS Health, Falls Church, VA, US | ||||
ISPOR 13th Annual International Meeting, Toronto, ON, Canada, May 3-7, 2008 ISPOR 2008 13th Annual International Congress |
||||
, Tutorial, Workshop | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Mental health, Regulatory | 2008 | English | , Methodology, Workshop | |
Got value? Determine it. Demonstrate it. Communicate it Realise it. | ||||
DeKoven M1, Hazard E1, Goldberg E1, Pokras S1 | ||||
1 IMS Health, Falls Church, VA, US | ||||
Journal of Commercial Biotechnology, 2008, 14, 299–306 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Abstract: http://www.palgrave-journals.com/jcb/journal/v14/n4/abs/jcb20087a.html | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous | 2008 | English | , Pricing & Reimbursement | |
Co-morbidities and co-medication use in epilepsy patients receiving antiepileptic treatment in a managed care setting. | ||||
Forlenza J, Yeaw J, Liu Y, Rupnow M | ||||
2 IMS Health, Watertown, MA, US | ||||
American Academy of Neurology 60th Annual Meeting, 2008, April, Chicago, IL, US |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2008 | English | , Retrospective database analysis | |
Triptan effectiveness and the impact of adding a fixed-dose combination of sumatriptan and naproxen sodium for acute migraine to a managed care plan formulary. | ||||
Smith T, Kowal-Podmore S, Runken MC | ||||
1 IMS Health, Falls Church, VA, US 2 IMS Health, Falls Church, VA, US 3 GlaxoSmithKline, Research Triangle Park, NC, US | ||||
ISPOR 13th Annual International Meeting, 2008, May, Toronto, ON, Canada |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2008 | English | , Budget impact | |
Diagnosis and treatment flows for morbidly obese patients visiting physician offices in the US | ||||
Pokras S1, Klingman D1, Tierce J1 | ||||
1 IMS Health, Falls Church, VA, US | ||||
ISPOR 2008 13th Annual International Congress |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2008 | English | , Retrospective database analysis | |
Factors Associated With Prescription Of Obesity Medications In The US. | ||||
S Pokras1, D Klingman1, J Tierce1 | ||||
1 IMS Health, Falls Church, VA,US | ||||
24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ISPE), Copenhagen, Denmark. August 19, 2008. |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2008 | English | , Retrospective database analysis | |
Poor health care behaviors among overweight individuals: opportunities for physician intervention. | ||||
Pokras SM1, Klingman D1, Annunziata K, Gupta S, Chapnick J, Tierce JC1 | ||||
1 IMS Health, Falls Church, VA, US 2 IMS Health, Falls Church, VA, US 3 Consumer Health Sciences Princeton, NJ, US 4 Consumer Health Sciences Princeton, NJ, US 5 Consumer Health Sciences Princeton, NJ, US 6 IMS Health, Falls Church, VA, US | ||||
Journal of General Internal Medicine 2008;23 (suppl 1, April); Poster presented at the 31st Annual Meeting of the Society of General Internal Medicine, Pittsburgh, PA, April 10, 2008 Society of General Internal Medicine (SGIM) 31st Annual Meeting. Pittsburgh, PA, April 2008. |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2008 | English | , Epidemiological study, Retrospective database analysis | |
Utilization & Patient Experience with Obesity Prescriptions in the US. | ||||
S Pokras1, D Klingman1, K Annunziata, J Chapnick, J Tierce1 | ||||
1 IMS Health, Falls Church, VA, US | ||||
24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ISPE), Copenhagen, Denmark. August 19, 2008 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2008 | English | , Retrospective database analysis | |
Economic Burdern of Toxicities Associated with Salvage Treatment in Advanced and Metastic Breast Cancer. | ||||
Kowal-Podmore S1, Munakata J1, Tencer T, Smith TW1 | ||||
1 IMS Health, Falls Church, VA, US | ||||
ISPOR 11th Annual European Congress, 2008, Athens, Greece; November 8-11, 2008. |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Cost analysis | |
Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a U.S. claims data analysis. | ||||
Pelletier EM1, Shim B1, Goodman S1, Amonkar MM2 | ||||
1IMS Health, Watertown, MA, USA, 2GlaxoSmithKline, Collegeville, PA, USA | ||||
Breast Cancer Research and Treatment, 2008, 108(2): 297-305 (epub 2007 Jun 19) |
||||
, Manuscript in preparation | ||||
, USA | ||||
Abstract: http://epidemiology.researchtoday.net/archive/4/2/1532.htm | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Burden of illness, Cost analysis | |
Patient out-of-pocket payments for oral oncologic therapies: results from a U.S. claims data analysis. | ||||
Pelletier EM1, Tierce J2, Reyes CM3 | ||||
1IMS Health, Watertown, MA, USA, 2IMS Health, Falls Church, VA, USA, 3Genetech Inc., South San Francisco, CA, USA | ||||
International Association for the Study of Lung Cancer (IASLC) Multidisciplinary Symposium in Thoracic Oncology, 2008, November 13-15, Chicago, IL, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Cost analysis | |
Payer costs of autologous stem cell transplant: results for a U.S. claims data analysis. | ||||
Pelletier EM1, Smith PJ1, Dembek CJ2 | ||||
1IMS Health, Watertown, MA, USA, 2Genzyme Corporation, Cambridge, MA, USA | ||||
American Society of Hematology (ASH) 50th Annual Meeting, 2008, December 6-9, San Francisco, CA, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Cost analysis | |
Utility of bortezomib retreatment in relapsed or refractory multiple myeloma patients: a multicenter case series | ||||
Wolf J, Richardson PG, Schuster M, LeBlanc A, Walters IB, Battleman DS1 | ||||
1 IMS Health, Falls Church, VA, US | ||||
Clin Adv Hematol Oncol. Oct;6(10):755-60. 2008 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Cost utility | |
Healthcare costs for rheumatoid arthritis patients treated with abatacept, infliximab, or rituximab. | ||||
Chapman RH1, Smith D, Semroc G1, Trivedi DN, Rosenblatt LR. | ||||
2 IMS Health, Falls Church, VA, USA 4 IMS Health, Falls Church, VA, USA | ||||
2008 American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, Academy of Managed Care Pharmacy’s 21st Annual Meeting, 2009, April 15-18, Orlando, FL, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2008 | English | , Retrospective cohort analysis | |
Patterns of rituximab use among patients in a managed care setting: results from a U.S. claims data analysis. | ||||
Pelletier EM1, Yu E2 | ||||
1IMS Health, Watertown, MA, USA, 2Genetech Inc., South San Francisco, CA, USA | ||||
Academy of Managed Care Pharmacy (AMCP) Educational Conference, 2008, October 15-18, Kansas City, MO, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2008 | English | , Retrospective database analysis | |
Direct medical costs for type 2 diabetes mellitus complications in the U.S. commercial payer setting. | ||||
Pelletier EM1, Smith PJ1, Boye KS2, Misurski DA2, Tunis SL3, Minshall ME3 | ||||
1IMS Health, Watertown, MA, USA, 2Eli Lilly & Company, Indianapolis, IN, USA, 3IMS Health, Noblesville, IN, USA | ||||
Applied Health Economics and Health Policy, 2008, 6(2-3): 103-112 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2008 | English | , Cost analysis | |
Cost-Effectiveness of Aliskiren in Addition to Losartan and Optimal Antihypertensive Therapy in Patients with Hypertension and Diabetic Nephropathy: A US Healthcare System Perspective | ||||
Thomas E Delea1; James L Palmer2; Lieven Annemans3; Helen Lau4; Veronica C Munk5; Jennifer Sung4; Alan Charney4; Sean D Sullivan6 | ||||
1 Policy Analysis Inc., Brookline, MA, USA; 2 IMS Health, Basel, Switzerland; 3 Ghent University, Ghent, Belgium; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA; 5 Novartis Pharma AG, Basel, Switzerland; 6 University of Washington, Seattle, WA, USA | ||||
, Poster | ||||
, USA | ||||
Abstract: N/A | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2008 | English | , Cost effectiveness | |
Impact of co-prescribed glatiramer acetate and antihistamine therapy on the likelihood of relapse among patients with multiple sclerosis. | ||||
Ollendorf DA, Castelli-Haley J, Oleen-Burkey M. | ||||
Institute for Clinical and Economic Review, Boston, MA, USA. dollendorf@icer-review.org | ||||
J Neurosci Nurs. 2008 Oct;40(5):281-90. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2008 | English | , Retrospective database analysis | |
Standardized type 2 diabetes complication costs from U.S. commercial payers to be used in modeling the long-term economic outcomes of diabetes complications. | ||||
Minshall ME1, Pelletier EM1, Smith PJ1, Forma FM2 | ||||
1IMS Health, Inc., Watertown, MA, USA, 2Eli Lilly and Company, Indianapolis, IN, USA | ||||
International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 11th Annual European Meeting. Athens, Greece, November 2008. |
||||
, Abstract, Podium presentation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2008 | English | , Retrospective cohort analysis, Retrospective database analysis | |
Utilization & Patient Experience with Obesity Prescriptions in the US. | ||||
S Pokras, D Klingman, K Annunziata, J Chapnick, J Tierce. | ||||
IMS Health; Consumer Health Sciences | ||||
24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ISPE), Copenhagen, Denmark. |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2008 | English | , Retrospective database analysis | |
Factors Associated With Prescription Of Obesity Medications In The US. | ||||
S Pokras, D Klingman, J Tierce | ||||
IMS Health | ||||
24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ISPE), Copenhagen, Denmark. August 19, 2008. |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2008 | English | , Retrospective database analysis | |
Poor health care behaviors among overweight individuals: Opportunities for physician intervention. | ||||
Pokras SM, Klingman D, Annunziata K, Gupta S, Chapnick J, Tierce J. | ||||
IMS Health, Consumer Health Sciences | ||||
Society of General Internal Medicine (SGIM) 31st Annual Meeting, Pittsburgh, PA: |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2008 | English | , Retrospective database analysis | |
Adherence to Guidelines for Use of Erythropoieses-Stimulating Agents in Patients with Chemotherapy-Induced Anemia: Results of a Retrospective Study of an Electronic Medical-Records Database in the United States, 2002-2006 | ||||
Luo, W., Nordstrom, B. L., Fraeman, K., Nordyke, R., Ranganathan, G., Linz, H. E., Winterkorn, A., Stokes, M., Ross, S. D., Knopf, K. | ||||
Clinical Therapeutics, 30(12):2423-35 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Retrospective database analysis | |
Use of Erythropoiesis-Stimulating Agents Among Chemotherapy Patients with Hemoglobin Exceeding 12 Grams Per Deciliter | ||||
Nordstrom, B. L., Luo, W., Fraeman, K. H., Whyte, J. L., Nordyke, R. J. | ||||
Journal of Managed Care Pharmacy, 14(9):858-69 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Retrospective database analysis | |
Utilization of Darbepoetin Alfa in Relation to Cancer Patients' Hemoblogin Levels | ||||
Hess, G., Hill, J., Clough, J., Hulnick, S., Nordyke, R. J. | ||||
Current Medical Research Opinion, 24(3):815-19 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Retrospective database analysis | |
The Importance of Clinical Variables for Propensity Score Matching When Comparing Costs: the Case of ESA Treatments for Chemotherapy Induced Anemia | ||||
Polsky, D., Eremina, D., Hess, G., Hill, J., Hulnick, S., Roumm, A., Whyte, J. L., Kallich, J. | ||||
Blood, 112(11):4695 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Retrospective database analysis | |
Effect of Changes in Labeling and Reimbursement on Use of ESAs and Transfusions | ||||
Hess, G., Nordyke, R. J., Pirolli, M., Hulnick, S., Curry, A., Gesme, D. | ||||
Journal of Clinical Oncology, 26:A20589) |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Retrospective database analysis | |
Red Blood Cell Transfusions Among Cancer Patients on Chemotherapy: A Descriptive Epidemiologic Study | ||||
Nordstrom, B. L., Fraeman, K. H., Luo, W., Collins, J. M., O'Malley, C. D., Nordyke, R. J. | ||||
Journal of Clinical Oncology, 26:A20623) |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Retrospective database analysis | |
Synchronization of Treatment with Erythropoiesis Stimulating Agents and Chemotherapy | ||||
Nordstrom, B. L., Fraeman, K. H., Collins, J. M., Luo, W., O'Malley, C. D., Whyte, J. L., Nordyke, R. | ||||
Journal of Managed Care Pharmacy, 14(7):694 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Retrospective database analysis | |
Red Blood Cell Transfusions Among Cancer Patients in Chemotherapy: A Descriptive Epidemiologic Study | ||||
Nordstrom, B., Fraeman, K., Luo, W., Collins, J., O'Malley, C. | ||||
Supportive Care in Cancer Journal, A41 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Retrospective database analysis | |
The Importance of Clinical Variables for Propensity Score Matching When Comparing Costs: the Case of EMA Treatments for Chemotherapy Induced Anemia | ||||
Polsky, D., Eremina, D., Hess, G., Hill, J., Hulnick, S., Roumm, A., Whyte, J., L., Kallich, J. | ||||
Blood, 112(11):4695 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Retrospective database analysis | |
Effect of Changes in Labeling and Reimbursement on Use of ESAs and Transfusions | ||||
Hess, G., Nordyke, R. J., Pirolli, M., Hulnick, S., Curry, A., Gesme, D. | ||||
Journal of Clinical Oncology, 26:A20589) |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Retrospective database analysis | |
Red Blood Cell Transfusions Among Cancer Patients on Chemotherapy: A Descriptive Epidemiologic Study | ||||
Nordstrom, B. L., Fraeman, K. H., Luo, W., Collins, J. M., O'Malley, C. D., Nordyke, R. J. | ||||
Journal of Clinical Oncology, 26:A20623 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Retrospective database analysis | |
Synchronization of Treatment with Erythropoiesis-Stimulating Agents and Chemotherapy | ||||
Nordstrom, B. L., Fraeman, K. H., Collins, J. M., Luo, W., O'Malley, C. D., Whyte, J. L., Nordyke, R. | ||||
Journal of Managed Care Pharmacy, 14(7):694 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Retrospective database analysis | |
Red Blood Cell Transfusions Among Cancer Patients in Chemotherapy: A Descriptive Epidemiologic Study | ||||
Nordstrom, B., Fraeman, K., Luo, W., Collins, J., O'Malley, C. | ||||
Supportive Care in Cancer Journal, A41 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Retrospective database analysis | |
Frequency of Self-Monitoring of Blood Glucose in Type 2 Diabetes: A Cost-Effectiveness Modeling Study in the U.S. Setting. | ||||
Erny-Albrecht KM, Tunis SL1, Minshall ME2, Valentine W, Foos V, Palmer AJ. | ||||
1 IMS Health, Falls Church, VA, US 2 Formerly of IMS Health, Falls Church, VA, US | ||||
American Diabetes Association 2007 Chicago, IL Diabetes, 2007; 56 (Suppl. 1):A308-A309. |
||||
, Abstract, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2007 | English | , Cost effectiveness | |
Long-Term CEA on Actos™ for the USA from PROactive | ||||
Palmer A, Minshall M, Valentine W, Foos V, Baran R, and Silberman C | ||||
American Diabetes Association 2007 Chicago, IL |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2007 | English | , Cost effectiveness | |
Long-Term Cost-Effectiveness Analysis on Actos™ for the USA from PROactive. | ||||
Palmer AJ, Minshall ME, Valentine WJ, Foos V, Baran RW, Silberman C. | ||||
Diabetes, 2007; 56 (Suppl. 1):A314. |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2007 | English | , Cost effectiveness | |
Cost-effectiveness of diabetes case management for low-income populations | ||||
Gilmer TP, Roze S, Valentine WJ, Emy-Albrecht K, Ray JA, Cobden D, Nicklasson L, Philis-Tsimikas A, Palmer AJ. | ||||
Health Serv Res. 2007 Oct;42(5):1943-59. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Abstract: http://findarticles.com/p/articles/mi_m4149/is_5_42/ai_n21041659 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2007 | English | , Cost effectiveness | |
Therapy conversion to insulin detemir among patients with type 2 diabetes treated with oral agents: a modeling study of cost-effectiveness in the United States. | ||||
Valentine WJ, Erny-Albrecht KM, Ray JA, Roze S, Cobden D, Palmer AJ. | ||||
Adv Ther. 2007 Mar-Apr;24(2):273-90. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17565917/ | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2007 | English | , Cost effectiveness | |
Estimating the Long-Term Cost-Effectiveness of Exenatide in the United States: an Adjunctive Treatment for Type 2 Diabetes mellitus. | ||||
Minshall ME, Oglesby AK, Wintle ME, Valentine WJ, Roze S, Palmer AJ. | ||||
Volume 11, Issue 1, Date: January/February 2008, Pages: 22-33 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Abstract: http://www.druglib.com/abstract/mi/minshall-me_value-health_20080100.html | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2007 | English | , Cost effectiveness | |
Burden of illness among commercially insured patients with Alzheimer’s disease | ||||
Joyce A1, Zhao T1, Bowman L1, Flynn J2, Carter C1, Ollendorf D1 | ||||
1 IMS Health, Watertown, USA 2 Eli Lilly & Co, Indianapolis, USA | ||||
Alzheimer’s & Dementia, 2007, 3(3): 204-210 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2007 | English | , Burden of illness | |
The Prevalence and Geographic Distribution of Crohn’s Disease and Ulcerative Colitis in the United States. | ||||
Kappelman M2, Rifas-Shiman S3, Lleinman K3, Ollendorf D1, Bousvaros A2, Grand R2, Finkelstein J3 | ||||
1 IMS Health, Watertown, USA 2 Center for Inflammatory Bowel Disease, Division of Gastroenterology and Nutrition, Children’s Hospital Boston and Harvard Medical School, Boston, USA 3 Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, USA | ||||
Clinical Gastroenterology and Hepatology, 2007, 5(12): 1424-1429 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2007 | English | , Retrospective database analysis | |
Is There Risk of MS Relapse With Concomitant use of Glatiramer Acetate and Antihistamines? | ||||
Oleen-Burkey M, Ollendorf D1, Castelli-Haley J | ||||
1 IMS Health, Watertown, USA | ||||
23rd Congress of the European Committee for Treatment and Research in Multiple Sclerosis, 2007, October 11-14, Prague, Czech Republic |
||||
, Oral presentation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2007 | English | , Retrospective database analysis | |
Risk of Renal Failure Associated with IV Bisphosphonate Use in Patients with Multiple Myeloma | ||||
Joyce A, Harrison D, Jun S, Feliu A, Anthony M | ||||
American Society of Clinical Oncology Annual Meeting, 2007, June 1-5, Chicago, USA |
||||
, Oral presentation | ||||
, USA | ||||
Abstract: http://www.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Abstracts?&vmview=abst_category_abstracts_view&confID=47&subCatID=44 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Retrospective database analysis | |
The impact of glaucoma coding in a large claims database. | ||||
Lee P, Levin L, Walt J, Chiang T, Doyle J, Stern L, Dolgitser M | ||||
American Journal of Ophthalmology, 2007, 143(5): 867-70 |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.unboundmedicine.com/medline/ebm/record/17452173/abstract/The_impact_of_glaucoma_coding_in_a_large_claims_database_ | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2007 | English | , Retrospective database analysis | |
Hospitalization risks in the treatment of bipolar disorder: comparison of antipsychotic medications. | ||||
Gianfrancesco F, Rajagopalan K, Goldberg J, Wang R | ||||
Bipolar Disord., 2007, 9(3): 252-61 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2007 | English | , Retrospective database analysis | |
A large retrospective analysis of acute urinary retention and prostate-related surgery in BPH patients treated with 5-alpha reductase inhibitors: dutasteride versus finasteride. | ||||
Issa M, Runken M, Grogg A, Shah M | ||||
Am J Manag Care., 2007; 13 Suppl 1:S10-6 |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.druglib.com/abstract/is/issa-mm_am-j-manag-care_20070200.html | ||||
Condition | Year | Language | Analysis type | |
, Urology | 2007 | English | , Retrospective database analysis | |
Differences in alpha blocker usage among enlarged prostate patients receiving combination therapy with 5 ARIs. | ||||
Naslund M, Black L, Eaddy M, Batiste L | ||||
Am J Manag Care. 2007; 13 Suppl 1:S17-22 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Retrospective database analysis | |
The contraceptive patch in relation to ischemic stroke and acute myocardial infarction. | ||||
Jick S, Jick H | ||||
Pharmacotherapy., 2007, 27(2): 218-20 |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.druglib.com/abstract/ji/jick-ss_pharmacotherapy_20070200.html | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2007 | English | , Retrospective database analysis | |
Finasteride versus dutasteride: a real-world economic evaluation. | ||||
Fenter T, Runken M, Black L, Eaddy M | ||||
Am J Manag Care., 2007, 13 Suppl 1:S23-8 |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.druglib.com/abstract/fe/fenter-tc_am-j-manag-care_20070200.html | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Retrospective database analysis | |
Descriptive analysis of the direct medical costs of multiple sclerosis in 2004 using administrative claims in a large nationwide database. | ||||
Prescott J, Factor S, Pill M, Levi G | ||||
J Manag Care Pharm., 2007; 13(1): 44-52 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2007 | English | , Retrospective database analysis | |
Reduced Mortality Rate after Intensive Statin Therapy in Managed-Care Patients. | ||||
Kuntze M, Ollendorf D | ||||
Value In Health, 2007, 10(2): 161-169 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2007 | English | , Retrospective database analysis | |
Risk of Lymphoma Following Exposure to Calcineurin Inhibitors and Topical Steroids in Patients with Atopic Dermatitis. | ||||
Arellano F, Wentworth C, Arana A, Fernandez C, Paul C | ||||
Journal of Investigative Dermatology, 2007, 127: 808–816 |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.nature.com/doifinder/10.1038/sj.jid.5700622 | ||||
Condition | Year | Language | Analysis type | |
, Dermatology | 2007 | English | , Retrospective database analysis | |
Epilepsy Diagnosis and Management. | ||||
Wilner, A | ||||
Medscape (Internet), 2007, August 13 (http://cme.medscape.com/viewarticle/560931) |
||||
, Online article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2007 | English | , Retrospective database analysis | |
Decline in Treatment of Pediatric Depression After FDA Advisory on Risk of Suicidality With SSRIs. | ||||
Libby A, Brent D, Morrato E, Orton H, Allen R, Valuck R | ||||
American Journal Psychiatry, 2007, 164(6): 884-891 |
||||
, Article | ||||
, USA | ||||
Abstract: http://ajp.psychiatryonline.org/cgi/content/full/164/6/884 | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2007 | English | , Retrospective database analysis | |
Spillover Effects on Treatment of Adult Depression in Primary Care After FDA Advisory on Risk of Pediatric Suicidality With SSRIs. | ||||
Valuck R, Libby A, Orton H, Morrato E, Allen R, Baldessarini R | ||||
American Journal Psychiatry, 2007, 164: 1198-1205 |
||||
, Article | ||||
, USA | ||||
Abstract: http://ajp.psychiatryonline.org/cgi/content/full/164/8/1198 | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2007 | English | , Retrospective database analysis | |
Characteristics and healthcare costs of patients with fibromyalgia syndrome. | ||||
Berger A1, Dukes E2, Martin S2, Edelsberg J1, Oster G1 | ||||
1 Policy Analysis Inc. (PAI), Brookline, USA 2 Pfizer, New York, USA | ||||
International Journal Clinical Practice, 2007, 61(9): 1498-1508 |
||||
, Article | ||||
, USA | ||||
Abstract: http://fmsglobalnews.wordpress.com/2007/08/26/characteristics-and-healthcare-costs-of-patients-with-fibromyalgia-syndrome-2/ | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2007 | English | , Retrospective database analysis | |
Medical costs and resource utilization for hemophilia patients with and without HIV or HCV infection. | ||||
Tencer T, Friedman H, Li-Mcleod J, Johnson K | ||||
Tencer T, Friedman HS, Li-McLeod J, Johnson K. | ||||
Journal of Managed Care Pharmacy, 2007, 13(9): 790-8 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2007 | English | , Retrospective database analysis | |
The Prevalence and Geographic Distribution of Crohn's Disease and Ulcerative Colitis in the United States. | ||||
Kappelman M, Rifas-Shiman S, Kleinman K, Ollendorf D, Bousvaros A, Grand R, Finkelstein J | ||||
Clinical Gastroenterology and Hepatology, 2007, 5(12): 1424-9 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2007 | English | , Retrospective database analysis | |
Inpatient use of enoxaparin reduces hospital-based treatment costs associated with VTE treatment. | ||||
Merli G, Ferrufino C, Lin J, Hussein M, Battleman D | ||||
Annual meeting ASH, Atlanta, GA, December 2007 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2007 | English | , Economic evaluation | |
Clinical and economic burden of nonadherence to lipid-lowering and antihypertensive therapy in a hypertensive population | ||||
Cherry SB, Benner JS, Hussein MA, Tang SK, Nichol MB | ||||
ISPOR 12th Annual International Meeting, May 19-23, 2007, Arlington, Virginia, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2007 | English | , Cost effectiveness | |
Clinical and economic consequences of a single-pill combination of amlodipine/atorvastatin compared with a two-pill regimen in hypertensive patients with additional cardiovascular risk factors | ||||
Smith TW, Cherry SB, Tang SSK, Benner JS | ||||
Presented at the European Society of Cardiology Congress 2007, Vienna, Austria, September 1-5th, 2007 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2007 | English | , Cost effectiveness | |
Clinical and Economic Outcomes of Amlodipine/Atorvastatin Single-Pill Formulation in a Hypertensive Population | ||||
Smith TW, Cherry SB, Tang SSK, Benner JS | ||||
American Heart Association's 8th Annual Scientific Forum ON Quality OF Care AND Outcomes Research IN Cardiovascular Disease AND Stroke, Washington, DC, May 9-11th, 2007 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2007 | English | , Cost effectiveness | |
Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in United States managed care enrollees? | ||||
Hussein MA, Chapman RH, Benner JS, Tang SSK, Solomon HA, Joyce A, Foody J | ||||
Journal of the American College of Cardiology 2007; 49(9SupplA):288A; American College of Cardiology 56th Annual Scientific Session, New Orleans, LA, March 24-27, 2007; |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2007 | English | , Retrospective cohort analysis | |
Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrollees? | ||||
Hussein MA, Chapman RH, Benner JS, Tang SSK, Solomon HA, Joyce A, Foody J | ||||
American Society of Hypertension 22nd Annual Scientific Meeting and Exposition, Chicago, IL, May 19-22, 2007 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2007 | English | , Retrospective cohort analysis | |
Translating Research into Action: Use of Premier Perspective™ transactional data to reduce hospital-based costs for the treatment and prevention of venous thromboembolism. | ||||
David S. Battleman1 | ||||
1 IMS Health, Falls Church, VA, US | ||||
2007 Premier Breakthrough Leadership Conference, June 21-22nd, Orlando, Florida |
||||
, Keynote address | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2007 | English | , Burden of illness | |
Venous Thromboembolism (VTE) Treatment With Low Molecular Weight Heparin Reduces Total Hospital Costs And Vte-Related Readmission. | ||||
Merli G, Ferrufino C, Lin J, Hussein M, Battleman D | ||||
American Heart Association Quality of Care and Outcomes Research Conference, 2007, May 9-11, Washington, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2007 | English | , Economic evaluation | |
Application of Cost-Effectiveness Analysis to Evaluate the Proposed Formulary Status of a Novel Antidiabetic Drug in a U.S. Commercial Health Plan. | ||||
Watkins J, Minshall M, Sullivan SD. | ||||
Value in Health, 2007; 10(3):A198. |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2007 | English | , Cost effectiveness | |
Health-related quality of life and utilities of respondents with type 2 diabetes compared with those with differing levels of cardiometabolic risk | ||||
Chapman RH, Fox KM, Grandy S | ||||
Value in Health 2007; 10(3):A69 ISPOR 12th Annual International Meeting, Arlington, VA, May 19-23, 2007 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2007 | English | , Survey research | |
Impact of obesity on work productivity among individuals with type 2 diabetes mellitus and varied levels of cardiometabolic risk | ||||
Stewart WF, Chapman RH, Gavin JR, Fox KM, Grandy S | ||||
Accepted at 67th Scientific Sessions of American Diabetes Association, Chicago, IL, June 22-26, 2007 |
||||
, Poster | ||||
, USA | ||||
Abstract: http://professional.diabetes.org/Abstracts_Display.aspx?TYP=1&CID=54373 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2007 | English | , Survey research | |
Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US. | ||||
Ray JA, Valentine WJ, Roze S, Nicklasson L, Cobden D, Raskin P, Garber A, Palmer AJ. | ||||
Diabetes Obes Metab. 2007 Jan;9(1):103-13. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Abstract: http://www.druglib.com/abstract/ra/ray-ja_diabetes-obes-metab_20070100.html | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2007 | English | , Cost effectiveness | |
Proposed Formulary Status of a Novel Antidiabetic Drug in a U.S. Commercial Health Plan. | ||||
Watkins J, Minshall M, Sullivan SD. Application of Cost-Effectiveness Analysis to Evaluate the | ||||
Value in Health, 2007; 10(3):A198. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2007 | English | ||
The Cost-Effectiveness of Pioglitazone Compared with Sitagliptin: an Economic Evaluation Using a Validated Economic Model from a Third Party Payer Perspective in the USA | ||||
Minshall ME, Donovan ME, Pandya BJ, Baran RW, Bron MS | ||||
ISPOR 2007 10th Annual European Congress |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2007 | English | , Cost effectiveness | |
The Cost-Effectiveness of Pioglitazone Plus Metformin Compared with Rosiglitazone Plus Metformin: an Economic Evaluation Using a Previously Validated Economic Model from a Third Party Payer Perspective in the USA | ||||
Minshall ME, Donovan ME, Pandya BJ, Baran RW | ||||
Diabetes Technology Society. October, 2007 USA |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2007 | English | , Cost effectiveness | |
The relationship of body mass index to diabetes, hypertension, and dyslipidemia: Comparison of data from two national surveys | ||||
Bays HE, Chapman RH, Grandy S for the SHIELD Investigators’ Group | ||||
International Journal of Clinical Practice 2007; 61(5):737-747 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2007 | English | , Survey research | |
Treatment failures in type 2 diabetes patients taking oral anti-diabetes drugs | ||||
Chapman R, Ferrufino C, Maclean JR, Krishnarajah G | ||||
American Diabetes Association’s 68th Scientific Sessions, San Francisco, CA, June 6-10, 2008 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2007 | English | , Retrospective cohort analysis | |
The spectrum OF health care costs associated WITH herpes zoster: acute pain vs. postherpetic neuralgia | ||||
Hawkins K, White R, Dworkin R, O'connor A, Baser O | ||||
ISPOR 12th Annual International Meeting, May 19-23, 2007 |
||||
, Poster | ||||
, USA | ||||
Abstract: http://www.ispor.org/research_study_digest/details.asp | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2007 | English | ||
A checklist for medication compliance and persistence studies using retrospective databases. | ||||
Peterson AM, Nau DP, Cramer JA, Benner J, Gwadry-Sridhar F, Nichol M. | ||||
Value in Health. 2007;10(1):3-12 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Medication compliance | 2007 | English | ||
Adherence to antihypertensive therapy | ||||
JoAnne M. Foody, Joshua S. Benner, William Frishman | ||||
THE JOURNAL OF CLINICAL HYPERTENSION VOL. 9 NO. 4 APRIL 2007 |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.unboundmedicine.com/medline/ebm/record/17396070/abstract/Adherence | ||||
Condition | Year | Language | Analysis type | |
, Medication compliance | 2007 | English | ||
Treatment persistence and compliance with Galantamine ER | ||||
Yeaw J, Crivera C, Rupnow M, Ollendorf D | ||||
ISPOR 12th Annual International Meeting, May 19-23, 2007 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Medication compliance | 2007 | English | ||
An Examination of Factors Affecting Persistence with Initial Antipsychotic Treatment in Patients with Schizophrenia | ||||
Tunis SL, Faries DE, Stensland MD, Hay DP, and Kinon BJ | ||||
Current Medical Research and Opinion 2007 Jan; Vol 23 (1): 97-104 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Abstract: http://www.druglib.com/abstract/tu/tunis-sl_curr-med-res-opin_20070100.html | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2007 | English | ||
Can you hear me now? Techniques for effectively communicating value to internal and external decision makers. | ||||
Jonothan Tierce , Claude LePen , Adrian Kielhorn , Elisabeth Hazard | ||||
ISPOR 2007 10th Annual European Congress |
||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2007 | English | ||
The impact of different resource cost definitions on results, interpretations, and comparability of health economic studies | ||||
Tunis SL1, Pelletier EM2, St. Charles M1, McEwan P3. | ||||
1IMS Health, Noblesville, IN, USA, 2IMS Health, Watertown, MA, USA, 3Cardiff Medicentre, University Hospital of Wales, Cardiff, UK | ||||
ISPOR 10th Annual European Meeting, 2007, October, Dublin, Ireland |
||||
, Workshop | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Methodology | 2007 | English | , Methodology, Retrospective database analysis | |
Association of long-term migraine preventive medication use and resource utilization/productivity loss: results from the American Migraine Prevalence and Prevention (AMPP) Study | ||||
Munakata J, Hazard E, Tierce J, Rupnow MFT, Serrano D, Reed M, Lipton RB | ||||
ISPOR 12th Annual International Meeting, May 19-23, 2007, Arlington, Virginia, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2007 | English | ||
Economic burden of brain metastases in breast cancer patients in a U.S. managed-care population. | ||||
Amonkar MM1, Pelletier EM2, Shim B2 | ||||
1GlaxoSmithKline, Collegeville, PA, USA, 2IMS Health, Watertown, MA, USA | ||||
American Society of Clinical Oncology (ASCO) 43rd Annual Meeting, 2007, June, Chicago, IL, USA Journal of Clinical Oncology, 2007, Part I. Vol 25, No 18S (June 20 Supplement): 17069 |
||||
, Poster | ||||
, USA | ||||
Abstract: http://www.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Abstracts?&vmview=abst_detail_view&confID=47&abstractID=33687 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Cost analysis | |
Incidence and prevalence of brain metastases among patients with advanced breast cancer in a U.S. managed-care population | ||||
Pelletier EM1, Amonkar MM2, Shim B1 | ||||
1IMS Health, Watertown, MA, USA, 2GlaxoSmithKline, Collegeville, PA, USA | ||||
American Society of Clinical Oncology (ASCO) 43rd Annual Meeting, 2007, June, Chicago, IL, USA |
||||
, Poster | ||||
, USA | ||||
Abstract: http://www.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Abstracts?&vmview=abst_detail_view&confID=47&abstractID=33687 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Epidemiological study | |
Reduction in the risk of pneumonia and otitis media following oseltamivir use for influenza - results from a health claims database (2001-2006) | ||||
Pelletier EM1, Blumentals WA2 | ||||
1IMS Health, Watertown, MA, USA, 2Roche Laboratories, Nutley, NJ, USA | ||||
American College of Emergency Physicians (ACEP) Scientific Assembly, 2007, October, Seattle, WA, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease, Respiratory disease | 2007 | English | , Burden of illness | |
Sub-acute lack of asthma control and subsequent acute asthma exacerbations: evidence from managed care data | ||||
Klingman D, Gutierrez B, Burudpakdee C, Wagner S | ||||
ISPOR 2007 10th Annual European Congress |
||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2007 | English | ||
Impact of oseltamivir for the treatment of influenza on secondary complications and healthcare costs. | ||||
Gums J1, Pelletier EM2, Blumentals WA3 | ||||
1University of Florida, Gaineville, FL, USA, 2IMS Health, Watertown, MA, USA, 3Roche Laboratories, Nutley, NJ, USA | ||||
American College of Clinical Pharmacy (ACCP) Annual Meeting, 2007, October, Denver, CO, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease, Respiratory disease | 2007 | English | , Burden of illness, Cost analysis | |
The impact of different resource cost definitions on results, interpretations, and comparability of health economic studies. | ||||
Tunis SL1, Pelletier EM1, St. Charles M1, McEwan P2 | ||||
1IMS Health, Inc., Watertown, MA, USA, 2 | ||||
International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 10th Annual European Meeting, Dublin, Ireland, October 2007 |
||||
, Workshop | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Methodology, Miscellaneous | 2007 | English | , Retrospective database analysis | |
The Utilization of Darbepoetin Alfa (DA) in Relation to Cancer Patients' Hemoglobin Levels | ||||
Hess, G., Hill, J., Hulnick, S., Nordyke, R. | ||||
Blood, 110(11):3756 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Retrospective database analysis | |
Adherence to Guidelines for Use of Erythropoiesis Stimulating Proteins in Patients with Chemotherapy-Induced Anemia: Trends from Electronic Medical Records | ||||
Luo, W., Nordstrom, B., Ranganathan, G., Fraeman, K., Linz, H., Stokes, M., Knopf, K., Ross, S. | ||||
Supportive Care in Cancer, 15(6):757 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Retrospective database analysis | |
Use Patterns of Erythropoiesis Stimulating Agent in Electronic Medical Records of Cancer Patients | ||||
Hess, G. P., Hulnick, S. A., Kallich, J. D., Whyte, J. L. | ||||
Supportive Care in Cancer, 15(6):758 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Retrospective database analysis | |
The Utilization of Darbepoetin Alfa (DA) in Relation to Cancer Patients' Hemoglobin Levels | ||||
Hess, G., Hill, J., Hulnick, S., Nordyke, R. | ||||
Blood, 110(11):3756 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Retrospective database analysis | |
Adherence to Guidelines for Use of Erythropoiesis Stimulating Proteins in Patients with Chemotherapy-Induced Anemia: Trends from Electronic Medical Records | ||||
Luo, W., Nordstrom, B., Ranganathan, G., Fraeman, K., Linz, H., Stokes, M., Knopf, K., Ross, S. | ||||
Supportive Care in Cancer, 15(6):757 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Retrospective database analysis | |
Use Patterns of Erythropoiesis Stimulating Agent in Electronic Medical Records of Cancer Patients | ||||
Hess, G. P., Hulnick, S. A., Kallich, J. D., Whyte, J. L. | ||||
Supportive Care in Cancer, 15(6):758 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Retrospective database analysis | |
Self monitoring of blood glucose in patients with type 2 diabetes: cost utility analysis in a United States third-party payer setting | ||||
Palmer AJ, Minshall ME, Valentine WJ, Foos V, Tunis SL | ||||
, Oral presentation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2006 | English | , Cost utility | |
Assessment of Subacute Lack of Asthma Control in a Real-World Setting Over 4 Years. | ||||
Long A, Bleecker E, O’Connor R, Tashkin D, Peters S, Silkoff P, Parasuraman B, Boggs R | ||||
American Thoracic Society (ATS), 2006, May 19-24, San Diego, USA |
||||
, Oral presentation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2006 | English | , Retrospective database analysis | |
Assessment of Severe and Nonsevere Asthma in a Real-World Setting Over 4 Years. | ||||
Bleecker E, Tashkin D, Peters S, Long A, O’Connor R, Parasuraman B, Boggs R | ||||
American Thoracic Society (ATS), 2006, May 19-24, San Diego, USA |
||||
, Oral presentation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2006 | English | , Retrospective database analysis | |
Assessment of asthma exacerbations in a real-world setting over 4 years. | ||||
O’Connor R, Tashkin D, Peters S, Long A, Bleecker E, Parasuraman B, Boggs R | ||||
American Academy of Allergy, Asthma and Immunology, Miami Beach, USA |
||||
, Oral presentation, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2006 | English | , Retrospective database analysis | |
Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch. | ||||
Jick S, Jick H | ||||
Contraception, 2006, 74(4): 290-2 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2006 | English | , Retrospective database analysis | |
Antirheumatic drugs and the risk of tuberculosis. | ||||
Brassard P, Kezouh A, Suissa S | ||||
Clin Infect Dis., 2006, 43(6):717-22 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2006 | English | , Retrospective database analysis | |
Antirheumatic drug use and the risk of acute myocardial infarction. | ||||
Suissa S, Bernatsky S, Hudson M | ||||
Arthritis Rheum., 2006; 55(4): 531-6 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2006 | English | , Retrospective database analysis | |
Overlap of anxiety and depression in a managed care population: Prevalence and association with resource utilization. | ||||
McLaughlin T, Khandker R, Kruzikas D, Tummala R | ||||
J Clin Psychiatry., 2006, 67(8): 1187-93 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2006 | English | , Retrospective database analysis | |
Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis. | ||||
Suissa S, Hudson M, Ernst P | ||||
Arthritis Rheum., 2006, 54(5): 1435-9 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2006 | English | , Retrospective database analysis | |
Administrative claims analysis of asthma-related health care utilization for patients who received inhaled corticosteroids with either montelukast or salmeterol as combination therapy. | ||||
Allen-Ramey F, Bukstein D, Luskin A, Sajjan S, Markson L | ||||
J Manag Care Pharm., 2006, 12(4): 310-21 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2006 | English | , Retrospective database analysis | |
Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol. | ||||
Jick S, Kaye J, Russmann S, Jick H | ||||
Contraception., 2006, 73(3):223-8 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2006 | English | , Retrospective database analysis | |
Moxifloxacin versus levofloxacin for treatment of acute rhinosinusitis: a retrospective database analysis of treatment duration, outcomes, and charges. | ||||
Keating K, Friedman H, Perfetto E | ||||
Curr Med Res Opin., 2006, 22(2): 327-33 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2006 | English | , Retrospective database analysis | |
Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome. | ||||
MacDougall D, Feliu A, Boccuzzi S, Lin J | ||||
Am J Health Syst Pharm., 2006; 63(20 Suppl 6): S5-15 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2006 | English | , Retrospective database analysis | |
Infliximab Drug and Infusion Costs Among Patients with Crohn’s Disease in a Commercially-Insured Setting. | ||||
Ollendorf D, Lidsky L | ||||
American Journal of Therapeutics, 2006, 13(6): 502-506 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2006 | English | , Retrospective database analysis | |
Risk of nonfatal thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 ug of ethinyl estradiol. | ||||
Jick SS, Kaye JA, Russmann S, Jick H | ||||
Contraception, 2006, 73: 223-228 Contraception; 73:223-228 |
||||
, Article, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Womens Health | 2006 | English | , Retrospective database analysis | |
Risk Evaluation and Communication Health Outcomes Utilization Trial (REACH OUT) | ||||
Benner JS, Cherry SB, Erhardt L, Moller RA, Rajicic N, Gaciong Z et al | ||||
European Society of Cardiology Congress , Vienna, Austria, September 3, 2007 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2006 | English | , Economic evaluation | |
Assessing health state utilities in elderly patients at cardiovascular risk. | ||||
Winkelmayer WC, Benner JS, Glynn RJ, Schneeweiss S, Wang PS, Brookhart MA, Levin R, Jackson JD, Avorn J | ||||
Med Decis Making 2006;26:247-254. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2006 | English | ||
Clinical burden of non-adherence in patients with hypertension and multiple risk factors. | ||||
Hussein MA, Cherry SB, Nichol MB, Tang S, Benner JS. | ||||
International Society of Hypertension (ISH 2006).October, 2006. Fukuoka, Japan. |
||||
, Oral presentation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2006 | English | ||
Impact of pill burden on adherence to antihypertensive and lipid-lowering therapy. | ||||
Benner JS, Petrilla AA, Schwartz JS, Rosenberg N, Chapman RH, Tang S. | ||||
Journal of Clinical Hypertension 2006; 8(5SupplA):A214. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2006 | English | ||
Inpatient Use Of Low Molecular Weight Heparin (Lmwh) Reduces Hospital-Based Treatment Costs Associated With Venous Thromboembolism (Vte) Prophylaxis | ||||
Ferrufino CP1, Lin J2, Hussein MA1, Battleman DS1 | ||||
1 IMS Health, Falls Church, VA, USA 2 Sanofi Aventis, NJ, USA | ||||
Society of General Internal Medicine 30th Annual Meeting, April 25-28, 2007, Toronto, Canada |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2006 | English | , Cost effectiveness | |
Knowledge, attitudes, and behavior of individuals with multiple cardiovascular risk factors: Data from the Study to Help Improve early Evaluation and management of risk factors Leading to Diabetes (SHIELD). | ||||
Lewis SJ, Chapman R, Grandy S, for the SHIELD Study Group. | ||||
4th World Congress on Insulin Resistance Syndrome, Las Vegas, NV, October 5-7, 2006. |
||||
, Oral presentation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2006 | English | ||
Medical resource utilization in non-hemorrhagic stroke in a commercially-insured US population. | ||||
McCollam PL, Ollendorf DA, Dennett SL | ||||
International Stroke Conference Kissimee, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2006 | English | ||
Patterns and predictors of adherence to concomitant antihypertensive and lipid-lowering medication in elderly patients. | ||||
Petrilla AA, Chapman RH, Rosenberg N, Benner JS, Schwartz JS, Tang S. | ||||
Journal of Clinical Hypertension 2006; 8(5SupplA):A143-A144. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2006 | English | ||
Patterns and predictors of adherence to concomitant antihypertensive and lipid-lowering medications in elderly patients. | ||||
Chapman RH, Petrilla AA, Benner JS, Schwartz JS, Tang S. | ||||
Circulation 2006; 113(21):13. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2006 | English | , Retrospective database analysis | |
Patterns and predictors of concomitant statin use in patients initiating antihypertensive therapy. | ||||
Chapman RH, Petrilla AA, Berman L, Benner JS, Tang S. | ||||
Journal of Clinical Hypertension 2006; 8(5SupplA):A214-A215. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2006 | English | ||
Prevalence of dyslipidemia estimated from a self-reported survey versus clinical and laboratory evaluation: Comparison of SHIELD and NHANES data. | ||||
Bays HE, Chapman RH, Grandy S, and SHIELD Study Group. | ||||
XIV International Symposium on Atherosclerosis, Rome, Italy, June 18-22, 2006. |
||||
, Oral presentation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2006 | English | ||
Short-term clinical consequences of nonadherence in patients hypertension and multiple risk factors. | ||||
Cherry SB, Hussein MA, Nichol MB, Tang SS, Benner JS. | ||||
Circulation 2006; 114(18 Suppl II):II-906. |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2006 | English | ||
Therapeutic goal attainment in patients with hypertension and dyslipidemia. | ||||
Johnson ML, Pietz K, Battleman DS, Beyth RJ. | ||||
Medical Care. 2006 Jan;44(1):39-46. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2006 | English | ||
Factors predicting healthcare professional consultation regarding symptoms of overactive bladder. | ||||
Nichol MB, Brubaker L, Fanning T, Hussein M, Becker R, Benner J, Jumadilova Z. | ||||
Internation Society for pharmacoeconomics and outcomes research (ISPOR 2007). May 20-24, 2006. Philadelphia, PA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice | 2006 | English | ||
Diabetes symptoms reported in SHIELD by people with or at high risk for type 2 diabetes. | ||||
Clark N, Chapman R, Grandy S, for the SHIELD Study Group. | ||||
American Diabetes Association’s 66th Scientific Sessions, Washington, DC, June 9-13, 2006. |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2006 | English | ||
High prevalence of misdiagnosis of the metabolic syndrome in a self-reported survey: Possible confusion with having “a metabolism problem”. | ||||
Bays H, Chapman R, Klingman D, Fanning K, Grandy S. | ||||
2006 Annual Scientific Meeting of NAASO, the Obesity Society, Boston, MA, October 20-24, 2006. |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2006 | English | ||
Identifying high-risk populations in SHIELD with a 12-item screener questionnaire. | ||||
Grandy S, Reed M, Chapman R, for the SHIELD Study Group. | ||||
American Diabetes Association’s 66th Scientific Sessions, Washington, DC, June 9-13, 2006. |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2006 | English | ||
Modelling the effectiveness of oral agents in achieving HbAlc and lipid targets in patients with type 2 diabetes mellitus. | ||||
Lloyd AC1, Smith TW2, Bergenheim K3. | ||||
1 Fourth Hurdle Consulting Ltd, London, UK 2ValueMedics Research LLC, Falls Church, VA, USA, 3AstraZeneca, Mölndal, Sweden | ||||
ISPOR 11th Annual International Meeting, Philadelphia, May 20th - 24th, 2006 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2006 | English | , Cost effectiveness | |
Overlapping cardiovascular risk factors in the United States adult diabetes population: Data from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes. | ||||
Stewart W, Clark N, Ansell B, Reed ML, Chapman R, Grandy S, for the SHIELD Study Group. | ||||
Circulation 2006; 113(21):44. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2006 | English | ||
Quality of life in people with and at risk for type 2 diabetes: Findings from the Study to Help Improve early Evaluation and management of risk factors Leading to Diabetes (SHIELD). | ||||
Chapman RH, Grandy S. | ||||
ISPOR 11th Annual International Meeting, Philadelphia, PA, May 20-24, 2006. |
||||
, Oral presentation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2006 | English | ||
Infliximab Drug and Infusion Costs Among Patients with Crohn's Disease IN a Commercially-Insured Setting. | ||||
Ollendorf DA, Lidsky L. | ||||
American Journal OF Therapeutics 2006;13:502-506. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2006 | English | ||
The Role of Pharmacoeconomics in US Managed Care Formulary Decisions: A Case Study | ||||
Minshall M | ||||
Pharma Pricing & Reimbursement, February 2007, pp46-50 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2006 | English | ||
Clinical and economic outcomes of nonadherence to highly active antiretroviral therapy in patients with HIV. | ||||
Munakata J, Benner JS, Becker SL, Dezii CM, Hazard EH, Tierce JC. | ||||
Medical Care 2006;44(10):893-899. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, HIV AIDS | 2006 | English | ||
Evaluation of a HCV Patient Support Program’s Impact on Patient Adherence. | ||||
M. Hussein, J. S. Benner, D. Lee, and others. Evaluation of a HCV Patient Support Program’s Impact on Patient Adherence. (Oral Presentation). Digestive Disease Week 2006 (DDW 2006). May 20-25, 2006. Los Angeles, CA. | ||||
Digestive Disease Week 2006 (DDW 2006). May 20-25, 2006. Los Angeles, CA. |
||||
, Oral presentation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, HIV AIDS | 2006 | English | ||
Evaluation of a program to improve adherence with pegylated interferon therapy: a propensity score matched retrospective cohort analysis. | ||||
Mohamed Hussein, Joshua S. Benner, David Lee, Anne-Marie Sesti, David S. Battleman. | ||||
Internation Society for pharmacoeconomics and outcomes research (ISPOR 2007). May 20-24, 2006. Philadelphia, PA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, HIV AIDS | 2006 | English | ||
The incidence and healthcare cost of genital warts in a commercially insured population in the United States | ||||
Schabert VF, Singhal, PK, Ye X | ||||
America’s Health Insurance Plans 2007 Medical Leadership Forum, Phoenix, AZ |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2006 | English | , Burden of illness | |
Effect of Initial Ziprasidone Dose on Length of Therapy in Schizophrenia. | ||||
Joyce AT, Harrison DJ, Loebel AD, Carter CT, Ollendorf DA. | ||||
Schizophrenia Research 2006;83(2-3):285-292. Schizophrenia Research, 2006, 83(2-3): 285-292 |
||||
, Article, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2006 | English | , Retrospective database analysis | |
Designing and developing budget impact models suited for global adaptation. | ||||
Smith TW, Tierce JC. | ||||
ISPOR Connections. 2006; 12(4). |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2006 | English | ||
A clinical tool for the indication of spine X-rays in postmenopausal women with osteoporosis presenting with back pain. | ||||
Roux C, Priol G, Fechtenbaum J, Cortet B, Liu-Leage S, Audran M. | ||||
Ann Rheum Dis. 2006 Jun 22. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2006 | English | ||
An examination of factors affecting persistence with initial antipsychotic treatment in patients with schizophrenia | ||||
Tunis SL, Faries DE, Stensland MD, Hay DP, Kinon BJ | ||||
Current medical research and opinion Vol. 23, No. 1, 2007, 97-104 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2006 | English | ||
Diagnosis and treatment flows for morbidly obese patients visiting physician offices in the US | ||||
Pokras SM, Klingman D, Tierce JC | ||||
Value in Health 2008;11,3 (May/June);Poster presented at the 13th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Toronto, Ontario, Canada, May 3-7, 2008 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2006 | English | , Retrospective database analysis | |
“Overactive bladder symptom bother is more prevalent in men than women at older ages.” | ||||
Albo M, Rovner E, Mullins C, Becker R, Jumadilova Z, Benner J. | ||||
American Urology Association Western Section Meeting, October 2006 |
||||
, Oral presentation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Overactive bladder | 2006 | English | , Epidemiological study | |
“Patient-Reported Reasons for Discontinuing Overactive Bladder (OAB) Medications.” | ||||
Brubaker L, Nichol M, Fanning T, Becker R, Jumadilova Z, Benner J | ||||
Annual International Continence Society Meeting, November 2006. |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Overactive bladder | 2006 | English | ||
Comparing overall treatment costs of OROS MPH and immediate-release MPH in the treatment of children with ADHD | ||||
Becker RV, Battleman DS, Zhang HF | ||||
Academy of Managed Care Pharmacy 19th Annual Meeting, San Diego, California, April 11-14th, 2007 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Pediatrics | 2006 | English | , Cost effectiveness | |
Ensuring Access for Specialty Pharmaceuticals through Payer Education. | ||||
Dekoven MP, Marlo K, Robinson S. | ||||
Specialty Pharma. 2006 Jan/Feb; 2(1): 62-65. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Pricing and reimbursement | 2006 | English | ||
Medicare Part D Reimbursement Hotlines: Just What the Doctor Ordered. | ||||
Braun L, DeKoven MP, De Masi C, Maltz J, Ross H. | ||||
Product Management Today. 2006 September; 17(9): 34-36, 38-39 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Pricing and reimbursement | 2006 | English | ||
Prevalence of Depressive Symptoms in Postmenopausal Women with Low Bone Mineral Density and/or Prevalent Vertebral Fracture: Results from the Multiple Outcomes of Raloxifene Evaluation (MORE) Study. | ||||
Silverman SL, Shen W, Minshall ME, Xie S, and Moses KH. | ||||
The Journal of Rheumatology, 2007; 34(1):140-144. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2006 | English | , Epidemiological study | |
An Examination of Treatment Patterns and Costs of Care Among Patients with Benign Prostatic Hyperplasia. | ||||
Black L, Naslund MJ, Gilbert TD Jr, Davis EA, Ollendorf DA. | ||||
The American Journal of Managed Care 2006;12(4):S99-S110. The American Journal of Managed Care, 2006, 12(4): S99-S110 |
||||
, Article, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Urology | 2006 | English | , Retrospective database analysis | |
Retrospective Evaluation of Outcomes in Patients with Overactive Bladder Receiving Tolterodine Versus Oxybutynin. | ||||
Jumadilova Z, Varadharajan S, Girase P, Ollendorf DA. | ||||
American Society of Health-System Pharmacists, 2006, 63(23): 2357-64 American Society of Health-System Pharmacists, Inc 2006;63:2357-2364. |
||||
, Article, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Urology | 2006 | English | , Retrospective database analysis, Review | |
Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations Implications for COX-2 cardiovascular profile | ||||
Arellano FM, Yood MU, Wentworth CE, Oliveria SA, Rivero E, Verma A & Rothman KJ | ||||
Risk Management Resources, LLC Bridgewater | ||||
Pharmacoepidemiol Drug Saf. 2006 Dec;15(12):861-72. |
||||
, Abstract | ||||
, UK, USA | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17086563 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Miscellaneous, Pain | 2006 | English | , Retrospective database analysis | |